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ABSTRACT 
 
 
Sulphathiazole is a highly polymorphic model system exhibiting at least five polymorphic forms: 
I, II, III, IV, and V. Polymorph stability is known to be susceptible to solvent environment, and it 
is established that 1-propanol stabilizes the most metastable form I. This study examines the 
effect of a range of alcohols on polymorph selection and attempts to elucidate the mechanism. 
The role of the alcohol functional group in the polymorph selection process is thus investigated 
and evaluated. Crystals were characterized using optical microscopy, SEM, PXRD, DSC, IR, and 
single-crystal X-ray diffraction for their polymorphic identity. The role of solvent in the 
stabilization of polymorphs was investigated by visualizing and calculating energy requirements 
for the interaction of each solvent molecule with α- and ȕ-dimers of sulphathiazole, using 
Cerius2 modeling software and GRID based systematic search simulation. These studies showed 
that solvent had a significant impact on polymorph selection. In common with 1-propanol, 1-
butanol was found to stabilize form I by inhibiting the formation of the ȕ-dimer, which is 
necessary for nucleation of and transformation to forms II-IV. Shorter chain alcohols and 
branched chain alcohols such as methanol, 2-propanol, and ethanol did not stabilize form I but 
stabilized forms II, III, and IV, respectively, showing that it is not only the alcohol functionality 
but also the steric effects of the alkyl chain that contributed to the effect. Sulphathiazole form I 
normally has a needlelike morphology. Form I with a modified rodlike morphology was 
produced by crystallization from 1-propanol with the addition of methanol in low concentration, 
showing that it is possible to control the morphology and selectively isolate polymorphs. 
 
Indomethacin is known to exhibit at least five polymorphs but only the stable Ȗ Form and 
metastable α Form are reported to be reliably produced by standard methods. The metastable α 
Form has an undesirable fibrous needle-like morphology. The current study focused on 
producing crystals of α Indomethacin with a well-defined morphology using additives. Adipic 
acid, myristic acid, oleic acid and structurally related 3-indoleacetic acid were selected as 
additives and their impact on the morphology and polymorphism of indomethacin were 
investigated in this study. Additives did not change the needle-like morphology of α-
indomethacin but less fibrous and less aggregated well defined needles were observed in 
presence of adipic acid, oleic acid and 3-indole-3-acetic acid. 
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1 Introduction  
 
1.1 Introduction 
 
Most solid drugs can be classified as either crystalline solids, which have regular 
arrangements of molecules that repeat in three dimensions, or amorphous solids, 
which lack the long range order present in crystals. These differences in the long-
range periodicity of the structures result in substantially different physical and 
chemical properties of crystals and amorphous solids. Amorphous forms are not 
marketed as widely as crystalline forms because of their innate tendency to 
crystallize. Many marketed pharmaceuticals therefore consist of solid molecular 
crystal forms (Datta et al, 2004). 
 
The arrangement of the molecules in a crystal determines its physical properties and, 
in certain cases, its chemical properties. These properties of the solid drug can 
influence its manufacturing process as well as its efficiency. A thorough 
understanding of the relationships between physical structures and the properties of 
pharmaceutical solids is therefore important in selecting the most suitable form of an 
active pharmaceutical ingredient (API) for development into a drug product. 
 
Pharmaceutical materials can show polymorphism, which occurs when the molecule 
packs in different ways giving rise to two or more crystal structures and is defined as 
the ability of a substance to exist as two or more crystalline phases that have different 
arrangements and/or conformations of the molecules in the crystal lattice (Giron, 
2001). Polymorphs can exhibit different mechanical, thermal, and physical properties, 
such as compressibility, filtration, solubility, bioavailability and tableting properties, 
which can impact on the efficacy of the final drug product (Byrn et al, 2002). So, it is 
necessary to design a crystallization process where the desired polymorph must be 
reproducible with consistent morphology. 
 
Control over the generation of polymorphs, morphology, and particle size can be 
achieved in the final drug product with knowledge of techniques in crystal and 
nucleation engineering. The ability to engineer nucleation and crystallization 
behaviour comes from changes to molecule-to-molecule interactions by either 
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manipulation of solution parameters or by the molecular recognition of structurally 
related additives (Weissbuch et al, 2001). 
 
In this study, sulphathiazole and indomethacin have been selected as model 
pharmaceutical solids to observe the effect of solvents, pH and temperature on the 
polymorphs of these compounds. The study investigates the control over 
polymorphism and morphology using sulphathiazole and indomethacin as model 
compounds.  
 
1.2  Crystal structure 
 
An ensemble of randomly organized molecules, ions or atoms in a fluid comes 
together to form an ordered three-dimensional molecular array, which is termed a 
crystal (Davey and Garside, 2000). The arrangement of these molecules in a crystal 
determines its physical and chemical properties (Kitamura, 2002). Therefore, an 
understanding of the crystalline state would lead to an understanding of the drug 
properties to some extent.  
 
In the crystal (crystalline state) the constituent molecules are regularly arranged into a 
fixed and rigid repeating array known as a lattice. A lattice is a set of points arranged 
so that each point has identical surroundings. The regularity of the internal structure 
of this crystal lattice results in the crystal having a characteristic shape; smooth 
surfaces or faces develop as a crystal grows, and the planes of these faces are parallel 
to atomic planes in the lattice. 
 
The smallest three-dimensional unit of the lattice that contains all the information 
necessary to replicate the lattice to any size is called the unit cell. When two atoms of 
the same element in the unit cell have identical atomic environments except for the 
orientation within the environment, they are said to be related by symmetry (Myerson, 
2005). The dimensions of the unit cell are characterized by six quantities; three axial 
lengths (a, b, c) and three inter axial angles (α, ȕ, Ȗ). Each unit cell contains at least 
one asymmetric unit. Frankenheim (1842) and Bravais (1850) investigated 
mathematically the number and types of three dimensional lattices that could exist in 
space. They found that there are only fourteen possible point lattices that can be 
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constructed and these are known as the Bravais lattices. This results in the lattices 
being divided into seven crystal systems known as; regular, tetragonal, orthorhombic, 
monoclinic, triclinic, trigonal, and hexagonal (Mullin, 2001). Each of these crystal 
systems has one or more symmetry elements that describe the internal symmetry of 
the unit cell (Datta et al, 2004).   
 
There are three simple elements of symmetry; a centre, an axes and a plane. A centre 
of symmetry (symmetry about a point) exists when each point on a crystal surface has 
an identical point on the opposite side of the centre at equal distance from it, for 
example a cube (Figure 1.1 a). An axis of symmetry (symmetry about a line) is an 
imaginary axis placed through the crystal, which if the structure is rotated about this 
axis then it appears to have reached its original position more than once during a 
complete rotation (360°). During this complete rotation, if the crystal reaches its 
original position twice then the axis is called a diad axis (two fold symmetry). 
Respectively, for three, four and six times, axes are termed triad axes, tetrad axes, and 
hexad axes. A perfect crystal with a cubic morphology displays 13 axes of symmetry: 
6 diad axes, 4 triad axes and 3 tetrad axes as shown respectively in Figures 1.1b, 1.1c 
and 1.1d. A plane of symmetry (symmetry about a plane) is an imaginary plane, 
which divides a crystal into two parts such that each reflects the image of the other. 
Crystals may have more than one plane of symmetry, for example, a cube has nine 
planes of symmetry; 3 rectangular and six diagonal planes as shown in Figure 1.1e 
and 1.1f. 
 
        
   
 
 
 
 
 
 
Figure 1.1a A cubic crystal exhibits Figure 1.1b A cubic crystal possesses 
a centre of symmetry at its mass centre 6 diad axes of symmetry through   
      opposite edges 
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Figure 1.1c  A cubic crystal possesses 4       Figure 1.1d  A cubic crystal possesses 
triad axes of symmetry through opposite      3 tetrad axes of symmetry through  
corner                                                                   opposite faces 
 
 
 
 
          
 
 
 
 
Figure 1.1e  A cubic crystal possesses 3 Figure 1.1f A cubic crystal possesses  
rectangular planes of symmetry, each   6 diagonal planes of symmetry, each 
parallel to two opposite faces of crystal  passing through opposite edges 
  
A fourth element of symmetry which is exhibited by some crystals is the symmetry 
about a rotation-reflection axis or axis of rotatory inversion (Mullin, 2001).  In this 
type of symmetry, a crystal face can be related to another face by performing two 
operations; rotation about an axis, followed by reflection in a plane at right angles to 
the axis. The sum of these two operations is known as inversion about the centre.  
 
There are only 32 possible combinations of the above-mentioned elements of 
symmetry, which are called the 32 point groups or classes (Aroyo et al, 2006). These 
32 classes are grouped into one of the seven crystal systems.  
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All symmetry operations (elements), when applied to a lattice, result in a return to the 
initial position. There is also a different type of symmetry operation, which is called 
translational symmetry. In translational symmetry, simultaneous use of reflection and 
translation or rotation and translation will result in a displacement of the original 
position to a new position, corresponding to the next lattice point. The former is called 
a glide plane and the latter a screw axis. If we add the concept of the screw axis and 
the glide plane, the number of combinations of symmetry elements that can be derived 
increases to 230, which are known as the crystallographic space groups (Myerson, 
2005). These 230 space groups describe all the possible ways in which identical 
objects can be arranged in an infinite lattice.  Every crystal structure can be assigned 
to one of the 14 Bravais lattices and to one of the 230 space groups (Bernstein 2002). 
 
1.3 Solubility and supersaturation 
 
At a given temperature there is a maximum amount of solute that can dissolve in a 
given amount of solvent. When this occurs, the solution is said to be saturated. The 
amount of solute required to make a saturated solution at a given temperature is the 
solubility (Myerson, 2005). In thermodynamics, saturation is defined as the state in 
which equilibrium is established between undissolved and dissolved solute in a 
dissolution process (Aulton, 2002). The solubility of most materials is a function of 
temperature, generally increasing with increasing temperature. 
 
A saturated solution is in thermodynamic equilibrium with the solid phase, at a 
specific temperature. When the concentration of the solute in the solution exceeds its  
equilibrium concentration (saturated concentration) at the given solution conditions, 
the solution is said to be in a supersaturated state and the concentration of the solute in 
the solution, termed the actual or supersaturated concentration (Mullin, 2001). 
However, a supersaturated solution would not result in spontaneous nucleation, unless 
the supersaturation level exceeds a certain metastable range, where solute molecules 
spontaneously form nuclei (Davey and Garside, 2000). Ostwald (1899) first 
introduced the terms ‘labile’ and ‘metastable’ supersaturation to classify 
supersaturated solutions in which spontaneous nucleation would or would not occur, 
respectively (Figure 1.2). Mier and Isaac (1906, 1907) represented these relationships 
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between supersaturation and crystallization using a diagram, which is known as the 
solubility – supersolubility diagram such as that shown in Figure 1.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 The solubility/supersolubility diagram, which classifies the metastable, 
supersaturated (labile/unstable) and unsaturated (stable) zones). 
 
A solution whose composition lies below the solubility curve is under saturated and 
existing crystals will dissolve. As shown in Figure 1.2, if cooled, a solution may 
become saturated and then supersaturated with further cooling. If a solution is 
continuously cooled down further without losing solvent (i.e. at constant 
concentration), spontaneous nucleation or crystal formation will take place at a certain 
temperature at point C (Line ABC, Figure 1.2), designated as the nucleation 
temperature. Supersaturation can be also achieved by evaporation of solvent 
(increasing concentration) at constant temperature (Line ADE) or by a combination of 
cooling and evaporation (Line AFG). The range between the saturation (solubility) 
temperature and nucleation temperature is designated as the metastable zone. Mier 
and Isaac (1906; 1907) divided this diagram into three zones; (1) the stable 
(unsaturated) zone, where crystallization is not favoured, (2) the metastable zone, 
between the solubility and supersolubility curves, where spontaneous crystallization is 
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improbable, and (3) the unstable or labile (supersaturated) zone, where spontaneous 
crystallization is probable. 
 
Mathematically, supersaturation can be defined in a number of ways. The most 
common expressions are the concentration driving force, Δc, and the absolute or 
relative supersaturation, σ, as shown in Equations 1.1 and 1.2 (Mullin, 2001), 
 
Δc = c – c*        (Equation 1.1) 
σ =  Δc/ c* (Equation 1.2) 
 
where c is the solution concentration, and c* is the solubility at a given temperature. 
 
1.4 Crystallization and importance of solubility 
 
Crystallization is used extensively in the manufacture of pharmaceuticals, 
agrochemicals and fine chemicals as a purification and isolation step (Davey and 
Garside, 2000). It is the process by which randomly organized atoms or molecules are 
arranged into an ordered solid state, called a crystal. 
 
The most common type of crystallization is that from solution, in which the 
component to be crystallized is completely dissolved in a solvent at elevated 
temperature, where the solubility is relatively high. When the system is cooled down, 
at some point the concentration of a solute exceeds the solubility at that temperature, 
i.e., the system is thus supersaturated. In supersaturated conditions, the solute 
molecules tend to transfer from liquid phase in to solid phase, which is seen as the 
formation of new crystals (nucleation) or as the growth of existing crystals (Pollenen 
et al, 2006).  
 
Therefore, the concentration difference between the actual concentration and 
equilibrium solubility, supersaturation, is the driving force of all crystallization 
processes. These crystallization processes occur in two steps known as nucleation and 
growth of crystals (Mullin, 2001). 
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1.5 Nucleation 
 
Crystallization from a solution involves two steps, nucleation, which is the process of 
creating a new solid phase from a super saturated homogeneous mother phase (Davey 
and Garside, 2000), and crystal growth, which is the growth of existing crystals to 
larger size. The properties of the crystals such as their size distribution, shape and 
polymorphism depend on these two steps and their relationship with each other 
(Myerson, 2005). 
 
Nucleation can be classified as primary and secondary. The term primary is reserved 
for all the cases of nucleation where systems do not contain crystalline matter prior to 
the formation of nuclei. Secondary nucleation is often generated in the vicinity of the 
crystals, which are already present in a supersaturated system (Mullin, 2001). Primary 
nucleation is further classified into homogeneous and heterogeneous primary 
nucleation. 
 
1.5.1 Primary nucleation: homogeneous nucleation 
 
Homogeneous nucleation occurs as spontaneous nucleation from a supersaturated 
solution due solely to the supersaturation driving force effect. Classical nucleation 
theory (Gibbs, 1948; Volmer, 1939) states that when a solution enters the non-
equilibrium supersaturated region, the molecules of the solute begin to form 
aggregates (clusters). If it is assumed that the clusters are spherical, Equation 1.3 can 
be written that gives the change in Gibbs free energy, ΔG, required to form a cluster 
of a given radius, r, 
 
ΔG =  [4πr2Ȗ] – [(4πr3/3Vm) RT ln (1+S)]    (Equation 1.3) 
 
where r is the cluster radius, Ȗ is the solid –liquid interfacial tension, Vm is the 
specific volume of a solute molecule, S is the supersaturation ratio and R is the gas 
constant. The first term in Equation 1.3 is the change in Gibbs free energy for forming 
the surface of the cluster, while the second term is the change in Gibbs free energy for 
forming the bulk of the cluster. It was also reported (Mullin, 2001) that nucleation 
requires a cluster of a critical size to be formed in the solution. Clusters (aggregates) 
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less than the critical size with low (or negative change in) Gibbs free energy will be 
likely to dissolve compared to clusters equal to critical size. Equation 1.3 indicates 
that clusters with higher surface area and lower volume are likely to achieve critical 
size radius more easily compared to clusters with lower surface area and higher 
volume. Equation 1.4 for the critical size, rc, of the cluster is given below. 
 
rc = 3Vmσ/RT ln(1+S)       (Equation 1.4) 
 
As the supersaturation increases, the likelihood of obtaining the critical cluster size in 
the solution will increase and hence, the possibility of nucleation. The rate of 
nucleation, J, the number of nuclei formed per unit time per unit volume, can be 
expressed in the form of the Arrhenius reaction velocity equation commonly used for 
the rate of a thermally activated process (Volmer, 1939; Nielsen, 1964): 
 
J = A exp (-ΔG/kT)       (Equation 1.5) 
 
where, k is the Boltzman constant, A is the surface area of cluster, ΔG is the change in 
Gibbs free energy, and T is the temperature (K).  
 
1.5.2 Primary nucleation: heterogeneous nucleation 
 
The rate of nucleation of a solution can be affected considerably by the presence of 
traces of impurities or a catalytic surface in the system. This type of nucleation 
induced by the presence of foreign bodies is referred to as heterogeneous nucleation 
(Davey and Garside, 2000). 
 
As the nucleation is induced by the presence of other foreign particles, the degree of 
supersaturation will be lower than that required for homogeneous spontaneous 
nucleation. Therefore, the overall free energy change associated with the formation of 
a critical nucleus under heterogeneous conditions, ΔG’crit, must be less than the 
corresponding free energy change, ΔGcrit, associated with homogeneous nucleation 
(Mullin, 2001), 
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ΔG’crit = φ ΔGcrit       (Equation 1.6) 
where, φ is the proportionality constant. 
 
Equation 1.6 indicates that nucleation is easier to achieve because the overall excess 
free energy required is less than that for a homogeneous nucleation. 
 
1.5.3 Secondary nucleation 
 
The term secondary nucleation is used when the nucleation of new crystals is induced 
only because of the prior presence of crystals of the material being crystallized. This 
nucleation mechanism generally occurs at much lower supersaturation than primary 
homogeneous or even heterogeneous nucleation. 
 
The most important and commonly encountered mechanism of secondary nucleation 
is contact nucleation, sometimes also referred to as collision nucleation (Davey and 
Garside, 2000). The existing crystals provide a source of nuclei through collision with 
each other, the walls of the vessel, and the mixing device used. 
 
1.6 Crystal growth 
 
When a nucleus is formed, it is the smallest stable cluster of molecules that can exist 
under a given set of conditions (Myerson, 2001). Lui et al (2007) found the critical 
nucleus size for ice crystallization in a microemulsion.  
 
However, immediately after the formation of nuclei, they begin to grow larger 
through the addition of solute molecules to the crystal lattice. This part of the 
crystallization process is known as crystal growth (Myerson, 2005). In this process, at 
supersaturated conditions, the flux of growth units (atoms, ions, or molecules) to the 
surface exceeds the equilibrium flux so that the number of growth units joining the 
surface is greater than the number leaving it (Davey and Garside, 2000). This results 
in growth of the surface. The ability of a surface to capture arriving growth units and 
integrate them into the crystal lattice is, among other things, dependent upon the 
strength and number of interactions that can form between the surface and the growth 
unit. 
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The first theoretical model of crystal growth was introduced by Kossel (1934) as 
shown in Figure 1.3. This model shows three types of sites at which the growth unit 
can be incorporated into a crystal. A site where the growth unit can bond in only one 
place is a flat face, F. A site which provides two places (two bonds) for the growth 
unit to bond to the crystal is a stepped or S face, while a site where three bonds are 
possible is known as a kink site, K (Hartman and Perdock, 1955).  
 
 
 
 
 
 
 
 
 
Figure 1.3 The surface of growing cubic shaped crystal shows three types of sites for 
the attachment of adsorbed atoms; (1) flat face, F, (2) Step face, S, and (3) Kink Site, 
K (re-drawn from Mulin, Crystallization, 4th edition, Butterworth-Heinemann, 2001) 
 
Kossel (1934) assumed that the strength of binding of an atom to the surface depends 
on the number of its nearest neighbours. As step or kinked sites display 2 or 3 
bonding sites with the growth unit/atom; at these sites atoms would be bound by the 
maximum number of neighbours. The growth rate, v, of a crystal surface is 
proportional to the total binding energy of an atom to that surface. Hence, the growth 
rate at kinked sites is highest followed by growth rate at stepped sites and flat faces 
(Equation 1.7) 
 
 vk > vs > vf         (Equation 1.7) 
 
This concept of crystal growth is based on thermodynamic reasoning as suggested by 
Volmer (1939). When an atom of a crystallizing substance arrives at the growing 
crystal face, it is absorbed on the surface and then diffuses along the surface until it is 
incorporated into the lattice at a step or kink site where its energy reaches a minimum 
(Figure 1.3). This stepwise build up will continue until kinked or step sites have 
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received sufficient atoms to move them to the edge of the crystal. Thereafter, these 
kinked and step sites can no longer function as low energy nucleation sites. The 
generation of a new layer/step for further crystal growth requires a launching of a 
molecule on the crystal surface.  
 
The ease of starting this new layer depends on the surface roughness (kink and step 
density). One of the earliest attempts to quantify surface roughness was made by 
Jackson et al (1958) using the dimensionless term, α,  
 
α = ΔE/kT      (Equation 1.8) 
 
where, ΔE is the energy change occurring when a perfectly flat surface is roughened 
by removing one block from the surface and using it to start a new layer. 
 
The parameter, α, is called the Jackson factor which measures the ease with which a 
surface/face can form sites with multiple binding interactions. Hence, this parameter 
reflects the ease with which a surface can grow. If the value of the α-factor is low then 
growth can proceed easily with many growth sites always present. As the value of α 
increases, growth becomes more difficult and specific mechanisms have to be 
envisaged by which necessary growth sites can be created. Depending on the value of 
α, possible mechanisms of crystal growth are classified, as shown below (Burton, 
Crabrera and Frank, 1951; Bourne and Davey, 1977).  
 
1.6.1 Continuous growth 
 
When the value of α is less than 3, the surface roughness will be high with many kink 
and step sites available. All the arriving growth units will find a growth site and will 
be bound by the maximum number of neighbours. Hence the energy required to form 
a step is low. The linear growth rate, in supersaturated systems, normal to the surface, 
v, is expressed as shown in Equation 1.9, 
     
   v = KCGσ     (Equation 1.9) 
where, KCG is the rate constant, and σ is supersaturation. 
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Crystals grow continuously without much effort inside the solution until the 
supersaturation is reduced and solution concentration is equal to equilibrium 
concentration.  
 
1.6.2 Surface nucleation 
 
As the value of α increases above 3 (and less than 5), the surface roughness is 
decreased (Mulin, 2001). The density of steps and kink sites will decrease. Not all the 
arriving growth units will find growth sites on the crystal surface. The growth units 
which do not find growth sites or are held loosely only by one neighbour (one bond) 
and may return to the fluid phase. Whereas the growth units which find available 
growth sites, will create steps for others, others will join them to create a surface 
island or nuclei. These islands and nuclei work as the steps and kink sites for other 
growth units and in this way islands spread across the crystal surface. The linear 
growth rate normal to the surface, v, is expressed as given in Equations 1.9 and 1.10. 
 
v = f1 (number of critical size nuclei formed per unit time) × f2 (step height) × f3      
(step velocity)              (Equation 1.9) 
 
v = KSNσ5/6 exp {(-π/γσ) (Ȗe/kT)2}          (Equation 1.10) 
 where, KSN is a rate constant, σ is the supersaturation, Ȗe is the edge tension, K is 
Gibbs-Boltzman constant, and T is the temperature (K). 
 
1.6.3 Spiral growth 
 
 As the value of α increases above 5, the surface roughness is very low with a nearly 
flat surface.  The surface would no longer contain any low energy nucleation sites 
(kink and steps). Generation of a new step on the flat surface requires the highest free 
energy (ΔG), which is energetically most unfavourable. In this case, at an α value 
above 5, growth can occur only if a step is created by an energetically cheap 
mechanism. Burton, Carbrera and Frank (1951) proposed that the energetically cheap 
process that enables a flat surface to grow is mediated by the presence of a screw 
dislocation lattice defect. A dislocation is the result of the stresses that occur during 
crystal growth, particularly during the crystal growth taking place on crystal seeds. In 
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a dislocated crystal, one part of the crystal will be misaligned with respect to the rest 
of the crystal. Burton, Carbrera and Frank (1951) explained that the emergence points 
of dislocations with screw components at crystal surfaces act as a continuous 
generator of surface steps at which further growth can then take place (Figure 1.4). 
These emergent surface steps extend over only the part of the surface and wind up 
into a spiral with growth.  
 
    
  
 
 
 
 
 
 
 Figure 1.4 A cubic crystal shows emergence point of screw dislocation at the 
crystal surface, which acts as a step site for the absorbed growth units (re-drawn from 
Mulin, Crystallization, 4th edition, Butterworth-Heinemann, 2001). 
  
 In this system, the growth rate is expressed as shown in Equation 1.11, 
   
 v = f1 (step velocity) × f2 (step height) × f3 (step density)  (Equation 1.11) 
  
 where, step velocity is the flux of growth units entering at kink sites. According to 
Burton, Crabera and Frank (1951) the step velocity may be controlled by the diffusion 
of solute molecules from the solution to the kink sites or by two-dimensional 
diffusion over the crystal surface. The step density is related to the spiral curvature, 
which increases with increase in supersaturation, and the height of the steps is 
dependent on the initial number of defects available in the nucleated crystal. The final 
form of the Equation 1.11 for growth rate in a supersaturated system is expressed as 
shown in Equation 1.12, 
 
 v = Aσ2 tanh (B/σ)      (Equation 1.12) 
Emergence point of screw dislocation  
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 where, A and B are complex temperature dependent constants, and σ is the 
supersaturation. 
1.7 Crystal Habit/Morphology 
The morphology/habit of a crystal is an important property of solid crystalline 
materials that influences a number of other important properties of the material, for 
instance, dissolution rate, flow, filtering and drying characteristics, compacting, 
milling, and dust formation. Therefore morphology control of crystals is important in 
pharmaceutical and fine chemical industry. 
As explained in Section 1.1, crystals are formed by the repetition of unit cells in three 
dimensional space. The extent or limit of building these unit cells in three dimensional 
space plays a major role in developing crystal faces. Therefore, the shape of a crystal 
face is in part related to the shape of the unit cell. 
Crystal morphology is also dependent upon the growth rate and direction in which the 
crystal grows as the variable growth rate of crystal faces in different directions defines 
the faces and shape of crystals. In other words the variable rates, at which molecules 
or atoms (from the surrounding supersaturated fluid/vapour) attach to different 
faces/directions of a growing crystal, play a major role in defining the final shape of 
the mature crystal. Among the faces of a growing crystal, the slowest growing face 
plays a major role in defining the final shape (morphology).  
    
 
(c)                                   (a)        (b) 
Figure 1.5 Example of a growing crystal to explain the effect of relative growth 
rates of faces on final morphology; (a) a nucleated rectangular crystal, (b) a nucleated 
crystal achieves rod-like morphology if Face 1 grows faster than Face 2, (c) a 
nucleated crystal maintains rectangular morphology if both Face 1 and Face 2 grow at 
the same rate.  
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If a crystal nucleates as a rectangle (Figure 1.5a), and exhibits a slower growth rate at 
Face 1 and a faster growth rate at Face 2, then after a period of growth the crystal 
would display a rod-like morphology (Figure 1.5b). However, similar growth rates on 
both Face 1 and Face 2 would maintain a rectangular morphology after a period of 
growth (Figure 1.5c). 
This process of molecule attachment to the surface of a growing crystal can be greatly 
influenced by external conditions such as level of supersaturation, temperature, 
pressure, pH, solvent and the presence of impurities or additives within the system. 
There are a number of studies reported in the literature and a few are described briefly 
to explain the influence of these factors on morphology. 
Finnie et al (1999) studied the crystal growth of paracetamol from aqueous solvent. 
They measured the growth rate of paracetamol crystals in the [010] and [001] 
directions, and reported that at low supersaturation, needles elongated along the [001] 
direction were produced whereas at a high supersaturation, the crystal morphologies 
were bipyramidal. Cano et al (2001) studied the morphology of ibuprofen crystals 
grown from ethanol and ethyl acetate. Crystals grown from ethanol were found to 
have a hexagonal prism morphology, whereas ibuprofen crystallization from ethyl 
acetate resulted in thin platelet crystals. Pakula (1977) and Rio (2002) reported the 
crystallization of two different forms of indomethacin (α – needle like morphology 
and Ȗ – rhombic plate like morphology) with a change in the temperature to which the 
solutions were cooled, and in the cooling rate. Glycine is a good example to explain 
the effect of pH on crystallization. There are studies (Yu and Ng, 2002) which report 
the change in morphology and surface of α and Ȗ glycine crystals with change in pH 
between 1 and 9.   
Foreign impurities can affect the growth rate of one or more faces even at very low 
concentrations (Grant, 2002). Impurities can become absorbed at the growing surfaces 
of a crystal to block the growth of certain faces/sites and hence change the 
morphology. When selected impurities are deliberately added to produce a desired 
morphological effect, they are referred to as additives or habit modifiers.  
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1.8 Habit modifying additives  
In many cases, crystallization processes result in undesirable crystal morphology in 
the final crystallized product. Even changes in external process parameters would not 
be able to change an undesirable morphology into a desirable one. In these 
circumstances, the crystal habit can be modified using habit modifiers (tailor-made 
additives) that selectively inhibit or promote growth of certain crystal faces, thereby 
changing the shape of the final crystal (Deji et al, 2007). Control over the morphology 
can be achieved in the final product by molecular recognition of tailor-made 
additives. 
 
The structure of a tailor-made additive molecule is very similar to that of the host 
molecule. Due to their structural similarity, mechanistically it is thought that they 
have enough molecular compatibility with the host system (the molecules that are 
crystallizing) to be able to incorporate onto the surface of the growing crystal and 
modify energetics, and hence morphology. 
 
A primary feature of most crystal structures is hydrogen bonding. This bonding leads 
to the formation of hydrogen-bonded chains of molecules, packed in a specific 
conformation within the crystal structure. Any additive which disrupts the hydrogen 
bonding network within the crystal has the potential to significantly alter its growth 
rate and, ultimately, its morphology. According to Hendiksen et al (1998) structurally 
related additives (tailor-made additives) may influence the nucleation and growth of 
growing crystals in three principal ways. Additives may: (i) block adsorption of solute 
molecules and therefore induce morphological changes (ii) dock onto the surface and 
become incorporated into the crystal lattice; (iii) disrupt the emerging nucleus and 
thus inhibit the nucleation process. 
 
A variety of important experimental studies for the effect of additives on crystal 
growth and morphology have been reported in the latter half of the last century. 
Changes in habit induced in sodium chloride crystals by the presence of α-amino 
acids are a well known early example being reported by Fenimore and Thraikill 
(1949).  
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The presence of structurally related compounds has been shown to alter distinctly the 
habit of pharmaceutical excipients, such as adipic acid (Fairbrother and Grant, 1978; 
Chow et al., 1984; Davey et al., 1992; Myerson and Jang, 1995) and α-lactose 
monohydrate (Garnier et al., 2002). A set of additives were reported to influence the 
growth of benzamide, each additive in a different growth direction. Benzoic acid 
blocks growth of benzamide in the b-axis direction, transforming the pure plate-like 
crystals into needles elongated along the a axis, and p- and o-toluamide block growth 
in the a-axis and the c-axis direction, respectively (Berkovitch-Yellin et al. 1982a). 
Weissbuch et al (1983) reported the crystallization of glycine from water as α-glycine 
with bipyramid morphology, but similar experiments of glycine in the presence of 
(R)- α-amino acid additives led to the formation of pyramid crystals of α-glycine with 
a (010) basal plane, because growth in the +b direction was inhibited. Hendriksen et 
al. (1998) studied the general effect of a range of molecularly similar additives 
(acetanilide, p-acetoxyacetanilide (PAA), orthocetamol, methylparaben, p-
acetoxybenzoic acid (PABA), and metacetamol) on the nucleation kinetics and 
crystallization of paracetamol and observed that the morphology of paracetamol 
crystals was modified to varying degrees with the presence of each additive. For 
example, paracetamol crystals grown in the presence of 4 mol % metacetamol attain a 
columnar habit, distinctly different from the tabular morphology observed in a 
paracetamol crystal growth in the presence of 4 mol % acetanilide (Clair, 2004). 
 
1.9 Polymorphs and its importance in the pharmaceuticals industry 
 
Polymorphism, a phenomenon of the crystalline solid state, is the ability of a 
substance to exist as two or more crystalline phases that have different arrangements 
and/or conformations of the molecules in the crystal lattice (Giron, 2001). Figure 1.6 
explains the term ‘polymorphs’ using the simple example of nine cross shaped units 
to represent molecules of a solid state substance. It shows three different 
conformations of nine molecules to result in three different polymorphs of a solid 
state substance.  
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Figure 1.6 Different conformations/arrangements of molecules in a crystalline 
solid state substance. 
 
A definition of polymorphic forms was first made by Mitscherlich in 1821 in relation 
to inorganic compounds such as arsenates, phosphates and sulphur (Schutt, 1996). 
The first example of polymorphism in an organic compound was discovered by 
Wohler and Liebig (1832) in benzamide. In 1899, Ostwald suggested that every 
substance could exist in two or more solid phases provided the experimental 
conditions are suitable. Approximately, one third of organic compounds and 80% of 
marketed pharmaceutical compounds exhibit polymorphism under assessable 
experimental conditions (Hilfiker, 2006). According to Haleblian and McCrone 
(1969) every compound has different polymorphic forms and that, in general, the 
number of forms known for a given compound is proportional to the time and money 
spent in research on that compound. 
 
Polymorphs can exhibit different mechanical, thermal and physicochemical 
properties, such as compressibility, melting point, solubility, and crystal habit, which 
can have great influence on the bioavailability, filtration, and tableting properties and 
other performance-related characteristic properties of pharmaceuticals (Ferrari et al., 
2003). For example the blockbuster drug Hytrin (terazosin) can exist in various 
polymorphic forms. The discovery of new polymorphs of Hytrin provides better 
medicine and more profit to the pharmaceutical company due to better 
physicochemical properties (Bauer et al, 2006). One famous example is ritonavir 
(Datta et al, 2004), this drug was crystallized and marketed as Form I but some 
batches of this drug failed a dissolution test. Investigation revealed that a new 
polymorph, Form II, had precipitated from the formulation of Form I. Form II was 
less soluble than Form I, resulting in the precipitation of solid and a decrease in the 
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dissolution rate of the marketed formulation. The adverse affect of decreased 
dissolution rate on the bioavailability of ritonavir led to withdrawal of the extant 
formulated products. Eventually after considerable efforts and expense, a new 
formulation of ritonavir was developed, submitted to FDA (Food and Drug 
Administration), approved and launched on to the market (Datta et al, 2004). The 
differences that could be shown in the physicochemical properties of drugs with 
different polymorphs (or with changes in polymorphism) are listed in Table 1.1; many 
of these can influence the drug performance greatly, as explained by the above 
example. 
 
Table 1.1 Differences in polymorphic properties with changes in polymorphism 
 Physicochemical properties that could changes with 
polymorphism 
Packing properties Molar volume and density, Hygroscopicity, Conductivity 
Thermodynamic 
Properties 
Melting point, Internal energy, Enthalpy, Entropy, Solubility, 
Free energy, Heat capacity 
Spectroscopic 
properties 
Electronic transition (UV spectra), Vibrational transitions (IR 
and Raman spectra), NMR chemical shift 
Kinetic properties Dissolution rate, Physical & chemical stability, etc. 
Surface properties Surface free energy, Interfacial tension, Crystal habit 
Mechanical properties Hardness, Tensile strength, Compactibility, Flowability 
 
Patent rights can also be affected since different polymorphs of the same substance 
may be associated with separate patent claims as in the high profile litigation 
surrounding Zantac, in which Glaxo lost the patent claim to Novapharm (Glaxo Inc., 
1995). Both of these issues have tremendous financial implication on pharmaceutical 
companies. Companies realize the importance of early discovery of polymorphism, to 
determine the most appropriate form to advance for development (lead optimization) 
and for that they carry out a ‘polymorph screen’. 
 
Regulatory bodies, like the Food and Drug Administration (FDA) provide guidelines 
and specifications that state appropriate analytical procedures should be used to detect 
polymorphic forms of drug substance. The FDA is an agency of the United States 
 39 
Department of Health and Human Services and is responsible for regulating and 
supervising the safety of drugs. Any new drug application (NDA) and abbreviated 
new drug applications (ANDA) are required to provide enough information to the 
FDA so that FDA scientists can assure that the drug product possesses acceptable 
standards of quality to reflect the product’s safety and efficacy that was demonstrated 
in clinical trials. This assessment of product quality also includes the scrutiny of solid 
state form and polymorph issues in a drug applicant. A thorough study on the 
occurrences of polymorphs, considering the effect of solvents, temperature and 
possibly pressure on the stability of drug applicant, would be required by FDA prior 
to NDA submission (Decamp et al, 1999). FDA has issued regulatory guidelines that 
outline the specifications and supporting documentation needed for a NDA, which 
contain several decision trees to guide their selection (Hilfiker et al, 2006). This FDA 
guideline also states that it is the applicant’s responsibility to control the crystal form 
and its properties (Byrn et al, 2002). 
 
1.9.1 Relative stability and thermodynamics of polymorphs  
 
The relative stability of polymorphs depends on their Gibbs free energy (G). 
Thermodynamically, the more stable polymorph will have the lower free energy. 
Under a defined set of experimental conditions (except at transition points) only one 
polymorph has the lowest free energy. This polymorph is thermodynamically the most 
stable form and the other polymorph(s) termed metastable form(s). A metastable form 
is the one that is unstable thermodynamically but has finite existence as a result of a 
relatively slow rate of transformation. The relative thermodynamic stability between 
two polymorphs can be determined by the difference in their Gibbs free energy, ΔG: 
ΔG = ΔH – TΔS      (Equation 1.13) 
where, the enthalpy term, ΔH, corresponds to the lattice energy difference, the 
entropy term, ΔS, derives from the difference in lattice vibrations and disorder 
between the two polymorphs. Difference in Gibbs free energy, ΔG, varies inversely 
with temperature as the TΔS term increases rapidly compared to ΔH with increased 
temperature. 
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The equilibrium between stable and metastable forms exists at certain conditions and 
can be explained using the Gibbs phase rule (Equation 1.14), 
 
F = C – P + 2        (Equation 1.14) 
where, F is the degree of freedom, C is the number of components, and P is the 
number of homogeneous faces. 
 
For example, in a glycine (C =1) system, equilibrium between two polymorphs α and 
Ȗ (P = β) can exist at only one degree of freedom (F). Hence, at constant pressure, 
equilibrium between two polymorphs occurs at a fixed temperature, whereas, at 
constant temperature equilibrium occurs at one fixed pressure. According to Myerson 
et al (2003), at constant pressure (ambient pressure) α and Ȗ polymorphs of glycine 
exhibit equilibrium at 177°C. At this temperature both forms of glycine can co-exist 
but above and below this temperature only α or Ȗ can exist, respectively. The 
temperature at which two or more forms are in equilibrium is called the transition 
temperature and its dependence on the pressure is explained by Clapeyron equation 
(Equation 1.15). 
 
dT/dP = TtΔV/ΔHt       (Equation 1.15) 
Where, dT/dP is the change in the transition temperature with pressure, Tt is the 
transition temperature, ΔV is the volume change when one form transforms to the 
other, and ΔHt is the enthalpy of transition. 
 
In pharmaceutical and fine chemical industries a metastable form may offer desirable 
properties over the stable form, such as, better bioavailability, better grinding and 
compressibility, or lower hygroscopicity.  In these cases, metastable forms become 
desirable (Hilfiker, 2006). However, a metastable form has a themodynamic tendency 
to reduce its free energy by transforming into the stable form. Such a polymorphic 
transformation is often detrimental to the efficacy of formulation. Furthermore, 
process conditions during manufacturing and pharmaceutical processing such as 
compaction, milling, wet granulation and freeze drying, can also result in 
polymorphic transition.  
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1.9.2 Classification of polymorphs 
 
Depending on their thermodynamic behaviour explained in Section 1.11 polymorphs 
can be divided into two distinct classes, monotropic and enantiotropic (Park et al, 
2003). In monotropic systems, only one polymorph is stable below the melting point, 
the solubility curves do not cross, and there is no reversible transition between the 
polymorphic forms below the melting point (Figure 1.7a). In enantiotropic systems, a 
transition point exists below the melting point (above and below this point different 
polymorphic forms are stable), and this transition is reversible. The solubility curves 
of an enantiotropic system cross before the melting point (Figure 1.7b) (Park et al, 
2003). The polymorphic phase diagrams for monotropic and enantiotropic systems are 
shown below.  
 
  
 
 
 
 
 
 
 
 
 
Figure1.7  Solubility curves in (a) monotropic and        (b) enantiomorphic systems. 
 
1.10 Polymorphic transformation 
 
Polymorphic transformation can be categorized by the type of structural changes 
involved, which can roughly be related to the rate of transformation (McCrone et al, 
1965). There are mainly two types of transformation reported in the literature, known 
as reconstructive and displacive. Reconstructive transformations involve extensive 
rearrangement of the crystal structure and require breaking of chemical bonds and 
reassembling the atoms into a different crystal structure. This usually involves a large 
change in energy of structure, which must occur at the transformation temperature or 
(a) (b) 
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pressure. Because of the extensive rearrangement involved, the rate at which this type 
of transformation occurs may be very slow, metastable polymorphs may exist for long 
periods of time. Displacive transformations involve only small adjustments to the 
crystal structure. Generally no bonds are broken, but the angles between the atoms 
may change slightly. Because there is little rearrangement, displacive transformations 
involve no change in energy at the transformation temperature and pressure, and the 
transformations are instantaneous and reversible. Thus, no unstable polymorphs will 
occur (Park et al, 2000). 
 
1.11 Case studies on model candidates: Sulphathiazole 
  
As mentioned, sulphathiazole and indomethacin have been selected as candidates for 
this project. The polymorphism, stability, crystallization of these drugs are discussed 
in detail. 
 
Sulphathiazole is a sulphonamide anti-bacterial drug, well-known for its use as an 
early antibiotic agent. It is a sulpha drug (C9H9N3O2S2) derived from thiazole and 
sulphanilamide. This drug was formerly used in the prevention and treatment of 
bacterial infections, especially in the treatment of pneumococcus and staphylococcus 
infections. It has largely been replaced by less toxic sulphonamides, but it has become 
a useful and well studied model in the investigation of organic polymorphism and 
crystal growth (Lagas and Lerk, 1981; Anwar et al, 1989; Blagden et al, 1998). 
 
                        
Figure 1.8 The molecule of sulphathiazole with numbering of its atoms 
 
Sulphathiazole is commercially available as a white to yellowish crystalline powder.  
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1.11.1  Polymorphisms of sulphathiazole  
 
The structure of suphathiazole and its polymorphs has been the subject of 
investigation for almost 60 years. Sulphathiazole is known to possess at least five 
polymorphic Forms: I, II and III (Kruger & Gafner, 1971, 1972), IV (Babilev et al, 
1987) and V (Anwer et al, 1989; Chan et al, 1999). Of these five polymorphs, four 
exhibit an enantiotropic relationship, while the fifth is a monotrope (Kordikowski et 
al, 2001).  
 
The single molecule of sulphathiazole is shown in Figure 1.8. It is known that the 
hydrogens H1, H2, H3 act as donors and O1, O2, N1 and N2 act as acceptors in the 
formation of a variety of hydrogen bonded structures, which lead to the formation of 
different polymorphs (Blagden et al, 1998). 
 
There has been some confusion about the number and naming of different polymorphs 
of sulphathiazole. The number of Forms reported ranges from two (Grove and 
Keenan, 1941) to five (Hughes et al, 1999; Chan et al, 1999). It is now commonly 
accepted that sulphathiazole forms five known crystal structures and their numbers 
and reference codes are listed in the Cambridge Crystallographic Data Centre 
(CCDC).  
 
The morphology of sulphathiazole has been widely discussed in the literature since 
the late 1930s. The morphological habits of sulphathiazole polymorphs reported 
include hexagonal, plates, rods (needle), and square shapes. 
 
In 1941, Grove and Keenam, obtained two distinct Forms of sulphathiazole; 
hexagonal prisms, which melted on rapid heating at 173 – 175 °C; and prismatic rods 
which melted at 200 – 202 °C. Miyazaki (1947) reported evidence for a third 
polymorph. He used the ,  and ’ terms for the three polymorphs. Later on 
Moustafa and Carless (1969), Shenouda et al (1970) and Mesley et al (1971) 
confirmed the existence of the two low temperature sulphathiazole polymorphs. 
Mesley et al (1971) had used the terms IIA and IIB for the two low temperature 
Forms. They reported a small endotherm peak at 157 °C and at 170 °C for IIA and 
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IIB, respectively, which transform into Form I upon heating above 180 °C and show 
melting of Form I at 202 °C. 
 
Kruger and Gafner (1971; 1972) determined the detailed structure of three 
polymorphs of sulphathiazole, reported by the above authors. They used 
nomenclatures for Forms as I, II and III corresponding to Forms B, A and C of 
Mesley (1971). 
 
Later on, Lagas and Lerk (1981) also reported the crystallization of polymorphs I, II 
and III. Form II (currently recognized as Form V) was prepared by boiling a 
supersaturated solution of sulphathiazole in water until all the solvent was evaporated 
while two other polymorphs were prepared by normal crystallization processes using 
different solvents. Melting points of 201 °C, 196.5 °C and 173.6 °C were obtained for 
Polymorphs I, II and III respectively. All three polymorphs were characterised by 
distinct IR spectra.  
 
Burger and Dialer (1983) recognised a fourth form of sulphathiazole. They recorded 
four different IR spectra for crystals of sulphathiazole, although the IR spectra of 
Forms III and IV showed very minor differences between them. Later, Babilev et al 
(1987) described the detailed crystal structure of Form IV. They also explained the 
close similarities between the crystal structures of Forms III and IV, and the 
uniqueness of the crystal structure of Form I with respect to the others. 
 
Because of the close similarities in crystal structures, IR spectra, and PXRD patterns 
of Polymorphs III and IV, there has been confusion about the separate existence of 
both polymorphs. Anwar et al (1989) re-examined all the four polymorphs of 
sulphathiazole and confirmed the existences of Form III and IV separately using 
techniques like Raman spectra and 13C NMR in addition to PXRD, IR and DSC. They 
prepared Polymorph II using the same technique as Lagas and Lerk (1981). During 
their study, the isolation of Forms I and II was without problem. In contrast, the 
isolation of pure samples of Form III and IV proved to be difficult, by the inability of 
techniques of DSC, PXRD and IR spectroscopy to resolve the separate existence of 
the two forms. Anwar et al (1989) analysed the individual single crystallite in a 
Gandolfi X-ray diffraction camera and confirmed the separate existence of 
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Polymorphs III and IV, which is supported by the results of Raman spectra and 13C 
NMR techniques.  
 
Blagden et al (1998) carried out an extensive study of crystal structure and hydrogen 
bonding networks of sulphathiazole Forms I, II, III and IV using graph set analysis, 
which led to the appreciation of the similarities between structures II, III and IV, and 
highlighted the uniqueness of Form I. 
 
In 1999, Chan and co-workers carried out a study of sulphathiazole polymorphs and 
found that, in the previous studies of Anwar et al (1989) and Lagas and Lerk (1981), 
the form referred as Form II, was actually Form V. They also determined the structure 
of Form V using Synchrotron high resolution powder X-ray diffraction data. In the 
same year Hughes et al (1999) carried out a single crystal study of Form V and 
supported Chan et al (1999) by stating that the form obtained from boiling water 
which has long been termed Polymorph II in the pharmaceutical literature and which 
had been assumed to have one of the previously known structures, does in fact have a 
new structure which therefore identifies a fifth polymorph. Appearly et al (1999) used 
NMR techniques for the identification of all five polymorphs and results showed that 
the NMR spectra of all forms were noticeably different, so that solid-state NMR 
appeared as an excellent technique for monitoring the polymorphic forms of 
sulphathiazole. 
 
Anderson et al (2001) used an automated platform (reactor) for determining the onset 
of sulphathiazole crystallization. The power of this technique is its ability to detect the 
crystallization phenomenon in real time to determine if the desired form is being 
precipitated. They have presented distinct IR and Raman spectra for all five 
polymorphs of sulphathiazole. They also confirmed that the range of sulphathiazole 
crystals was dependent mainly on the crystallization solvent rather than the onset 
temperature or processing conditions. Kordowski et al (2001) reported a new 
technique for the control of sulphathiazole polymorphs. They investigated polymorph 
control in liquid and supercritical CO2. They obtained crystals of pure Forms of I, II, 
and IV and their mixtures, at different temperatures and flow ratios of CO2/methanol. 
With acetone instead of methanol, Form I or a mixture of Form I and amorphous 
sulphathiazole was obtained. 
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1.11.2 The crystal structure and hydrogen bonding of sulphathiazole  
polymorphs.  
 
The crystal structure and molecular arrangements of the five polymorphs of 
sulphathiazole are reported in the literature. The unit cell data of these five 
polymorphs are listed in Table 1.2. The differences between their molecular 
arrangements and hydrogen bonding are discussed below.    
 
Table 1.2 Unit cell data of Sulphathiazole polymorphs 
Unit cell data 
(CCDC code) 
Form I 
(SUTHAZ01) 
Form II 
(SUTHAZ) 
Form III 
(SUTHAZ02) 
Form IV 
(SUTHAZ04) 
Form V 
(SUTHAZ05) 
Transition Point 
(°C) 
  none 173-175 160-173 150-173 ---- 
Space group P21/c P21/c P21/c P21/n P21/n 
a (Å) 10.554 8.235 17.570 10.867 14.330 
b (Å) 13.220 8.550 8.574 8.543 15.273 
c (Å) 17.050 15.558 15.583 11.456 10.443 
Β (°) 108.06 93.67 112.93 88.13 91.05 
Z 8 4 8 4 8 
 
1.11.2.1 Sulphathiazole, Form I 
 
 
The detailed crystal structure of Form I was first described by Kruger and Gafner 
(1971). The crystal data for Form I are listed in Table 1.2.  
 
The numbering of atoms in the sulphathiazole single molecule is shown in Figure 1.8. 
In Form I, two molecules are contained in the asymmetric unit and this situation 
provided two independent molecular structures in each case. Kruger and Gafner 
(1972) described those molecular structures as A and B in their discussion. The bond 
lengths and bond angles were reported in detail in their study.  
 
In Form I, unique centrosymmetric dimers, designated as α (this nomenclature was 
used by Blagden et al, 1998), are formed by pairs of molecules through symmetrical 
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hydrogen bonds between the imine nitrogen N(2) and amino hydrogen atom H(3). 
These separate dimers are bonded together through hydrogen bonds between the 
amino hydrogen atoms (H1 & H2) and sulfato oxygen atoms (O1 & O2) to make 
chains of α dimers, which link to form extended layers of α dimer sheets. The 
hydrogen-bonding of the α-dimer is shown in Figure 1.9. 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 Hydrogen bonding in Sulphathiazole Form I, forming the α dimer as a 
basic unit of crystal structure. 
 
Only symmetry related molecules are bonded, i.e. no hydrogen bonds exist between 
the independent molecules IA and IB. This means that two intermeshed but 
independent systems of hydrogen bonded molecules exist in the crystal. These 
systems are the same except that only one amino hydrogen (H1A) and one sulfato 
oxygen (O2A) are involved in hydrogen bonding (H1A—O2A). H2A and O1A are 
not involved in any bonding and remain free in IA. In system IB, both amino 
hydrogens (H1B & H2B) and sulfato oxygens (O1B & O2B) are involved in 
hydrogen bonding (H1B—O2B & H2B—O1B).  
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1.11.2.2 Sulphathiazole, Forms II, III and IV  
 
The crystal structure of Forms II and III were reported first by Kruger and Gafner in 
1972 and 1971, respectively, whereas, the crystal structure of Form IV was reported 
later by Bablidev et al in 1987. The crystallographic data of all three polymorphs are 
shown in Table 1.2. 
 
The crystals of Forms II and III belong to the monoclinic system and space group 
P21/c. Intermolecular bond lengths and angles were calculated and listed in detail by 
Kruger and Gafner (1972; 1971). Form III crystallised with two molecules in the 
asymmetric unit. Similar to Form I, Form III also has two sets of enantiomerically 
related molecules, which are referred to as A (L in Blagden et al, 1998) or B (R in 
Blagden et al, 1998) depending on the direction of the thiazole -NH- bond. The 
intramolecular bond lengths and angles were listed in detail by Kruger and Gafner 
(1971). The crystals of Form IV belong to the monoclinic system and space group 
P21/n. Intermolecular bond lengths and angles were calculated and listed in detail by 
Bablidev et al (1987). 
 
Forms II, III and IV are all based on a common dimer, designated as ȕ (Blagden et al, 
1998), which in all three cases is constructed from a sulfato oxygen to aniline 
hydrogen contact (O2—H1) and an aniline nitrogen to amino hydrogen (N1—H3) 
contact as shown in Figure 1.10.  
 
 
 
 
 
 
 
 
 
Figure 1.10 Structure of ȕ dimers, which exist in sulphathiazole polymorphs II, III 
and IV. 
 49 
These ȕ dimers are linked in an eight membered chain motif of ȕ rings. Therefore the 
ȕ dimer was considered as the basic molecular packing unit of Forms II, III and IV. In 
each of the three structures, Forms II, III and IV, ȕ dimer chains are linked with each 
other into two-dimensional sheets by O2—H2 and/or N2—H2 contacts. The structural 
differences between these polymorphs arise from the utilisation of the O2—H2 and 
N2—H2 interaction in forming the interchain linkages between ȕ dimer chains, as 
shown in Figures 1.11a, b and c. 
 
As shown in Figure 1.11a, in Form II, all the ȕ dimer chains in a sheet are found to be 
in one direction only, L (left) or R (right) depending on the direction of the thiazole 
ring, which make two independent sheets of L-ȕ dimer chains and R- ȕ dimer chains 
in Form II. These ȕ chains are connected with each other via Hβ—O2 contacts by 
making a ring formation, which was denoted as ε by Blagden et al (1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                      
              
In Form IV, all the ȕ dimer chains in a sheet are found to be alternate with each other 
in a left (L- ȕ dimer chains) and right (R- ȕ dimer chains) direction, which make only 
one type of ȕ dimer sheets in a structure, as shown in Figure 1.11b. These ȕ chains are 
ε ring 
ȕ dimer 
ȕ dimer 
ȕ dimer 
ȕ dimer 
ζ ring 
Figure 1.11a Formation of ε ring 
in Form II to join ȕ  dimer chains 
Figure 1.11b   Formation of ζ ring 
in Form IV to join ȕ dimer chains 
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connected with each other via N2—H2 contacts by making a ring, which was denoted 
as ζ, by Blagden et al (1998).  
 
The hydrogen bonding in sulphathiazole Form III can be thought of as the addition of 
Form II and IV (Figure 1.11c). In Form III, only one sheet is found, containing 
configuration of ȕ dimers such that pairs of L- ȕ dimer chains alternate with pairs of 
R- ȕ dimer chains. The ȕ dimer chains within a left (L) or right (R) sided pairs are 
connected with each other via H2—O2 contacts, whilst alternate left (L) and right (R) 
sided ȕ-chain pairs are connected with each other via N2—H2 contacts. Unlike Form 
II and IV, Form III shows both H2—O2 & N2—H2 contacts between ȕ-chains.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11c      Formation of ε and ζ rings to join stacked chains of ȕ dimers in Form 
III (re-drawn from Blagden et al, 1998).                                                             
 
ȕ dimer 
ε ring 
ζ ring 
ȕ dimer 
ȕ dimer 
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Thus the structural differences between these polymorphs arise from the way in which 
these  chains are arranged with each other to make sheets. 
 
1.11.2.3 Sulphathiazole, Polymorph V 
 
The crystal structure of Form V was reported by Anwar et al (1999) and Hughes et al 
(1999). The unit cell data of form V are listed in Table 1.2. 
 
The crystal structure contains two independent molecules, termed as A and B, which 
associate through hydrogen bonds and van der Waals interactions to produce a two 
dimensional sheet structure. Both of the molecules (A and B) in the asymmetric unit 
possess the ‘L’ shape.  
 
The molecular packing is characterized by sheets of molecules lying perpendicular to 
the a axis. A two-dimensional schematic of the hydrogen-bonding network in Form V 
is shown in Figure 1.12. 
  
Figure 1.12 The molecular structure and hydrogen bonding of sulphathiazole V 
(after Anwar et al, 1999) 
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Each sheet is two molecules thick, being integrated by hydrogen bonding. The 
alignment of the sheets with respect to each other is staggered along the b axis. This 
staggering enables the protruding heterocyclic rings in one sheet to occupy the voids 
close to the benzene rings in the adjacent sheets and thus optimise the packing. Each 
sheet consists of chains of molecules that are linked by hydrogen bonding running 
along the b direction. The chains are inter-linked by hydrogen bonds in the c 
direction. Within a sheet, the benzene rings all lie with their respective vertical axis 
(defined as the vector linking the N atom of the NH2 group to the S atom of the SO2 
group) pointing along the b axis.  
 
1.11.3 Morphology of crystals 
 
The different shapes of sulphathiazole crystals for different polymorphs are reported 
in the literature and listed in Table 1.3. 
 
Table 1.3 Summary for the reported morphologies of sulphathiazole Polymorphs  
Authors Form I Form II Form III Form IV Form V 
(Kruger et al, 
1971) 
elongated 
needles   
Hexagonal 
Plates 
 
Thin hexagonal 
platelets 
(Kruger et al, 
1972) 
 
Hexagonal 
prisms 
 
    
(Blagden et al, 
1998) 
elongated 
needles cuboid 
Hexagonal 
truncated 
Hexagonal 
plates   
(Anwar et al, 
1989) 
elongated 
needles 
Thin 
hexagons 
Hexagonal 
Plates 
 Undefined 
small plates   
(Groove et al, 
1941) 
elongated 
needles   
 
    
(Burger et al, 
1983) 
elongated 
needles 
Thin 
hexagonal 
platelets 
 
Hexagonal 
plates   
(Higuchi et al, 
1967) 
 
  
Hexagonal 
Plates     
(Miyazaki et 
al, 1947) 
elongated 
needles   
Hexagonal 
Plates     
(Kordikowski 
et al, 2001) 
elongated 
needles   
Hexagonal 
Plates 
 Hexagonal 
prisms   
Anwar  et al 
(1999) 
    
Thin Hexagonal 
platelets 
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In all previous studies, the morphology of Form I is consistently reported as a rod-like 
needle shape morphology. The morphology of crystals mainly depends on the way 
crystals grow after nucleation (Section 1.8). Different phases of crystals grow at 
different rates. Blagden et al (1998) investigated the fastest growing faces of Form I 
to IV, where Form I possesses a needle-like morphology with (010) faces as the 
fastest growing face. Form II possesses a cuboid morphology in which (110) faces are 
identified as the fastest growing faces, Form III possesses a truncated hexagon 
morphology with (110) as the fastest growing face, while Form IV possesses a plate-
like hexagonal morphology with (111) being the fastest growing face. 
 
From Table 1.3, it is clear that Form I is easy to identify with unique morphological 
shape. However, analytical analysis (e.g. DSC, PXRD, IR, Solid state NMR) 
accompanied with morphological analysis would be needed for the unambiguous 
characterization of sulphathiazole polymorphs. 
 
1.11.4  Properties of sulphathiazole polymorphs 
 
(a) Stability 
Ostwald’s (189γ) rule of stages suggests that crystallization of a compound from any 
solvent at a given temperature should crystallize initially to the least stable form in the 
solution followed by its stepwise conversion to the thermodynamically most stable 
form. It has been established that sulphathiazole follows the rule of stages (Blagden, 
1998). The subsequent appearance of the stable form was observed to occur in a 
stepwise manner in water; the system proceeded from the most metastable Form I, 
followed by other metastable Forms II and III to the thermodynamically most stable 
Form IV. Any of the pure forms of sulphathiazole were observed to remain 
unchanged for several months once separated and preserved in dry ambient 
conditions. 
 
After the recognition of Form V, Chan et al (1999) made a few comments about the 
thermodynamic stability of the five forms. Assuming that the lattice energies are 
directly related to unit cell densities, the rank of order of thermodynamic stability at 0 
K was III ≈ IV > II > I > V. Form III and IV were both found to be kinetically stable 
and did not show any conversion at ambient conditions.  
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(b) Dissolution rate/ solubility 
Various studies have examined the dissolution rate of sulphathiazole. For example 
Lagas and Lerk (1981) reported dissolution rates of polymorphs in the order of V > I 
> III, while Burger and Diler (1983) reported that order as I > II > III. Polymorph IV 
was revealed by Bablidev et al (1987); thereafter Anwar et al (1989) measured the 
solubilities of four polymorphs that ranked as I > V > IV > III.  
 
Generally high energy or metastable polymorphs show higher dissolution rates than 
the stable form (Niazi, 1976), which is also true in the case of sulphathiazole as most 
studies report that the most metastable Form I has the highest dissolution rate. 
 
However, in some instances, where the conversion of the metastable to a stable form 
is extremely rapid in the solvent medium, the differences between the dissolution 
rates of metastable and stable forms are indistinguishable as the transformation occurs 
very rapidly (Niazi, 1976). This kind of rapid conversion was reported for 
sulphathiazole (Anderson et al, 1976). Niazi (1976) observed the dissolution rates of 
Forms I and III to be indistinguishable in water and in a water-ethanol mixture due to 
rapid conversion of Form I into Form III. Lagas and Lerk (1981) performed 
dissolution studies in water at 37°C. They reported that only the dissolution rate of 
Form III was constant during entire run, whilst dissolution rates of Polymorphs I and 
V were constant for only a few minutes and started to decrease after four minutes to 
approach those for Form III. These studies suggested that metastable Polymorphs I 
and V must be converted rapidly into the more stable Form III under the experimental 
conditions.  
 
The use of additives has been also reported to enhance the solubilities of 
sulphathiazole. Niazi (1976) and Boldyrev et al (2005) reported the use of 
polyethylene glycol 4000 and calcium carbonate respectively to enhance the overall 
solubilities of sulphathiazole polymorphs. 
 
(c) Compressibility 
The compaction behaviour of crystalline powder is critically dependent on the 
mechanical properties of the compound and hence on the arrangements of molecules 
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in the crystal form, and consequently on the polymorphic form (Roberts and Rowe, 
2000). 
 
The critical properties for powder compaction are the Young’s modulus (which 
describes the elasticity or stiffness of the material) and yield stress (Roberts and 
Rowe, 1996). These properties vary between polymorphic pairs depending on the 
structural differences in the packing motif. The most stable form would have the 
higher Young’s Modulus and yield stress, which make it the most difficult to compact 
amongst all the forms of the compound. Conversely, the most metastable form would 
be easy to compact/deform due to its lower Young’s Modulus and yield stress (Sheth 
et al, 2004). However, according to Roberts and Rowe (1996) and Summers et al 
(1976), Sulphathizole Forms I and III showed very close values of Young’s modulus 
and yield stress. Roberts and Rowe (1996) explained that, although both polymorphs 
show different hydrogen bonding, the number of hydrogen bonds and their strength 
are very similar in both polymorphs and these similarities are reflected in the 
closeness of both Young’s modulus and yield stress of Forms I and III. 
 
Roberts and Rowe (1996) also reported that Forms I and III did not show any 
transformation due to compaction. However, 100% conversion of Form I into Form 
III was reported at very high pressure (1052 MPa) (Kala et al, 1982). Aaltonen et al 
(2003) observed the transformation of Form I into Form III during compression. 
 
(d) Surface energy and roughness 
The surface energy of a substance is defined as the amount of work required to 
increase the surface area of a substance by 1 m2 (Buckton et al, 1955). The surface 
energy of a system is of importance in many pharmaceutical dosage forms, such as 
suspensions and pressurised metered dose inhaler formulations (Traini et al, 2005; 
Parsons et al, 1992). Surface energy is also a very important factor during 
pharmaceutical processing, such as granulation, in the prediction of granule strength, 
morphology, failure process and film formation with binders. It is known that positive 
values of surface energy can lead to strong granules, whereas negative values of 
surface energy leads to weaker granules (Rowe et al, 1989a). Hence, prior knowledge 
of surface energy can be used to select the best binders for a particular drug substance. 
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For a crystalline substance changes in surface chemistry/energy can occur as a result 
of shift in a polymorphic form and crystal habit. 
 
Hooten et al (2001) measured the roughness and surface energy of sulphathiazole 
Form I, III and IV crystals using Atomic Force Microscopy. At a sample size less than 
1µm × 1µm the polymorphs rank in terms of roughness as I > IV > III, whereas at 
larger scale the polymorphs rank in terms of roughness as I > III > IV. The surface 
energy of polymorphs was ranked in order of IV > III ≈ I. The similarities of surface 
energies between Form I and III could be explained by the similarities in the number 
and strength of hydrogen bonds in these polymorphs (Section 1.11.2.2). 
 
1.11.5 The role of solvent on crystallization of polymorphs 
 
The ability to select the desired polymorph during crystallization can be achieved by 
either manipulation of solution parameters or by the molecular recognition of 
structurally related additives (Weissbuch et al, 2001). 
 
From previous studies (Blagden et al, 1998), it was established that 1-propanol 
stabilised the metastable Form I. In case of Form II to IV (Table 1.4), for example: 
Form II was observed to crystallize from nitromethane, ethanol, and n-propanol; Form 
III crystallized from water, dilute ammonia, or chloroform-acetone mixture, and 
ethanol; and Form IV crystallized from water, n-propanol and a chloroform-acetone 
mixture. Clearly, in most solvents, sulphathiazole showed polymorph selection with 
the use of different solvents. However, apart from 1-propanol for Form I, no other 
solvents were repetitive or consistent for the selection of a particular polymorph. 
 
Blagden et al. (1998) investigated the differences and similarities between the 
structures of sulphathiazole polymorphs using graph set analysis and used these to 
explain the observed solvent dependence of polymorph appearance. The study 
reported the crystallisation of Forms I, II, III and IV from n-propanol, nitromethane, 
aqueous ammonia and water, respectively. In agreement with other studies, this study 
also reported that n-propanol stabilised Form I and did not show conversion of Form I 
into the thermodynamically more stable Forms II to IV for a long period of time when 
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slurried in n-propanol. Blagden et al (1998) observed from the graph set analysis that 
one bond, H3—N1, which was required for the ȕ dimer (basic unit of Form II, III and 
IV; Section 1.11.2.2) was absent from the Form I structure.  They suggested that the 
interference of n-propanol could be responsible for the non-appearance of this 
bonding required to complete ȕ dimer and conversion of Form I into the more stable 
polymorphs II to IV. Similarly, for Forms II, III and IV, the effect of the other 
solvents on the ring to ring contact between ȕ chain motifs could relate to the 
solvent’s ability to stabilize a particular mode of ring association and then desolvate 
without disrupting the overall ring to ring association process. However, Blagden et al 
(1998) concluded that, on the basis of these qualitative considerations, it was hard to 
predict any sure solvent dependence of polymorph appearance in the system.  
 
1.11.6 Effect of other factors on sulphathiazole polymorphs. 
 
Apart from the solvent, there are several other factors that can also affect the 
polymorph appearance and structure of crystals. 
 
(a) By product and additives 
 
Blagden et al (1998) explored the role of additives in controlling sulphathiazole 
polymorphs. They observed the effect of the ethamido group on the crystallisation 
behaviour of sulphathiazole. From the results of this study, it was clear that while 
water yields only Form IV after 24 h, in a solution containing 10 mol % of additive 
only Form I crystallises. Within the range of 1 – 0.5 mol % of impurity a mixture of 
Form I (40%), II (20%), III (20%) and IV (40%) was obtained. The 0.01 mol % 
sample was identical to the pure system, yielding 100 % Form IV. In this context the 
effect of the ethamido derivative is to inhibit the nucleation and growth of Forms II, 
III and IV, thus kinetically stabilising Form I. The ethamido group is found to be one 
of the main by-products during synthesis of sulphathiazole. According to Blagden 
(1998), an increase in the level of ethamido by-product, during the manufacturing 
process would result in the stabilisation of Form I. This selectivity of ethamido to 
crystallise/stabilise Form I was shown to be possible through the differences in 
hydrogen bonding contacts along the fastest growing faces of Form I compared to 
Forms II, III and IV.  
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(b) Cooling rates 
Helenski et al (2003) reported that a very high cooling rate could also affect the 
crystal form of sulphathiazole. The polymorph obtained with slow cooling rates was 
Form III and, with the same solvent system, the polymorph formed with fast cooling 
rate was Form I. Theoretically, differences in polymorphic form were more likely due 
to the polymorphic conversions that happen according to Oswald’s rule of stages than 
dependent on the cooling rate.   
 
(c) Grinding 
The effect of grinding on sulphathizole Form III was examined by Anwar et al (1989). 
Samples of Form III were ground in a pestle and mortar for 1, 3 or 5 min. They 
observed the PXRD pattern of all the samples and compared it with the theoretical 
pattern of Form III. The agreement between the observed and the theoretical pattern 
was seen to improve with increased grinding for Form III. 
 
(d) Effect of heating/temperature 
The effect of heating was checked on sulphathiazole polymorphs using DSC. Form I 
did not show any change on heating and was observed to melt at 202 °C. Forms II, III 
and IV show transformation into Form I in the temperature range of 148° – 177°C 
followed by melting at 202 °C. So, it can be said that Forms II – IV are not stable at 
temperatures higher than 140°C and show the transformation to Form I (Table 1.2). 
 
1.11.7 Crystallization of sulphathiazole polymorphs 
 
The crystallization technique and its conditions are very important for achieving a 
particular polymorph and for the isolation of a particular form. In the case of 
sulphathiazole polymorphs, the literature is dominated by cooling and evaporation 
methods using various solvents.  
 
Nevertheless, there are consistent reports of crystallising Form I from n-propanol. 
Kruger and Gafner (1971) and Lagas and Lerk (1981) obtained crystals of Form I by 
evaporation or cooling of a saturated n-propanol solution from 80 °C to room 
temperature. Anwar et al (1989) and Blagden et al (1998) also obtained Form I using 
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a saturated solution of n-propanol by cooling from 90 °C or above to room 
temperature. Apperley (1999) reported the heating of commercial sulphathiazole at 
180°C to obtain Form I. 
 
Kruger and Gafner (1971) and Burger et al (1983) obtained crystals of Form II from a 
saturated n-propanol solution at room temperature by evaporation. Anderson et al 
(2001) reported the preparation of Form II by slow cooling of a saturated aqueous 
solution. Blagden et al (1998) obtained crystals of Form II by cooling from saturated 
nitromethane or ethanol solution, while Apperley et al (1999) used a supersaturated 
aqueous solution and evaporated it to dryness to obtain Form II.  
 
Form III was crystallized by slow evaporation from dilute ammonium hydroxide 
solution at room temperature (Kruger and Gafner, 1971). Lagas and Lerk (1981) 
obtained Form III by very slow cooling/evaporation from water, ethanol and water-
ethanol or chloroform-acetone mixtures. Anwar et al (1989) recrystallized Form III 
from saturated aqueous solution by cooling at 5-10 °C/h. Blagden et al (1998) 
crystallized Form III by cooling a saturated aqueous ammonia solution at 40 °C to 
room temperature. 
 
Form IV was crystallized mainly by cooling or evaporation from saturated solutions 
of acetone-chloroform mixtures, boiling water and n-propanol. Burger et al (1983) 
reported the crystallization of hexagonal crystals of Form IV by evaporation using n-
propanol as a solvent. Anwar et al (1989) recrystallized Form IV from a 50:50 
mixture of acetone and chloroform by cooling to room temperature. Blagden et al 
(1998) prepared a saturated solution of sulphathiazole in water (25 g/l) and obtained 
Form IV by cooling the solution from 40 °C to room temperature. Apperely et al 
(1999) crystallized a sample of Form IV by cooling from acetonitrile.  
 
Form V was prepared by boiling a supersaturated solution of sulphathiazole in water 
until all the solvent evaporated (Lagas and Lerk, 1981; Anwar et al, 1989; Chan et al, 
1999; Hughes et al, 1999). Appearly et al (1999) purified Form V by dissolution in 
alkali followed by neutralization.  
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There were also some unique techniques reported for the crystallization of 
sulphathiazole polymorphs. Anderson et al (2001) used a HEL-Auto-MATE (HEL, 
Hertfordshire, UK) laboratory reactor for the crystallization of sulphathiazole with 
different solvents. Their objective of using the automated reactor system was to 
determine if the proper form was being precipitated, and real time onset of 
crystallization. Kordikowski (2001) used the SEDSTM process (Solution Enhanced 
Dispersion using Supercritical fluids) to separate the enantiotropic forms of 
sulphathiazole. Variation of temperature and flow rate of CO2 and solvent proved that 
thermodynamic and kinetic control could be applied to generate certain forms. Three 
Forms (I, II and IV) could be crystallized with methanol only by choosing the 
appropriate temperature and flow rate conditions (Kordikowski et al, 2001).   
 
1.12 Indomethacin 
 
Indomethacin is a non Steroid Anti-Inflammatory drug (NSAID) used primarily to 
relieve pain and inflammation caused by conditions such as gout and arthritis, and 
works by blocking cyclooxygenase. The structure of indomethacin is shown in Figure 
1.13. The main features are the benzoyl ring, the benzoyl chlorine atom, an indole 
ring and a carboxylate group.  
 
 
Figure 1.13   A molecule of indomethacin 
 
Indomethacin was first approved by the FDA in 1965 (Yamamoto, 1968). It is 
available in three dosage forms; capsules, suspension and suppositories with the first 
two dosage forms containing the drug as a solid. A good understanding of the 
properties of its solid state is therefore essential in designing dosage forms with 
optimum drug delivery characteristics and stability. 
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1.12.1 Polymorphs of indomethacin 
Indomethacin is known to exhibit at least five polymorphs and has a tendency to form 
solvates with a wide range of solvents under super-saturation conditions (Slavin et al, 
β00β). The Ȗ Form (Form I) is the most thermodynamically stable and forms at low 
supersaturation conditions. It has a plate-like morphology, largely unchanged by 
solvent of crystallization. The α Form (Form II) is observed under high 
supersaturation conditions, is metastable, but can be isolated and stored for up to 18 
months without transformation (Slavin et al, 2002). Only these two forms are 
produced reliably. The remaining polymorphs, Forms III, IV and V (ȕ), exist only in 
thin films grown from the melt and in the presence of co-solutes (Yamamoto, 1968; 
Borka et al, 1974, Slavin et al, 2002). All of these Forms, III, IV and V (ȕ), are 
metastable and readily transform to Forms I or II on standing or heating. The relative 
appearance of the two principle Polymorphs α (II) and Ȗ (I) is consistent with 
Ostwald’s rule (189γ) which would predict that the α phase should form under rapid 
precipitation conditions followed by its transformation to the stable Ȗ Form on long 
periods of standing or lengthy growth periods.  
 
The polymorphism of indomethacin has been discussed extensively, particularly, after 
FDA approval for use as a medicine in 1965. First of all, Yamamoto (1968) stated that 
indomethacin can be found in different crystalline forms determined as α (Form II), ȕ 
(Form V) and Ȗ (Form I) and also presented distinct PXRD patterns of these three 
forms. However, later reports reported only two of these forms. Allen and Kwan 
(1969) reported Form I and Form II with melting points respectively at 160 and 154 
°C. Monkhouse and Lach (1972) identified Forms I and II, with melting points 
respectively at 158 and 152 °C, and presented IR spectra. Borka (1974) identified 
another two Forms, III and IV and a solvent containing (solvate) Form V. Borka 
stated that Form V may contain various amounts of different solvents without any 
stoichiometry. Form I (160 °C) and Form II (154 °C) can easily be isolated in pure 
form both from the melt and from solvents. Form III (148 °C) can only be observed 
by its appearance and melting point in microscopic preparations. Form IV (134 °C) 
can be isolated in pure form from the melt and from warm methanol (Borka, 1974). 
Borka (1974) also interpreted that Yamamoto’s (1968) Form ȕ was a solvate of Form 
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V, which melted at low temperature, lost the solvent, recrystallized into Form I and 
gave the high melting point of 160 °C.  
 
Polymorphic forms of indomethacin show different therapeutic properties as well as 
side effects (Singhal et al, 2003). Thus, the preparation of polymorphic forms of 
indomethacin was an important technological problem. Pakula et al (1977) defined the 
technologically useful methods of preparing α (II), ȕ (V), and Ȗ (I) Forms of 
indomethacin, and also defined the influence of various parameters, such as solvent, 
heating and cooling rate, concentration and temperature, on the formation of 
individual forms of indomethacin during crystallization. Kaneniwa et al (1985) also 
established the methods for the preparation of the pure α (II) and Ȗ (I) Forms of 
indomethacin, and also re-examined the physico-chemical properties of these 
polymorphs. 
 
Lin et al (1992) reported that a new polymorph of indomethacin was precipitated from 
an aqueous solution of indomethacin and ȕ-cyclodextrin by a titration method. The 
DSC analysis of crystals that precipitated from the solution of indomethacin without 
ȕ-cyclodextrin was the same as that of the α Form (II), which suggested that the 
formation of the new polymorph of indomethacin depended on the absence or 
presence of ȕ-cyclodextrin (Lin et al, 1992). However, the occurrence of this new 
polymorph could be considered as a complex of indomethacin and ȕ-cyclodextrin 
rather than Form VI. Bratu et al (2001) reported the α (II) and Ȗ (I) Forms and solvate 
of indomethacin from various solvents and presented X-ray diffraction and FTIR 
spectra.  
 
Also there are many reports available on the crystallization of indomethacin 
polymorphs from the amorphous state. Andronis and Zografi (2000) determined the 
effect of temperature on the overall crystallization, and the crystal nucleation of 
indomethacin polymorphs from the amorphous state. They reported that 
crystallization of amorphous indomethacin at close to or below its glass transition 
temperature, Tg, (42 °C), favours the formation of the stable Ȗ Form, while 
crystallization at higher temperature favours the formation of α Form. Wu and Yu 
(2006) concluded that the liquid dynamics of indomethacin control its crystal growth 
kinetics over a wide range of temperatures but changes of growth morphologies near 
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Tg also lead to apparent acceleration of growth of certain polymorphs. 
 
Indomethacin is used in many pharmaceutical preparations (Yamamoto, 1968, Rio et 
al, 2002). Despite its utility and the need to understand the morphological properties 
of its crystals for the purpose of formulation, little has been published on the 
morphologies of the polymorphic forms. Slavin et al (2002) described the 
morphological variation of α, Ȗ, and solvates grown from a range of solvents, and 
particularly defined the morphologies of the Ȗ Form and compared the results with 
modelling calculations of the predicted morphology of the Ȗ Form. Also Rio et al 
(β00β) developed the recrystallization method of the desired α and Ȗ Forms, using 
specified solvent ratios and cooling parameters, at a satisfactory level of efficiency. 
Moreover, they also defined the pre-formulation properties of both forms, such as 
dissolution, flowability, and compressibility for the production of pharmaceutical 
tablet forms. 
 
Often metastable forms have desirable properties, and are preferable to the stable 
form. The stability to transformation of the metastable α Form of indomethacin makes 
commercial usage viable. Both α and Ȗ Forms are monotropic polymorphs and they 
did not report inter conversion in the solid-state without a solvent such as ethanol 
(Andronis et al, 1997; Okumura et al, 2006). However, the α Form has an undesirable 
morphology consisting of fibrous structures. For this reason, its properties are 
uninvestigated and its potential for exploitation remains untapped. This project will 
examine the morphological expression of the α and Ȗ Forms of indomethacin with the 
aims of producing crystals of the α Form with a well defined morphology, and 
producing Ȗ crystals with modified morphology. 
 
1.12.2 Crystal structure of indomethacin forms 
 
The crystal structures of both α and Ȗ Forms were reported in detail in the previous 
literature. They will be referred to briefly here in order to understand differences, 
particularly, in their hydrogen bonding.  
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(a) γ Indomethacin (Form I) 
Kistenmacher et al (1972) were the first to report the solid-state structure of Ȗ-
indomethacin by single crystal x-ray diffraction methods. There are three chemical 
groups present in the structure of indomethacin; a benzene ring, indole ring and 
carbonyl group. Ȗ-indomethacin crystallizes in the centro-symmetric triclinic space 
group P1 (triclinic) with Z = 2, and unit cell a = 9.β95 Å, b = 10.969 Å, c = 9.74β Å, α 
= 69.38°, ȕ = 110.79°, and Ȗ = 9β.78°. Also, Galdecki et al (1976) solved the structure 
of Ȗ indomethacin using three dimensional photographic data. They also compared 
their data with x-ray data of Ȗ indomethacin found by Kistnemacher et al. (1972). 
 
                                      
 
 
 
 
 
 
 
 
Figure 1.14 Dimer formation in Ȗ indomethacin structure via hydrogen bonding 
between carboxylic functional groups (re-drawn from Kistemnmacher et al, 1972) 
 
Two features dominate the crystal packing. The first is the expected hydrogen 
bonding of the carboxylic acid group about centres of inversion to form molecular 
dimers as shown in Figure 1.14. The second important feature of the crystal packing is 
the overlapping of the indole ring with the acetic acid group of another molecule.  
 
Chen et al (2001) reported that these hydrogen bond dimers are caged inside a 
hydrophobic shield. In one direction, the bulky indol and phenyl rings of the molecule 
protect the dimers. Two indol rings from neighbouring unit cells block the second 
direction. In the third direction, two phenyl rings provide protection. Recently, 
Carpentier et al (β006) characterized the crystalline Ȗ phase by the existence of 
rotational dynamics related to the chlorobenzyl group motion using solid state NMR.  
 
Molecule A 
Molecule B 
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(b)  α Indomethacin (Form II) 
The crystal structure of the metastable α Form was not published until 2001 due to the 
small size of α crystals, which were not large enough for single crystal x-ray 
diffraction. In 2001, Chen et al developed large single crystals of the α Form by 
diffusion of water vapour into a solution of glacial acetic acid, and reported the crystal 
structure of α indomethacin using single crystal X ray diffraction. α indomethacin 
crystallized in the non centrosymmetric monoclinic space group P21 with Z = 6. The 
unit cell constants were a = 5.46β Å, b = β5.γ10 Å, c = 18.15β Å, α = 90.00°, ȕ = 
94.38°, Ȗ = 90.00°, with V = 2501 Å3 (Chen et al, 2001). The calculated density, 
obtained from single crystal data, was measured as 1.43 g/cm3, which agrees well 
with the experimentally determined value of 1.40 g/cm3 (Andronis et al, 2001). 
 
The asymmetric unit of α indomethacin consists of three molecules with very 
different conformations. These three molecules exist as trimers in which two of the 
molecules form mutually hydrogen bonded carboxylic acid dimers and the third 
molecule forms a hydrogen bond between the carboxylic acid and an amide carbonyl 
in the dimer (Figure 1.15). Furthermore, the hydrogen bond between the carboxylic 
acid of molecule C and the amide carbonyl of molecule B in the α-Form is the longest 
in the two modifications, and the hydrogen bond of the A-B carboxylic acid dimer is 
considerably longer than the B-A hydrogen bond of the A-B dimer and the hydrogen 
bond of the γ-Form dimer 
 
 
 
 
 
 
 
 
 
 
                                      
Figure 1.15  A trimer formation in α-indomethacin (re-drawn from Chen et al, 2001) 
 
Molecule A 
Molecule B 
Molecule C 
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The determination of the crystal structure of the α Form gave confirmatory evidence 
that this metastable form has a greater density as compared to that of the γ Form 
(Chen et al, 2001). Typically, in comparing two polymorphs, the form having a lower 
density than the other is assumed to be less stable at 0 K, which is known as the 
density rule (Burger et al, 1979). In indomethacin, however, the metastable α Form 
has a greater density than the more stable γ Form. There are some exceptional cases to 
the density rule reported in the literature (Burger et al, 1979), which involve strong 
hydrogen bonding or conformational changes along with hydrogen bonding. Thus, the 
greater density of the α Form may be related to the additional hydrogen bonding 
present (between a carboxylic acid hydroxyl group and the carbonyl oxygen of an 
amide group) and the three conformations that indomethacin adopts in the α Form as 
compared to the single conformation in the γ Form. The additional conformations of 
the α Form provide a closer packed crystal and hence a greater density than that 
possible in the γ Form (Chen et al, 2001). 
 
Recently, Carpentier et al (2006) used solid state NMR to characterize the molecular 
mobility of indomethacin in its different forms below its Tg. They reported that no 
molecular mobility exists in the α phase, except methyl group rotations. In a similar 
study, Masuda et al (2006) analyzed the difference in the molecular conformation 
packed in the crystal lattice between the metastable α Form and stable Ȗ Form of 
indomethacin on the basis of solid state 13C NMR spectral pattern. The chemical shifts 
of each resonance of the α Form were distinctly different from the Ȗ Form. Carbon 
nuclei of the α Form showed a complicated set of resonances for each carbon. 
 
1.12.3 Properties of Indomethacin Polymorphs 
 
The significance of polymorphism to the pharmaceutical industry lies in the different 
properties of various polymorphs, which affect the efficiency of the active substance 
(Brutu et al 2001). Many of these physico-chemical properties of indomethacin 
polymorphs were already reported in the literature and are discussed briefly here.  
 
(a) Toxicity 
There are few studies in the literature, concerning indomethacin toxicity or the 
influence of its crystalline forms on toxicity and absorption. Naciazek-Wieniawska  et 
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al (1975) found that α indomethacin was more toxic than the Ȗ Form. This study 
reported that α indomethacin was 1.γ-β.β times more toxic than Ȗ indomethacin in 
mice.  
 
(b) Solubility and bioavailability 
Many drugs are poorly soluble or insoluble in water, which results in poor 
bioavailability because the solubility of a drug is an important factor in determining 
the rate and extent of its absorption. Hence, this property is of a great importance in 
developing pharmaceuticals. Indomethacin is a hydrophobic drug and both forms 
show poor solubility in water. However, α indomethacin has been reported to have a 
better dissolution rate compared to Ȗ indomethacin (Andonis et al, 2000). Rectal 
absorption rate of the metastable α Form (dissolution rate) in the rat was greater than 
the stable Ȗ Form (Yokoyama, 1979). According to Rio et al (2002), the higher 
solubility of the α Form is not only due to its crystal state, but also to its higher 
original specific surface.  
 
(c) Stability 
The Ȗ Form is the most thermodynamically stable as implied by melting point. 
melting/fusion of all the polymorphs are reported in the literature (section 1.12.1). 
From this Slavin et al (2001) suggested that indomethacin polymorphs follow the rank 
of stability in order of I (Ȗ) > II (α) > III > IV > V > amorphous. The α Form (II) can 
be prepared by direct crystallization, however and although metastable, has been 
shown to persist at room temperature for periods of longer than 18 months without 
transformation (Slavin et al, 2002).  
 
Forms III, IV, V and the amorphous form are not kinetically stable and therefore not 
of interest for pharmaceutical use.  
 
(d) Compressibility and Flow ability 
Rio et al (2002) reported the compressibility and flowability of Ȗ and α Forms. They 
measured the compression ratio, which showed that the α Form had a better capacity 
for compressibility compared to the Ȗ Form. This was further confirmed by α Form 
tablets offering greater resistance to fracturing due to their higher hardness indices 
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(Rio et al, 2002). The flowability was also expressed as good for the α Form (Rio et 
al, 2002). 
 
(e) Chemical stability 
Chen et al (2001) showed that the distinct crystal packing of the α and Ȗ Forms of 
indomethacin has a profound impact on the chemical stability of the forms. They 
demonstrated this by exposing both forms to the presence of ammonia gas. The α 
Form single crystals became opaque within 8 minutes, which indicates that there was 
a rapid interaction between α -indomethacin and ammonia gas. Chen et al (2001) 
suggested that the development of opacity in α indomethacin is due to an acid-base 
reaction with ammonia to make the ammonium salt. Conversely, Ȗ indomethacin 
showed inertness to ammonia gas and did not show any changes even after 24 hours 
of exposure. Additionally, Chen et al (2001) supported this result by weight gain 
measurements of the α and Ȗ Forms, when exposed to ammonia for 1 hour. The results 
showed that α-indomethacin crystals gained significant weight, 3.81 %, by reacting 
with (absorbing) ammonia gas, whereas the weight gain for the Ȗ Form was nearly 
zero, which further confirms the inertness of the Ȗ Form and reactivity of α Form to 
ammonia gas. 
 
1.12.4 Crystallization methods of indomethacin 
 
As shown in Table 1.4, there are three types of crystallization techniques reported in 
the literature for indomethacin; (1) evaporation, (2) cooling and (3) precipitation. 
 
Table 1.4 Summary of the crystallization techniques reported in literature for 
Indomethacin polymorphs. 
Solvent Crystallization 
technique used 
Polymorphs Literatrure 
 
Acetonitrile Cooling/evaporation Ȗ A, E, K 
α E,  
Ethyl ether  Cooling/evaporation Ȗ B, E, K, L, P 
α /solvates E 
Ethanol Water precipitation, 
cooling/evaporation 
α  D, E, F, G, J, K, L, 
M, P, Q, R  
Ȗ D, E, M 
Range of 
alcohols 
Cooling at room 
temperature 
α /solvates E 
Ȗ E 
 69 
Ethyl 
acetate 
Cooling at room 
temperature 
Ȗ  E, G,   
α /solvates E 
Evaporation α K 
Toluene Cooling Ȗ E, H 
α /solvates E 
Acetone Evaporation/cooling α /solvates E, F 
Water precipitation 
/fast cooling 
α F, G,  
Cooling Ȗ E, F 
Cooling (3 hour) Ȗ G 
ȕ G 
Acetic 
acid: water 
Fast cooling 
/evaporation/water 
vapor diffusion 
α G, K, M 
Slow cooling to 45°C  Ȗ G, 
Benzene Cooling ȕ G, J, P 
CHCl3, 
CCl3 
Cooling ȕ G 
 
Key used in Table 1.4 A – Kistenmacher et al (1972); B –Galdecki et al 
(1976); C – Kim et al (2003); D – Andronis et al (2000); E – Slavin et al (2002); F – 
Rio et al (2002); G – Pakula et al (1977); H – Brutu et al (2001); J – Yamamoto et al 
(1968); K – Borka et al (1974); L – Otsuka et al (2001); M – Chen et al (2001); P – 
Lin et al (1999); Q – Masuda et al (2006); R – Okumura et al (2006) 
 
According to the literature (Table 1.4) the Ȗ Form is normally crystallized from 
diethyl ether and acetonitrile as plates and prisms; whereas the α Form is mainly 
crystallized from ethanolic solutions. However the choice of solvent is not the only 
parameter responsible for the polymorphic outcome. It is clear from the data 
presented in Table 1.4 that attention should be given to experimental techniques and 
conditions such as concentration, cooling rate or temperature.  
 
For example, Pakula et al (1977) reported that the crystallization of indomethacin 
from aqueous ethanol by cooling from elevated temperature to 40-45 °C gives 
reproducibly pure α Form, whereas cooling below 40 °C caused, in the majority of 
cases, the precipitation of a mixture of α and ȕ Forms. For the majority of alcohols 
low super-saturation conditions yielded the Ȗ Form alone and high supersaturation 
yielded a mixture of the α Form and solvates (Table 1.4). In the same way, 
acetonitrile generally resulted in the crystallization of Ȗ Form. However, Slavin et al 
(β00β) reported that acetonitrile gave the pure α Form at high supersaturation and 
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pure Ȗ Form at low supersaturation conditions. They studied a range of solvents and 
observed a similar effect of supersaturation on the polymorphic outcome of 
indomethacin (Table 1.4).  
 
In addition to temperature and concentration, cooling rate is also reported as one of 
the deciding parameters for the crystallization of indomethacin. Rio et al (2002) 
studied the recrystallization of Ȗ Form from aqueous acetone solution at a cooling rate 
of 0.17 °C/min. If the rate was increased to 0.4 °C/min, α Form crystals were 
obtained. Previously, Pakula et al (1977) also observed the effect of cooling rate and 
solvent ratio on the crystallization of polymorphs. They reported that fast cooling of 
an acetic acid and water solution (2:1.5) within 10 min, resulted in the formation of 
the α Form; whereas, slow cooling to 45 °C of an acetic acid and water solution (2:1), 
resulted the crystallization of the Ȗ Form. 
 
The ȕ Form occurs during crystallization from a range of solvents such as acetone, 
benzene, chloroform, carbon tetrachloride by cooling (Table 1.4). The ȕ Form is, 
however, unstable and storage at room temperature as well as drying or any other 
operation causes its transformation into the α- or Ȗ-Form. 
 
Apart from solvent crystallization, melt crystallization was also studied for 
indomethacin at higher temperatures. By preparing a crystal film and placing it on a 
Kofler hot stage, most forms were observed within the melt with increase in 
temperature (Borka et al, 1974). Form IV grows readily between 70 and 90 °C in a 
crystal film. By raising to the higher temperature of 110-115 °C, Form III grew as 
spherulites, but always together with α Form (II) and Form IV. Form III was not 
obtained in its pure form. At a few degrees higher, α Form (II) dominated with Ȗ Form 
(I). They grew side by side up to 150 °C, then α Form (II) melted at 154 °C and Ȗ 
Form (I) crystals grew and remained in the melt below 156 °C as plates and prisms 
until they melted finally at 160-161 °C.  
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1.12.5 Morphological studies of indomethacin polymorphs 
 
Despite its utility and the need to understand the morphological properties of product 
crystals for the purpose of formulation, surprisingly little has been published on the 
morphologies of the predominant polymorphic forms of indomethacin. 
 
Transparent yellowish crystals of Ȗ-indomethacin were obtained by Galdecki et al 
(1976). Ȗ-indomethacin showed a well defined large, prismatic and plate-like 
morphology in most previous studies (Table 1.4). The α-Form grew as a 
fibrous/spherulitic micronized needle/columnar like morphology (Slavin et al, 2002), 
white in colour (Rio et al, 2002). These micronized needles of the α Form were 
observed to be clustered into bundles.  
 
Of particular note was the close similarity of the morphologies of the Ȗ-species 
precipitated under similar conditions from a wide range of solvent types. This implies 
that there is little or no solvent direction of the morphology or polymorphic type. This 
assumption was confirmed by the observation of similar morphologies following 
growth from the melt where no solvent direction or mediation can be envisaged 
(Slavin et al, 2002). 
 
A full analysis of the morphology of the Ȗ Form has been carried out for crystals 
grown from acetonitrile, at both high and low super saturation. Morphological 
modelling calculation based on the Attachment Energy (Slavin et al, 2002) model was 
also carried out on the Ȗ Form, which showed good agreement with the Ȗ-
indomethacin crystals grown at low super-saturation from acetonitrile. 
 
1.12.6 Effect of various factors on indomethacin polymorphs 
 
(a) Humidity 
Absorbed water vapour lowers the Tg of amorphous indomethacin and enhances the 
overall crystallization rates, favouring the Ȗ-Form at low water content and the α-
Form at higher water content of the amorphous form (Andronis et al, 2000).  
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(b) Grinding with controlled temperature 
Otsuka et al (1986) investigated the effect of grinding on the polymorphs of 
indomethacin at various temperatures. The results suggested that the α -and Ȗ-Forms 
of indomethacin were converted to a non-crystalline solid during grinding at 4 °C by 
mechanical stress. However, it seems that the Ȗ Form was more stable than the α Form 
during grinding at 4 °C since the Ȗ-Form was converted to non-crystalline solid after 
grinding for 4 h, but the α-Form was converted in only 2 h. At 30 °C, the α-Form of 
indomethacin was more stable than the Ȗ-Form during grinding since the latter was 
transformed to the metastable α-Form on grinding, whereas the α-Form did not 
change and finally converted to a non-crystalline solid after intensive grinding.  
 
(c) Pressure 
Indomethacin powder was examined under a hydrostatic pressure of 400 Mpa to 
determine the effect of pressure on the powder. Under high pressure, the Ȗ -Form of 
indomethacin showed the transformation into α-Form. However the α-Form showed 
traces of amorphousness at higher pressure but did not show transformation into other 
polymorphic forms (Okumura et al, 2006).  
 
1.12.7 Effect of additives 
 
No relevant studies were found in the literature for the effect of additives on the 
morphology of indomethacin. However, there are some reports which describe the 
complex of indomethacin with carriers and excipients. Also amorphous indomethacin 
is reported to complex with polymers. Hamza et al (1994) studied the enhanced 
aqueous solubility of indomethacin in the form of physical mixtures, with 
nicotinamide as a carrier. The authors reported the formation of an 
indomethacin/nicotinamide complex. This complex is formed in the molten state or in 
solution. H bonding and π- electron donor- acceptor links are probably the main 
contributions to the interaction mechanism between indomethacin and nicotinamide. 
(Bogdanova et al, 1998; Truelove et al, 1984; Fawzi et al, 1980). 
 
In solution, PVP (Poly Vinyl Pyrrolidone) has been found to interact with numerous 
organic molecules and it has been suggested that the mechanism of crystallization 
inhibition is related to the extent of interaction between drug and polymer (Zograffi et 
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al, 1998). The addition of PVP to amorphous indomethacin to form a miscible binary 
amorphous phase, results in the disruption of the indomethacin dimers. This is 
brought about by a hydrogen bond formed between the PVP amide carbonyl group 
and the indomethacin hydroxyl group. The formation of a hydrogen bond between 
indomethacin and PVP offers an explanation as to how PVP is able to inhibit 
crystallization from the amorphous phase at levels where the antiplasticising effect is 
minimal (Zograffi et al, 1998). 
 
1.13 The scope of the thesis 
 
As discussed in Sections 1.8 and 1.10, polymorphs and their morphology can have 
great influence on the final product/drug efficacy. The control over the appearance of 
polymorphs and morphology can be achieved in the final product with a knowledge of 
techniques in crystal and nucleation engineering. Understanding of the 
supramolecular processes that take place when polymorphic materials nucleate is 
expanding and can be applied to a variety of systems to control the polymorphic 
outcome of nucleation. 
 
Sulphathiazole is a highly polymorphic model system (five polymorphs, I to V), 
which is used to demonstrate the ability to isolate polymorphs from different solvents. 
Already the subject of extensive study, the sensitivity of this material (for polymorph 
selection) to solvent environment is well established (Anwar et al, 1989; Blagden et 
al, 1999). The crystal structures of five polymorphs are already reported in the 
literature.  It is also established that 1-propanol stabilizes the most metastable Form I.  
The current project aims to examine the effect of a range of alcohols on polymorph 
selection of sulphathiazole and attempts to elucidate the mechanism of alcohols in 
polymorph selection process.  The role of the alcohol functional group in the 
polymorph selection process will be thus investigated and evaluated. Various 
experimental crystallization and analytical techniques will be employed for the 
crystallization and polymorphic identification of sulphathiazole polymorphs. Based 
on an experimental study, the role of solvent in the stabilization/selection of 
polymorphs will be also investigated by visualizing and performing thermodynamic 
calculations using Cerius2 molecular modelling software. 
 
 74 
Another model system, Indomethacin is known to exhibit at least five polymorphs. 
However, only Ȗ Form (I, the most stable form) and α Form (II, metastable form) are 
produced reliably. The remaining polymorphs, Forms III, IV and ȕ (V), are 
metastable and readily transform to Forms Ȗ (I) or α (II) on standing or heating. The α 
Form (II) is metastable, but can be isolated and stored for up to 18 months without 
transformation, which makes commercial usage of the metastable form viable. 
However, the α-Form has an undesirable morphology consisting of fibrous structures. 
For this reason, its properties have not been investigated and the potential for 
exploitation untapped. The project will examine the morphological expression of the 
α- and Ȗ Forms of indomethacin with the aims of producing crystals of the α 
polymorph with a well defined morphology using structurally related additives. 
Various experimental techniques will be employed for the crystallization of 
indomethacin with structurally related additives. 
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Chapter 2 Materials and Methods 
 
 
In this study, sulphathiazole and indomethacin were crystallized using various 
methods and conditions. The crystallization of sulphathiazole using different solvents 
with an alcohol (-OH-) functional group, was studied for effects on polymorphic and 
morphological behavior. Indomethacin was crystallized using various crystallization 
techniques/conditions to study the effect on crystal morphology. In addition, additives 
were also used with indomethacin to improve the fibrous morphology of the α-Form. 
Crystal samples were characterized using analytical techniques such as optical 
microscopy, hot stage microscopy, powder X-ray diffraction, differential scanning 
calorimetry, and infra-red spectroscopy to study the morphological and polymorphic 
behavior of the samples. The effect of solvents (alcohols) on polymorph selection of 
sulphathiazole was predicted using ‘Cerius2’ (Accelrys, Cambridge, UK) and ‘GRID’ 
based molecular modelling software (Roberts et al, 2007).  
 
2.1 Materials 
 
All the materials used in this study are listed in Table 2.1.  
 
2.1.1 Sulphathiazole 
Sulphathiazole (98%) was used as a model drug to study the role of solvents on 
polymorph selection.  
 
2.1.2 Indomethacin 
Indomethacin (99.5%) was used to study the effect of additives and various 
crystallization conditions on crystal morphology.  
 
2.1.3 Solvents and Additives 
A number of solvents and additives were used in the experimental studies. A list of all 
these solvents and additives is given in Table 2.1 
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Table 2.1 List of all chemical compounds used in experimental studies 
Reagents Supplier appearance Boiling 
point (BP) 
or melting 
point 
(MP) 
Sulphathiazole 
 
Sigma-Aldrich, 
Dorset, UK 
White crystalline  
powder 
MP 200-202°C  
Indomethacin Sigma-Aldrich, Dorset 
UK 
White powder MP155°C 
Adipic acid Sigma-Aldrich, Dorset 
UK 
white crystalline 
powder 
MP 151-154°C 
Myristic acid 
 
Sigma-Aldrich, 
Dorset, UK 
White powder MP 52-54°C 
Oleic acid Sigma-Aldrich, 
Dorset, UK 
Colourless liquid MP 13-14°C, BP 
194-195° 
Capric acid 
 
Sigma-Aldrich, 
Dorset, UK 
Crystalline white 
powder 
MP 27-32°C, BP 
268-270°C 
1-indole 3-
acetic acid 
Sigma-Aldrich, 
Dorset, UK 
White crystalline 
powder 
MP 168-170°C 
Tetramethylsil
ane 
Sigma-Aldrich, 
Dorset, UK 
Colourless liquid BP 28 °C 
1-propanol VWR International 
Ltd, Lutterworth, UK 
Clear colorless 
liquid 
BP 97°C 
2-propanol VWR International 
Ltd, Lutterworth, UK 
Clear colorless 
liquid 
BP 82°C 
Ethanol BDH, Poole, UK Clear colorless 
liquid 
BP 78°C 
Methanol BDH, Poole UK Clear colorless 
liquid 
BP 64.7°C 
Butanol BDH, Poole, UK Clear colorless 
liquid 
BP 116-118°C 
Deionised 
water 
Inhouse Clear colorless 
liquid 
BP 100°C 
Acetonitrile VWR International 
Ltd, Lutterworth, UK 
Clear colorless 
liquid 
BP 81-82°C 
Ethyl acetate VWR International 
Ltd, Lutterworth, UK 
Clear colorless 
liquid 
BP 76.5-77.5°C 
Acetic acid VWR International 
Ltd, Lutterworth, UK 
Clear colorless 
liquid 
BP 117-118°C 
 
2.2      Methods 
 
The experimental techniques employed in this study are discussed in detail in this 
Section.  
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2.2.1 Solubility experiments  
 
The solubility data for sulphathiazole and indomethacin were determined 
experimentally in each of the solvents used in the crystallization studies. The 
solubilities were determined at various temperatures ranging from 25° to 65 °C.  
 
A 400 ml jacketed beaker, a magnetic stirrer and a waterbath (Thermo Haake, 
Dieselstr.4.D-76227 Karlsruhe, Germany) with temperature control were used for the 
solubility measurement experiments. 100 ml pure solvent was added to the jacketed 
beaker. The beaker was enclosed with a glass lid to prevent evaporation. The beaker 
was equipped with a water bath for the control of temperature and placed on a 
magnetic stirrer. The experimental set up is shown in Figure 2.1. Initially, the 
temperature of the water bath was set at 25 °C. Very small quantities of solid were 
added gradually into the solvent with constant stirring, until no more solid drug was 
observed to dissolve at 25 °C in the solvent. At this point the solvent is said to be 
saturated with dissolved material.  
 
 
  
      
 
Figure 2.1 Generic set up used for solubility and crystallization experiments 
 
  
Thereafter, the temperature of the waterbath was raised by 10 °C to 35 °C. The 
increase in temperature made the solution undersaturated (Section 1.2). Therefore, 
again, very small quantities of solid were added gradually into the solution with 
constant stirring, until the solution became saturated at 35 °C. The total weight of 
solid added to the solvent was noted as the solubility at 35 °C. Similarly, the solubility 
was measured at 45 °, 55 °, and 65 °C using the same method. The solubility for 
sulphathiazole and indomethacin is reported in Table 3.1 and Table 6.1.  
Waterbath with 
temperature 
controller. 
Magnetic stirrer 
Jacketed 
beaker 
Water circulating 
tubing 
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2.2.2 Crystallization methods 
 
Different crystallization techniques were used for the crystallization of sulphathiazole 
and indomethacin.  
 
2.2.2.1 Crystallization by cooling 
 
Crystallization experiments of sulphathiazole and indomethacin were performed by 
cooling supersaturated solutions. Batch experiments were conducted in thermostated, 
jacketed beakers with magnetic stirrer and water bath as shown in Figure 2.1. Known 
quantities of sulphathiazole or indomethacin (see Tables 2.2, 2.3, 2.4 and 2.5 for the 
quantity of drug dissolved in experiments) were dissolved in 100 ml of selected 
solvent at 60 °C with stirring (250 rpm) for 40-60 minutes to allow complete 
dissolution of solid material. Thereafter the solution was cooled to 26 °C at 1 °C/min 
for crystallization. Finally, the resultant crystals were filtered and dried in a vacuum 
oven at 30 °C overnight to remove solvent. 
 
 The quantity of model drug to be dissolved in 100 ml of solvent at 60 °C to make a 
supersaturated solution was determined from the solubility data. Any additive, where 
appropriate, was added as 2% or 10% of dissolved drug by weight (see quantities of 
additives in particular experiments in Table 2.6) to the hot solution prior to cooling. 
Any seeds, where appropriate (Table 2.3), were added (0.1g) to the solution once 
cooling started, prior to the nucleation of crystals. In the case of adding seeds to the 
solution, it was also ensured that seeds remained in the solution without any 
dissolution prior to nucleation. All the crystallization experiments performed by 
cooling with sulphathiazole and indomethacin are listed in Tables 2.2 to 2.6. 
 
Table 2.2   Cooling crystallization experiments of sulphathiazole in various solvents  
 
 
 
 
 
Experiment Solvent 
used 
Sulphathiazole 
dissolved (g) 
1 1-Propanol 1.1 
2 1-Butanol 0.9 
3 2-propanol 1 
4 Ethanol 1.15 
5 Methanol 1.3 
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Table 2.3 Cooling crystallization experiments of sulphathiazole with seeding of 
stable polymorphs of sulphathiazole 
 
 
Table 2.4 Cooling crystallization experiments of sulphathiazole using various 
ratios of 1-propanol and methanol as solvents 
 
 
 
 
 
 
 
 
 
 
Table 2.5     Cooling crystallization experiments of indomethacin in various solvents 
 
 
 
 
 
 
 
 
 
 
Experiment Solvent 
used 
Sulphathiazole 
dissolved (g) 
Seeds 
used 
Quantity of 
seeds added (g) 
1 1-Propanol 1.1 Form II 0.1 
2 1- Propanol 1.1 Form III 0.1 
3 1-propanol 1.1 Form IV 0.1 
Experiment Ratio of 
1-propanol:methanol 
used as Solvent 
Sulphathiazole 
dissolved (g) 
1 0:100 1.35 
2 20:80 1.29 
3 40:60 1.24 
4 50:50 1.21 
5 60:40 1.2 
6 80:20 1.15 
7 90:10 1.08 
8 100:0 0.99 
Experiment Solvent used Indomethacin  
dissolved (g) 
1 Ethanol 1.40 
2 Acetonitrile 1.45 
3 Ethyl acetate 1.48 
4 Aqueous Acetic acid 1.1 
5 Butanol 1 
6 Acetone 1.25 
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Table 2.6     Cooling crystallization experiments of indomethacin in ethanol in the 
presence of additives 
 
 
2.2.2.2     Crystallization by slow evaporation. 
 
Saturated solutions were prepared by dissolving sulphathiazole (see Table 2.7 for the 
amount of drug dissolved in solvents) in 100 ml of solvent at 25 °C with stirring (250 
rpm) for 40-60 minutes to allow complete dissolution of solid material.  
 
The saturated solution was transferred to two glass petri dishes in equal amount (50ml 
in each petri dish) at ambient conditions. The petri dishes were covered with parafilm 
(Bemis, USA), which was pierced to make eight small holes to promote slow 
evaporation. Nucleation and crystal growth occurred with evaporation of solvent. In 
the first petri dish, sulphathiazole crystals crystallized immediately after nucleation 
(within 5 minutes of nucleation) and were isolated by filtration and dried in the 
vacuum oven prior to solid state characterization. The second petri dish was left 
undisturbed on the bench until the complete evaporation of solvent was observed. 
Finally, crystals were collected from this second petri dish and dried in the vacuum 
oven at 30°C prior to further use. Experiments performed using this technique are 
listed in Table 2.7. 
 
Experi
ment 
Indomethacin 
dissolved (g) 
Additive used Quantity 
of 
additive 
added (g)  
% w/w of 
additive to 
Indomethacin 
1 1.40 Myristic acid 0.028 2 
2 1.40 Myristic acid 0.14 10 
3 1.40 Adipic acid 0.028 2 
4 1.40 Adipic acid 0.14 10 
5 1.40 oleic acid 0.028 2 
6 1.40 oleic acid 0.14 10 
7 1.40 3-Indoleacetic 
acid 
0.028 2 
8 1.40 3-Indoleacetic 
acid 
0.14 10 
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Table 2.7    List of crystallization experiments of sulphathiazole by evaporation in 
various solvents 
 
 
 
 
 
 
 
2.2.2.3   Crystallization by liquid precipitation (drown out method) 
 
Crystallization by liquid precipitation requires two solvents, a solvent in which the 
solute compound shows good solubility and an anti-solvent in which the solute 
compound has low solubility (Uusi-Penttilä and Berglund, 1996). 
 
A solution of 1.40g of indomethacin in 100 ml ethanol was prepared at 60°C as 
described in Section 2.2.2.1. The solution was kept at 60 °C with stirring for 20 
minutes and during this period 400 ml of water as the anti-solvent was added drop-
wise into the solution, which caused the precipitation of crystals in the solution. 
Slavin et al (2002) suggested the use of 1:4 solvent: anti-solvent ratio for liquid 
precipitation experiments. Thereafter, the solution was further cooled to 26 °C at 1 
°C/min. Finally, the precipitated crystals were separated by filtration and dried 
overnight in a vacuum oven at 30 °C.  
 
2.3 Analytical analysis of crystal samples 
 
2.3.1 Optical microscopy 
 
Morphology of crystals was observed using an Olympus BH2 Optical Microscope 
(London, UK) under a magnification of X 10. Pictures and video were taken using a 
digital video camera (JVC TK-C1381, colour video camera, Japan) fitted to the 
microscope and linked to a computer. The studio capture software (version 1.3.4 for 
FP80 controller) was used to display the captured image on a computer screen. 
 
Experiment 
Solvent used 
(100 ml) 
Sulphathiazole 
dissolved (g) 
1 1-Propanol 0.4 
2 1-Butanol 0.25 
3 2-propanol 0.3 
4 Ethanol 0.45 
5 Methanol 0.5 
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Crystal samples were placed on microscopic slides and covered with cover slips and 
then observed. Also crystals were observed from solution (crystal slurry) by taking a 
drop of liquid on a microscopic slide, covered with a cover slip, to observe the 
morphology whilst the crystals were growing.  
 
2.3.2 Scanning Electron Microscopy (SEM) 
 
Scanning electron microscopy is widely used to study the morphological and surface 
features of chemical and biological samples (Goldstein et al, 1981). In a scanning 
electron microscope, an electron beam is induced from an electron gun, which 
contains a tungsten filament as an anode (Figure 2.2). The electrons then pass through 
the condenser lens (magnetic lens) to focus into a very fine spot of 0.4 nm to 5 nm 
diameter. The beam then travels through the scanning coils in the electron column to 
the specimen surface. The incident beam emits radiation from the specimen, which is 
detected and amplified using a detector and a video amplifier. SEM is able to measure 
particle sizes less than 5 µm and particles can be magnified from 25X up to 250,000X 
magnitude. Unlike the optical microscope, the magnifying power of the SEM is 
controlled by the current supplied to the scanning coils, and not by the objective lens. 
                     
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Schematic diagram of Scanning Electron Microscope (re-drawn from 
Perdue university’s module http://www.purdue.edu/rem/rs/sem.htm) 
 83 
2.3.2.1  Methodology 
 
A Scanning Electron Microscope (Jeol Electron Microscope, JSM 840 Rontec 
Scanvision, Image Capture) was used to study the morphology of crystals. A small 
sample of crystals was mounted onto aluminium stubs using 13 mm aluminium pin 
stubs with double-sided carbon conductive adhesive tab and a sputter coater was used 
to apply a thin layer of gold at 10 Torr vacuum before examination. Samples were 
scanned with an electron beam of acceleration potential of 1.2 KV and the images 
were collected using an image capture software (Spirit, UK).  
 
2.3.3 X-Ray Diffraction method 
 
Powder x-ray diffraction (PXRD) is a powerful tool for identifying different 
crystalline phases by their unique diffraction patterns. Typical applications of powder 
x-ray diffraction methodology include the evaluation of polymorphism and solvates, 
evaluation of degree of crystallinity, and the study of phase/polymorph transitions 
(Pecharsky and Zavalij, 2003). Even small changes in the x-ray powder patterns of a 
crystalline compound due to the appearance of new peaks, additional shoulders or 
shifts in the peak position can imply the presence or occurrence of new polymorphs in 
that compound.  
 
As explained in Section 1.1, crystalline solids consist of atoms and atomic groupings 
that are regularly arranged in space in three dimensions. In a crystal, all planes with 
identical sets of Miller indices (Section 1.1) are parallel to one another and they are 
equally spaced (Pecharsky & Zavalij, 2003). Thus each plane in a set (hkl) (Figure 
2.3) may be considered as a separate scattering object. The set is periodical in the 
direction perpendicular to the planes and the repeat distance in this direction is equal 
to the interplaner distance dhkl (Figure 2.3).  
 
In x-ray diffraction, x-rays are generated by a cathode ray tube, filtered to produce 
monochromatic radiation, collimated to concentrate, and directed toward the sample. 
When x-rays interact with the random orientation of a crystal lattice in a powder 
sample, the scattering centres arranged in a plane act like a mirror to incident x-rays, 
so that diffraction patterns at specific angles (θ) occur when conditions satisfy 
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Bragg’s law (Bragg et al, 1913) (Equation 2.1) for a series of crystallographic planes. 
Bragg’s law relates the wavelength of electromagnetic radiation (λ) to the angle of 
diffraction (2θ) and the lattice spacing (d) in a crystalline sample. The specific angle 
, is established from Braggs law, as explained in Figure 2.3. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Diffraction of x-rays explained by Bragg’s law 
 
Consider an incident front of waves with parallel propagation vectors, which forms an 
angle  with the planes (hkl). In a mirror reflection, the reflected/diffracted wavefront 
will also consist of parallel waves, which form the same angle  with all planes. The 
path differences introduced between a pair of waves both before and after they are 
reflected by the neighbouring planes, Δ (XB’ or YB’), are determined by the 
interplaner distance as Δ = dhklSin. The total path difference is 2Δ, and constructive 
interference is observed when 2Δ = n, where n is an integer and  is the wavelength 
of the incident wavefront. This simple geometrical analysis results in Bragg’s law 
(Equation 2.1). 
                                                
 n = 2dhklSinhkl.   (Equation 2.1) 
 
Diffraction occurs only when Bragg’s law is satisfied. By scanning the sample 
through a range of 2θ angles, all possible diffraction directions of the lattice should be 
attained due to the random orientation of the powdered material. The diffracted x-rays 
are then detected and processed by the detector and recorded electronically.  
Incident X-rays Diffracted X-rays 
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2.3.3.1 Methodology for Powder X-ray Diffraction 
 
A Miniflex PXRD Instrument (Rigaku Corporation, Japan) was used for generating 
PXRD patterns of the samples. Dried crystals were ground in a mortar and pestle. The 
cavity of the metal sample holder was filled with the ground powder of the sample 
and pressed with a glass slide to make the surface of the powder flat and smooth. The 
samples were scanned at a scanning rate of 10 ° 2θ/min over a range of 5 – 50 ° 2 
values. The sample was irradiated with x-rays of wavelength of 1.54059Å.  
 
The resulting patterns were compared against the reference patterns of the samples for 
polymorphic identity. The reference patterns were obtained from literature and the 
Cambridge crystallographic database (Mercury 2.1, CCDC, Cambridge, UK). 
  
2.3.3.2 Methodology for single crystal X-ray Diffraction 
 
In some cases, PXRD patterns for polymorphs of the same substance are very similar 
and very hard to distinguish from their fingerprint PXRD pattern. In that case, single 
crystal -xray diffraction can be used. Every solid crystalline compound has its own 
particular unit cell, which should be unique in its dimensions (Section 1.1). Different 
polymorphs of the same compound also differ from each other in their unit cell 
dimensions (a, b, c and , ,  - Section 1.1). An understanding of a unit cell 
simplifies the understanding of a crystal as a whole and this is the basis of single 
crystal x-ray studies.  
 
Single crystal x-ray diffractometers consist of three basic elements, an x-ray tube, a 
sample holder, and an x-ray detector. x-rays are generated in a cathode ray tube by 
heating a filament to produce electrons. The incident x-ray beam strikes a mounted 
single crystal, which diffracts the x-ray beam and generates the diffraction patterns 
through the planes of a crystal to provide detailed information of the crystal structure 
including unit cell dimensions. 
 
In this study, unit cells of a single crystal samples were measured for polymorphic 
identification using a Stoe IPDS area detector (Stoe, Germany) and calculated by least 
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squares refinement using the setting angles of 25 reflections. Crystals in excess of 200 
micron size were selected and mounted in the diffractrometer for single crystal x-ray 
diffraction analysis.  
 
2.3.4 Infra Red (IR) Spectroscopy 
 
Spectroscopy is the study of the interaction between electromagnetic radiation and 
matter. All molecules are capable of vibrating when they absorb infrared radiation 
energy (Stuart, 2004). According to the Beer-Lambert law the fraction of light 
absorbed by a sample is proportional to the number of molecules in the light path. 
Mathematically it can be expressed by Equation 2.2. 
 
                     log10(I0/I) = A = cl    (Equation 2.2) 
Where,  I0 and I are the incident and transmitted intensity (i.e. the light entering 
the sample and the light coming out from the sample, respectively) 
 l, is the thickness of the absorbing medium, 
 log10(I0/I) is defined as the absorbance A, 
 , is the molar absorption coefficient, 
 and c, is molar concentration of the sample. 
 
In Equation 2.2 transmittance, T, is defined as I/I0 (the fraction of radiation 
transmitted). Hence, Equation 2.2 could be rewritten to Equation 2.3. 
 
A = log101/T       (Equation 2.3) 
 
According to quantum mechanics, no vibration can be excited unless the molecule is 
provided with a certain minimum energy absorbed by electromagnetic radiation. The 
frequency at which these absorptions occur gives valuable structural information of 
molecules. Even certain fragments within a molecule adsorb at different wavelengths. 
An IR spectrum is generally displayed as a plot of the energy of the infrared radiation 
(expressed in wave numbers, cm-1) versus the percentage of radiation intensity 
transmitted or absorbed through the sample. Therefore within a particular energy 
range, the spectrum of a molecule will appear as a series of broad absorption bands of 
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variable intensity, each of which corresponds to a bend or stretch within a bond. 
Absorption bands in the range of 4000-1500 cm-1 are typically due to functional 
groups, such as –OH, C=O, N-H, CH3, etc. The regions between 1500-400 cm-1 are 
generally due to intra-molecular phenomena, and are highly specific for each 
compound (Beckett & Stenlake, 2001). So, for any molecule, there will be a unique 
spectrum.  
 
As explained in Section 1.9, different polymorphs have different structural 
configurations and due to that the appearance of shoulders, shifts or new adsorption 
bands would be observed in their IR spectrum. The resulting spectrum of each sample 
was compared against the reference spectrum (Anderson et al, 2001; Burger et al, 
1983; Anwar et al, 1989) of the polymorph of the model compound for polymorphic 
identity. 
 
2.3.4.1     Methodology for Infra Red spectroscopy 
 
In this study, a Perkin Elmer FT-IR (Spectrum BX, USA) was used for the infra-red 
analysis of samples. A small amount (2-5 mg) of sample was placed on the 1.8 mm 
diamond window and compressed with a pressure clamp. Samples were irradiated 
with infra-red radiation and absorption measured in the range of 600-4000 cm-1. 
 
2.3.5 Differential Scanning Calorimetry 
 
Differential Scanning Calorimetry (DSC) monitors heat flow differences associated 
with phase transitions and chemical reactions as a function of temperature. In DSC, 
the equipment involves two parallel temperature measurement systems, a sample and 
a reference. The reference is an inert material such as alumina, or just an empty 
aluminum pan, and the sample pan usually contains 2 to 10 mg of sample. Each pan is 
placed over separate heaters (Figure 2.4). The temperature of pans, the sample and the 
reference, are controlled. The differences in heat flow needed to maintain the sample 
and a reference at the same temperature (T = 0) is recorded as a function of 
temperature. This information is sent to an output device, a computer, to plot the 
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difference in heat flow as a function of temperature. Since the DSC is at constant 
pressure, heat flow is equivalent to the enthalpy changes (Equation 2.4). 
 
 (dq/dt)p = dH/dt      (Equation 2.4) 
Where, dq/dt is the differences in heat flow per unit time, p is the pressure, and dH/dt 
is the difference in enthalpy per unit time. 
 
Therefore, the heat flow difference between the sample and reference pan is, 
 
  dH/dt = (dH/dt) of sample  (dH/dt) of reference   (Equation 2.5) 
 
This heat flow difference can be positive or negative, which can depend on the 
changes that occur in the sample material with heating, such as endothermic (melting 
and phase transition) or exothermic (crystallization) changes. In DSC graphs of 
temperature increases (x-axis) verses the difference in heat flow between the sample 
and reference pan (y-axis) are produced. If a sample shows any phase changes with 
heating (melting, sublimation of vapour, crystallization, glass transition, polymorphic 
transition) then the heat flow curves shows those changes as peaks in the graph 
relevant to that temperature. Hence, DSC is commonly used to measure melting 
points, polymorphic stability and polymorphic transformation, glass transition, 
presence of hydrate/solvates, purity, and crystallinity of the samples (Ferrero et al, 
1999; Leităo et al, 2002).  
 
 
 
 
 
 
 
 
 
Figure 2.4 Schematic diagram of Differential Scanning Calorimeter 
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2.3.5.1  Methodology for DSC 
 
In this study, a DSC (DSC7, Perkin Elmer, USA) was used to determine the 
polymorphic identity of the sample from the melting points and the phase 
transformation peaks for each polymorph. Perkin Elmer pans and lids were used for 
sample preparation. A small quantity of each sample (2 to 8 mg) was weighed 
accurately into the pan and the lid was crimped with the press. The samples were 
scanned at 10 °C/min from 40° to 250 °C. Onsets, offsets of the melting peaks and 
enthalpies of fusion were calculated using Perkin Elmer software (Pyris version 7).  
    
2.3.6 Hot Stage Microscopy 
 
Hot-stage microscopy (HSM) is used for the visual observation of a sample whilst it is 
heated. The microscope is fitted with the stage (an aluminium block), on which a 
sample is placed and can be heated from room temperature to the specified 
temperature at a controlled rate. HSM allows visual characterization of phase 
transitions occurring in a sample with increase in temperature such as, melting, glass 
transition, polymorphic transformation, crystallization. These observations aid 
interpretation of data obtained by other thermo-analytical methods, such as DSC.  
 
2.3.6.1   Methodology for Hot Stage Microscopy 
 
A Mettler FP82 Hot Stage and a Mettler FP80 central processor were used with an 
Optical Microscope (Olympus, BH2 microscope) for HSM analysis. A small amount 
of sample (1-5 mg) was spread on a microscopic slide and covered with a cover slip. 
The samples were heated from room temperature to 250 °C at 10 °C/minute. 
Observations were recorded using Studio Capture (version 1.3.4 for FP80 controller) 
and a camera (JVC TK-C1381, Japan) connected to the microscope.  
 
2.3.7 Liquid 1H NMR studies 
 
Liquid 1H NMR allows identification of hydrogen atoms and their position in 
compounds. This technique is useful in analyzing hydrogen bonds and the role of 
hydrogen in the structure of any compound. The technique can help to identify the 
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different types of hydrogen present in a molecule and the electronic environment of 
the different types of hydrogen (Silverstein et al, 1991).  
 
Hydrogen atoms, within a sample, absorb energy of different wavelengths depending 
on their bonding environment. For example, the hydrogen of the hydroxyl group in 
propanol is different from the hydrogens of its carbon skeleton. 1H NMR can easily 
distinguish between these two sorts of hydrogen. It is known that the use of different 
solvents can led to the formation of different pre-nucleation clusters of solute 
(sulphathiazole), which led to different polymorphs (Blagden et al, 1998). The 
electronic environment surrounding the hydrogen atoms of the solute also changes 
with the formation of different pre-nucleation clusters in different solvents, which can 
result in variation in chemical shifts in the 1H NMR spectrum. Therefore in the 
current study 1H NMR was used to investigate the role of different alcohol solvents in 
the formation of pre-nucleation clusters of sulphathiazole. 
  
 
 
 
 
 
 
 
 
 
Figure 2.5  Schematic diagram of nuclear magnetic resonance spectroscopy 
(re-drawn from Michigan State University module for 1H NMR   
www2.chemistry.msu.edu/faculty/reusch/VirtTxtJml/Spectrpy/nmr/nmr1.htm) 
 
The nuclei of hydrogen, as an elemental isotope, have a characteristic spin, I = 1/2. 
The spinning charge of nuclei generates the magnetic field and that results in a 
spinning magnet (spinning nuclei) with a magnetic moment, µ. This magnetic 
moment is proportional to the spin (I) of the nuclei (Clayden et al, 2001). In the 
presence of an external magnetic field, nuclei of hydrogen can show two states of 
spin, +1/2 (lower energy state) and -1/2 (higher energy state). The magnetic moment 
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of the lower energy spin state, +1/2, is aligned with the external field, whereas the 
higher energy spin state, -1/2, is opposed to the external field.  In 1H NMR, when the 
sample is irradiated with a short pulse of radio frequency energy, rf, the equilibrium 
balance between the two energy levels is disturbed and causes the excitation of a low 
energy spin state, +1/2, 1H nuclei to the higher energy spin state, -1/2 (Clayden et al, 
2001). When 1H nuclei fall back down to the lower energy level, they emit the 
absorbed rf energy, which will be detected using a sophisticated radio receiver and 
computer as shown in Figure 2.5.  
 
2.3.7.1 Methodology of 1H NMR  
 
The 1H NMR study was performed on a Bruker Avance 300 MHz Spectrometer 
(Germany) operating via XWIN-NMR software (version 3.5) and locked using the 
deuterium signal from deuterated methanol, ethanol and 1-butanol solvents. 
 
5-8 mg of samples powder were dissolved in 1 ml deuterated methanol, ethanol or 1-
butanol at room temperature. 0.2 ml of the reference solvent (Tetramethylsilane) was 
also added to the sample solution. 400-600 microlitres of this solution were placed in 
a thin-walled NMR glass tube. Thereafter, the NMR glass tube was oriented between 
the poles of a powerful magnet and irradiated with the appropriate energy of radio 
waves.  The results are displayed in the form of intensity against frequency, rf.  
 
Each nucleus/atom in a molecule is shielded from the applied external magnetic field 
to a greater or lesser extent by the other atoms in the vicinity and their electrons. The 
less the shielding experienced, the higher the chemical shift; whereas the more 
heavily shielded hydrogen atoms display lower chemical shift. Even, similar hydrogen 
atoms of different polymorphs would absorb energy of different wavelengths and 
represent variation in chemical shifts due to different bonding and electron 
environment surrounding these hydrogen atoms. Based on this principle, in a NMR 
spectrum, peaks are assigned to each hydrogen atom in a molecule. The area under 
each NMR peak/resonance is proportional to the number of hydrogens which that 
resonance represents. By integrating the different NMR resonances, information 
regarding the relative numbers of chemically distinct hydrogens can be evaluated. 
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2.4. Molecular modelling  
 
2.4.1 Molecular modelling using Cerius2 
 
Cerius2 (Accelrys, Cambridge, UK) is a comprehensive molecular modelling and 
simulation package used for the visualization and thermodynamic calculation of 
crystal structures. The package runs on a Silicon Graphics workstation (Silicon 
Graphics Inc., USA) and provides a three dimensional graphic of the molecules which 
make up a crystal.  
 
The Cerius2 program offers a broad range of application modules for various 
molecular environments, such as, visualizer, crystal builder, force field editor, mopac, 
etc. The energy of α- and β-dimers of sulphathiazole and proposed clusters (pre 
nucleation clusters of sulphathiazole molecules with solvent molecule) of α- and β-
type dimers in the presence of each of the solvents was investigated using Cerius2. 
Detail of this molecular modelling study is presented in Chapter 4.  
 
2.4.2 Molecular modelling via Grid based systematic search 
 
The systematic search approach uses a grid based search system of translations and 
rotations to assess all the possible intermolecular packing arrangements or interactions 
in direct space (Hammond et al, 2003). The systematic search approach has been 
successfully applied to predict the crystal structures of various materials from 
knowledge of unit cell parameters and space group alone, and to solve the crystal 
structures of various materials from the powder diffraction data (Kutzke et al, 2000; 
Smith et al 2001; Hammond et al, 2003). In the current study, the systematic search 
approach has been applied to calculate the interaction energies between sulphathiazole 
dimers and solvent molecules. Further details of this method are described in Chapter 
4. 
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Chapter 3 Crystallizations of sulphathiazole and characterization of 
experimental samples 
 
 
3 Introduction 
 
It has been established that the polymorphic outcome of the crystallization of sulphathiazole 
is susceptible to the solvent environment and that the metastable form, Form I, can be 
selectively stabilized by 1-propanol (Anwar et al, 1998, Blagden et al, 2001). In this study, 
the mechanism of the selection of the metastable and stable polymorphs by solvent change 
was probed by investigating the influence of a range of alcohols on the polymorphic outcome 
of sulphathiazole crystallization. The role of the alcohol functional group in the polymorph 
selection process was thus investigated and evaluated.  
 
Methanol, ethanol, 1-propanol, 2-propanol, and n-butanol were selected as solvents for the 
crystallization of sulphathiazole by cooling and slow evaporation. Crystal samples were 
characterised using optical microscopy, PXRD, DSC, IR, and single crystal x-ray diffraction 
to identify their polymorphic form. Details of experimental methods are described in Sections 
2.2 to 2.4 (Chapter 2). 
 
3.1 Solubility of sulphathiazole in alcohols 
 
The solubility of sulphathiazole was determined over the temperature range of 25 – 70 °C. 
Amounts of sulphathiazole were added gradually into the solvent to determine its solubility, 
as described in Chapter 2. The solubilities in the various alcohols are shown in Table 3.1. 
 
Table 3.1 Solubility data of sulphathiazole in various alcohol solvents 
 
  Methanol Ethanol 
1-
Propanol 
2-
Propanol 1-Butanol 
Temp (0C) Sulphathiazole concentration (g/100 ml) 
28 0.42 0.37 0.3 0.21 0.17 
35 0.5 0.45 0.38 0.30 0.24 
55 0.88 0.81 0.73 0.62 0.57 
70 1.23 1.12 1.05 0.92 0.88 
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                                         Temperature (°C) 
Figure 3.1 Solubility of sulphathiazole in the chosen solvents at different temperatures. 
Key – Solubility in methanol, Solubility in ethanol, Solubility in 1-propanol, Solubility in 2-
propanol, and solubility in 1-butanol 
 
The solubility of sulphathiazole showed a near linear relationship in all solvents with increase 
in temperature (Fig 3.1). These data were also used to determine the amount of sulphathiazole 
to be added to obtain supersaturation in the crystallization experiments. The solubility of 
sulphathiazole was higher in the lower carbon chain alcohols (methanol and ethanol) but it 
decreased in long chain alcohols (1-propanol, 2-propanol, and 1-butanol).  
 
 
3.2 Characterization of sulphathiazole crystals obtained from cooling crystallization 
 
The experimental method of crystallization of sulphathiazole by cooling with five different 
alcohols is described in Section 2.3.1.1. A list of these experiments is also indicated in Table 
2.2  
 
Samples obtained from cooling crystallization, were analyzed using optical microscopy, 
powder x-ray diffraction, infrared spectroscopy, differential scanning calorimetry, and hot 
stage microscopy (methods are described in Section 2.3) to determine polymorphic identity.  
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3.2.1 Morphological analysis of crystallized samples 
 
Samples were taken periodically from each cooling experiments and analysed under the 
optical microscope to observe the growth and changes in morphologies. Time resolved 
morphologies of crystals are shown in Figures 3.2 to 3.6.  
 
 
Figure 3.2 (a) sample from 1-propanol within       Figure 3.2 (b) sample from 1-propanol  
5 minutes of nucleation               1 hour after nucleation observed 
 
 
 
Figure 3.3 (a) Sample from n-butanol within       Figure 3.3 (b) sample from n-butanol 
5 minutes of nucleation    1 hour after nucleation observed 
 
 
60 µm 60 µm 
60 µm 60 µm 
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Figure 3.4 (a)  Sample from 2-propanol   Figure 3.4 (b) Second sample from  
5 min after nucleation observed   2-propanol 5 min after nucleation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Figure 3.4 (c) Sample from 2-propanol 4 h  
after nucleation observed 
 
 
Figure 3.5 (a) Sample from ethanol  Figure 3.5 (b) Sample from ethanol  
5 minutes after nucleation observed  30 minutes after nucleation observed 
 
60 µm 60 µm 
60 µm 
60 µm 60 µm 
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Figure 3.6 (a) Sample from methanol   Figure 3.6 (b) Sample from methanol 
5 min after nucleation observed   30 min after nucleation observed 
 
All samples initially crystallised as elongated, or needle particles.  This is established in the 
literature as the morphology of Form I, (Anwar et al, 1989, Blagden et al, 1998) and 
predicted by Ostwald’s Rule to crystallise first (Section 1.11.3).  
 
When methanol or ethanol was the solvent, needles nucleated initially followed by small 
hexagonal plates which appeared within 5 minutes of nucleation (figure 3.5 a and 3.6 a).  The 
needle-shaped particles dissolved very quickly, within a few minutes of nucleation and 
hexagons grew in size and thickness resulting in hexagonal prisms in the case of methanol 
(figure 3.6b), and thin plates in the case of ethanol (figure 3.5b).  This change in morphology 
may indicate polymorphic changes from the needle-like metastable Form I to the more stable 
Forms II, III, or IV as growth progressed. Once mature crystals were obtained, there was no 
further change in the morphology.  
 
When 2-propanol was the solvent, sulphathiazole initially nucleated as needles and very 
small square plates (Figure 3.4a).  Initially needles were present predominantly. Figure 3.4b 
shows the prompt nucleation of needles when a droplet as a sample was taken on microscopic 
slide from the 2-propanol solution. However, with time, square plates grew slowly in size and 
numbers, and the needles disappeared from the slurry/solution when left for 4 hours as shown 
in Figure 3.4c. Square plates also converted into hexagonal plates by developing faces on the 
angles of the square plates (Figure 3.4c). The rate of growth was slower than for those 
crystals grown from the straight chain alcohols, with growth continuing for more than 4 hours 
after nucleation.  There was no further change to the morphology during growth. As with 
60 µm 60 µm 
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samples grown from methanol and ethanol, changes in morphology during the crystal growth 
process indicate the polymorphic transformation from metastable to more stable forms.  
 
For 1-propanol and 1-butanol, nucleation of needle-shaped crystals was very prompt, within a 
minute of reaching temperature, with maximum growth having occurred within 17-20 min of 
nucleation. No further growth was observed and the particles remained without 
transformation for the length of the experiment (1 hour) as shown in Figures 3.2a to 3.3b.  No 
platey or prismatic crystals were observed.   
 
3.2.2 Powder X-ray analysis of sulphathiazole crystals samples 
 
Powder X-ray diffraction studies were carried out for polymorphic identification of samples 
obtained from cooling crystallization. The results of the PXRD patterns were compared with 
previous PXRD studies for the identification of sulphathiazole polymorphs. 
 
Only a few reports have previously mentioned clear PXRD patterns of sulphathizole 
polymorphs. Anwar et al (1989) have reported the PXRD patterns of sulphathiazole Form I to 
IV. Kordikowski (2001) obtained polymorphs I, III and IV and performed PXRD analysis for 
each polymorph. Blagden et al (2001) and Appearly et al (1999) have reported identification 
peaks for Form I (Table 3.2). In addition, PXRD spectra were also obtained from the 
Cambridge Crystallographic Database and used as reference for polymorphic identification 
(Figure 3.8). These studies reported very similar spectra for Forms II, III and IV, which make 
it very difficult to differentiate between these polymorphs from their PXRD results. The 
similarities in their spectral behaviour were reported due to the structural and molecular 
similarities of these three polymorphs as all of them contain  dimers as their basic unit 
(Section 1.14.1.2). Many previous studies, such as Anwar et al (1989) and Appearly et al 
(1999) confirmed the identity of each polymorphic sample by combining PXRD results with 
various solid state analytical techniques such as Solid state NMR, single crystal XRD, and 
Raman spectra.  
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Table 3.2 Characteristic peaks for each of the reported polymorphs  
 
Study Identification peaks reported at 2 values in the diffraction 
patterns of each polymorph 
Form I Form II Form III Form IV Form V 
Anwar et al 
(1989) 
11, 16, 18, 
19, 21, 
22.2, 24.5 
 15.1, 15.4, 
16.2, 18.5, 
19.2, 20, 
21.7, 21.8, 
25.3, 26.9 
15.1, 15.5, 
16.3, 18.5, 
19.3, 20, 
21.6, 25.3, 
26.9 
16, 16.2, 18, 
18.7, 20.1, 
21.4, 21.6, 
23.5, 25.1, 
26, 26.8 
Appearly et 
al (1999) 
21.9  21.9 21.7 22.1 
Blagden et al 
(2001) 
11  {010}     
Kordikowski 
et al (2001) 
11, 16, 
17.8, 18.9, 
21, 22, 
22.3, 24.6 
 15.32, 
15.56, 18.4, 
18.5, 19.3, 
20.1, 20.7, 
21.6, 22, 
25.4, 26.8, 
26.9 
15.1, 15.5, 
18.4, 19.25, 
19.9, 20.3, 
20.5, 21.6, 
22, 21.8, 
24.9, 25, 
25.4, 26.7, 
26.8, 26.9 
 
 
In the current study, the resultant crystals, obtained from crystallization from each of the 
solvents by cooling as described in Section 2.3.2.1, were analysed by powder x-ray 
diffraction for polymorphic identification. The powder diffraction data of each sample were 
collected using a Miniflex (Rigaku Corporation) laboratory powder x-ray diffractometer at 
ambient conditions as described in Section 2.4.3. The PXRD spectra obtained for 
crystallization of sulphathiazole by cooling are shown in Figure 3.7.  
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Figure 3.7 Powder –X-Ray Patterns of sulphathiazole samples obtained from 
alcohols. Samples from 1-propanol, n-butanol, methanol, 2-propanol and ethanol, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Reference powder X-ray pattern of Sulphathiazole polymorphs obtained 
from CCDC. Form I, Form II, Form III, and Form IV 
2 theta  
2 theta 
0 
1000 
2000 
3000 
4000 
5000 
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A detailed comparison was carried out to investigate the polymorphic identity of the 
sulphathiazole samples obtained from the different solvents. It was easy to identify 
sulphathiazole samples crystallized from 1-propanol and butanol as Form I. These samples 
were identified by the peak with a 2 value of 11, which is a characteristic peak for Form I 
(Blagden et al, 1998 & Appearly et al, 2001). In addition, the intense peak at 21.9 in both 
samples also stands as one of the identification peaks for Form I (Appearly et al, 1999). 
Furthermore, PXRD patterns of these two samples also showed an exact match with the 
PXRD pattern of Form I obtained from CCDC (Figure 3.8). This evaluation of PXRD 
patterns leads to the conclusion that the sample crystallized from 1-propanol and n-butanol 
were each sulphathiazole Form I. 
 
In contrast, samples crystallized from methanol, ethanol and 2-propanol did not show a peak 
at 2 value of 11, so the possibility of the presence of polymorph I in these samples could be 
eliminated. By comparing the PXRD patterns of these samples with reference values in Table 
4 and CCDC patterns (Figure 3.8), it was clear that these three patterns contain most of the 
peaks found in the reference PXRD patterns of Forms II, III and IV. Therefore it is likely that 
sulphathiazole samples crystallized by cooling from methanol, ethanol and 2-propanol may 
contain Form II, III or IV, or a mixture of these polymorphs.  
 
Due to structural and molecular similarities, Forms II, III and IV show very similar PXRD 
patterns and their peak values coincide with each other. So, it was possible to identify 
samples crystallized from 1-propanol and butanol as Form I, but not to positively identify the 
other three polymorphs.  
 
3.2.3 Infrared (IR) analysis of sulphathiazole samples 
 
Each of the samples of crystals, obtained from the crystallization of sulphathiazole by cooling 
from each solvent as described in Section 2.3.2.1, were analysed by IR spectroscopy (Perkin 
Elmer) for polymorphic analysis in the sample.  
 
The IR spectrum of each of the samples was compared with the previous IR studies of 
sluphathiazole polymorphs for polymorphic identification. In the early 1980s Lagas and Lerk 
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(1981) reported the IR spectra of polymorphs I, III and II. Thereafter Burger et al (1983) 
presented the detailed IR spectra of sulphathiazole polymorphs I to IV. Anwar (1989) studied 
polymorphs of sulphathiazole and reported IR spectra similar to Burger et al. (1983). 
Anderson et al (2001) presented the IR spectra for all the five polymorphs of sulphathiazole 
with a list of the characteristic peaks for all the five polymorphs. A brief description of 
previous IR studies for each polymorph is listed in Table 3.3. It is clear from the previous 
studies mentioned in Table 3.3 that the IR spectra of sulphathiazole polymorphs II to IV have 
similar peak values (wavelength, cm-1) and similar spectral patterns. Thus, it would be 
difficult to distinguish polymorphs II to IV from the results of the IR spectra only. 
 
Table 3.3     Characteristic peaks of IR spectrums for each of the polymorphs reported 
 
Study Identification peaks reported at different wavelengths (cm-1) in the  
                             spectra of each Polymorph. 
Form I Form II Form III Form IV Form V 
Anderson 
et al (2001) 
3464, 3354, 
1627, 1672, 
1418, 1278, 
929, 856, 
830, 733, 
703 
3442, 3417, 
3346, 1643, 
1565, 1408, 
1290, 1264, 
935, 732, 
710 
3351, 3318, 
3278, 1627, 
1590, 1572, 
1424, 1280, 
1294, 1265, 
920, 886, 
730, 702 
3347, 3287, 
1627, 1592, 
1575, 1428, 
1265, 937, 
887, 730, 
703 
3320, 3279, 
1625, 1596, 
1574, 1428, 
1281, 1267, 
927, 732, 
700 
Burger et 
al (1983) 
3460, 3356, 
1671, 1415, 
1280, 930, 
854, 831, 
730, 701 
3442, 3417, 
3346, 1643, 
1565, 1408, 
1290, 1264, 
935, 732, 
710 
3350, 3320, 
1630, 1595, 
1575, 1425, 
1298, 1280, 
1269, 924, 
732, 705 
3350, 3322, 
3285, 1628, 
1595, 1575, 
1430, 1269, 
935, 885, 
729, 701 
 
Anwar et al 
(1989) 
Values found to be similar to Burger et al (1983) 
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The IR spectra, obtained in the current study for sulphathiazole crystallized from each solvent 
by cooling, are presented in Figure 3.9. The identification of polymorphs was carried out by 
comparing the above IR spectra with previous studies reported in Table 3.3. 
 
Figure 3.9 IR analyses of sulphathiazole samples obtained from cooling 
crystallization 
 
The samples from the crystallization by cooling in propanol-1 and butanol were analysed by 
IR for the identification of polymorphs. The IR spectra for both experiments are shown in 
Figure 3.9. In agreement with PXRD patterns, samples crystallized from 1-propanol and n-
butanol also showed similar IR spectra and peak values, which suggest that both experiments 
result in a similar polymorph. These samples, obtained from n-butanol and 1-propanol, 
produced the spectra which exactly matched with the absorption bands of polymorph I 
previously reported by Anderson et al (2001) and Anwar et al (1989), Burger et al (1983) and 
Lagas and Lerk (1981) (Table 3.3). According to Anderson et al (2001) (Table 3.3), the 
diagnostic peaks for Form I, are 3355, 3462, 1627, 1418, 1499 and 633 cm-1 which were also 
found in the spectra of above samples. The IR spectra of Form I is distinct and unique 
compared to the IR spectra of other sulphathiazole polymorphs. So, samples crystallized 
using 1-propanol and n-butanol are easily identified as polymorph I. In both samples, a very  
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broad absorption centred near 2900 cm-1 appeared for the sulphonamide NH group in 
polymorph I (Anderson et al, 2001). This broad feature is attributed to strong hydrogen 
bonding to a second nitrogen atom, probably that in the thiazole ring. The NH2 bands in Form 
I occur at 3460 and 3555 cm-1, corresponding to some degree of hydrogen bonding, probably 
to the oxygen atoms of the SO2 group. The identification of each of these samples as Form I 
by IR also agrees with the result obtained by PXRD. 
 
The infra-red spectra of the samples, obtained from the crystallization of sulphathiazole by 
cooling using 2-propanol, ethanol, and methanol as solvents, are very similar to each other. 
The IR spectra of these samples are shown in Figure 3.9. IR spectroscopy of the samples did 
not yield any distinct spectra; the minor sample-to-sample variations in the spectra were 
insufficient to categorize any sample as being different. However, these spectra were 
compared with the reference spectra of sulphathiazole polymorphs, reported by Anwar et al 
(1989), Anderson et al (2001), Burger et al (1983), and Lagas and Lerk (1983) (Table 3.3). 
None of the spectra of samples crystallized from 2-propanol, ethanol and methanol, contain 
the characteristic peaks of polymorph I (3464, 3354) and polymorph V (3442, 3417) (Table 
3.3), so, polymorphs I and V were absent in these samples. However, the IR spectra of 
samples crystallized from 2-propanol, ethanol, and methanol, follow the similar pattern as 
shown in Figure 3.9 and match with the reference IR spectra of Forms II to IV (Table 3.3) 
which showed the appearance of very similar and repetitive peaks with minor differences. 
The use of the data in Table 3.3, to distinguish each spectrum for the remaining 
sulphathiazole polymorphs (II, III and IV), did not seem to be practically possible due to the 
high occurrence of duplicated and overlapping bands among the spectra of these polymorphs. 
For example, one of the characteristic bands of polymorph III at 730 is also apparent in the 
spectra of polymorph II and IV. Therefore, from this IR study, it was not easy to distinguish 
any of these samples as a separate existence of polymorph II, III or IV. However, it could be 
said that they may contain Form II, III, IV or a mixture of them, but do not contain Forms I or 
V. 
 
As shown in the IR results, the spectrum for polymorph I is undoubtedly distinct from the IR 
spectra of polymorphs II to IV. The difference between the IR spectrum of polymorph I on 
the one hand and polymorphs II to IV on the other, lie in the hydrogen bonding variation 
involving the NH2 group (Appearly et al, 1999). In polymorphs II to IV, the amino nitrogen 
acts as a hydrogen bond acceptor (the donor atom being the ring NH nitrogen of another 
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molecule), and leading to a partial positive charge on the amino nitrogen. This H-bonding 
occurs as part of a dimeric ring structure referred to by Blagden et al (1998) as the -dimer. 
Hydrogen bonding of this type also causes a low frequency shift in the IR for these three 
polymorphs, giving a band at 3280 cm-1, which is shown in the spectra of polymorphs II to 
IV (Figure 3.9). This close relationship between the structures of polymorphs II to IV is 
responsible for the similarities in their IR spectra and PXRD patterns (Section 1.11.2.2). 
 
3.2.4 Thermal characterization of sulphathiazole samples 
 
The thermal properties of sulphathiazole using Differential Scanning Calorimetry (DSC) have 
been known from previously reported studies. The DSC data were not definitive in 
distinguishing different polymorphic forms. Anderson et al (2001), Kordikowski et al (2001), 
Anwar et al (1989), Lagas and Lerk (1981) and Kruger and Gafner (1972), consistently 
reported that Form I melts around 201-203 °C without any transformation. The remaining 
polymorphs of sulphathiazole can undergo multiple transformations when heated in the DSC 
above 140°C, and ultimately convert to the most stable Form I, which melts at 201 °C.  
 
In the current study, the effect of heating on all samples obtained by cooling crystallization of 
sulphathiazole, were analysed using DSC to observe any polymorphic transformations and to 
identify the polymorphic identity of the samples. All the samples were scanned at 10 °C/min 
on DSC. Samples were also examined by Hot Stage Microscopy (HSM) to complement the 
results obtained from DSC. 
 
The DSC results of the sulphathiazole samples obtained by cooling crystallization using 1-
propanol and n-butanol as solvents, are presented in Figure 3.10 and 3.12, respectively. 
Photographs from HSM for these samples are also presented in Figures 3.11 and 3.13.  
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Figure 3.10 DSC scan at 10ºC/min of sulphathizole sample, obtained by cooling from 
1-propanol 
  (a)       (b) 
Figure 3.11   Sulphathiazole crystal sample, obtained by cooling from 1-propanol, 
analysed under Hot Stage Microscope to observe the thermal events (a) Crystal sample 
before melting at 197 °C (b) Crystal sample after melting at 204 °C 
 
Figure 3.12 DSC scan at 10ºC/min of sulphathiazole sample, obtained by cooling from 
n-butanol 
60 µm 60 µm 
107 
 
      (a)           (b) 
   
Figure 3.13    Sulphathiazole crystals, obtained by cooling from n-butanol, analysed 
under Hot Stage Microscope to observe the thermal events (a) Crystal sample before 
melting at 197 ºC (b) Crystal sample after melting at 204 ºC   
 
As shown in Figures 3.10 and 3.12 both samples, obtained from 1-propanol and n-butanol, 
resulted in similar DSC scans with only a single melting event at 200-201 °C being observed. 
Also they do not show any transformation until melting at 201 °C. Pictures obtained from 
Hot Stage Microscopy (Figure 3.11a and 3.13a) also suggest that both samples maintained 
their needle like crystal morphology and did not show any changes/transformation in crystals 
prior to melting, which started at 199 °C. As shown in Figure 3.11b and 3.13b both samples 
showed complete melting of the crystals by 204 °C on HSM. The HSM results also support 
melting events seen in DSC. According to Anderson et al (2001), Kordikowski et al (2001), 
Anwar et al (1989), Lagas and Lerk (1981) and Kruger and Gafner(1972), Form I melts 
around 201-203 °C without any transformation. Therefore the above samples were 
undoubtedly confirmed as polymorph I. This result also confirms the results of IR and PXRD 
obtained in previous sections, which suggested samples obtained from 1-propanol and n-
butanol to be the polymorph I of sulphathiazole. 
 
The DSC result of sulphathiazole sample obtained by cooling crystallization from 2-propanol, 
is presented in Figure 3.14. To complement the results of DSC analysis, pictures from HSM 
for this sample are presented in Figures 3.15a to e.  
 
 
 
 
60 µm 60 µm 
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Figure 3.14 DSC scan at 10 ºC/min of sulphathiazole sample obtained by cooling from 
2-propanol 
 
          (a)                 (b) 
 
                                  (c)                                                                              (d) 
60 µm 60 µm 
60 µm 60 µm 
109 
 
      
            (e)               (f)  
 
Figure 3.15  Sulphathiazole crystal sample, obtained by cooling from 2-propanol, 
analysed under Hot Stage Microscopy to observe the thermal events (a) at 148°C (b) at 
157°C (c) at 166°C (d) at 173°C (e) at 199°C (f) at 204°C 
 
In the above DSC results, the sample crystallized from 2-propanol showed two endotherms, 
one around 153°C and another around 172°C, prior to the final melting at 201°C. These 
events were also captured by HSM. As shown in Figures 3.15a and b, during the first 
transformation event some of the platey crystals shrank in size and showed movement when 
heated up to 157°C. In contrast, during the second transformation event most of the crystals 
become opaque when heated above 172°C (Figures 3.15c and d) without showing any 
changes in morphology. These opaque crystals finally melted completely above 201°C 
(Figure 3.15e and f). 
 
According to Anwar et al (1989) polymorphs II to IV can transform to polymorph I anywhere 
between a temperature range of 140 – 177°C. Thus it is difficult to distinguish between them. 
However, other reports (Kordikowski et al, 2001; Melesly et al, 1971) observed the 
transformation of polymorph IV into I around 144-148°C and transformation of polymorph II 
and III into I around 166-172°C. The melting point for form V has been reported to be at 
198°C (Anwar, 1989; Lagas & Lerk, 1981). 
 
From the results and observations in Figures 3.14.and 3.15 (3.15 a to e), it could be said that 
the first endothermic peak shown at around 153°C shows the transformation of polymorph IV 
into polymorph I. The second small endotherm around 172°C could be assigned to the 
60 µm 60 µm 
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transformation of the polymorph II or III into Form I. However, from HSM, it was observed 
that most of crystals in the sample become opaque and transformed around 172°C. This 
would suggest the predominant presence of either Form II or III in the sample. Finally all 
crystals show melting, as converted Form I, at ~201°C. From the DSC and HSM of the 
sample, obtained from 2-propanol, the sample may be either Form II or III with a small 
presence of Form IV.  
 
The DSC of sulphathiazole obtained by cooling crystallization from ethanol is presented in 
Figure 3.16. The DSC scan is also supported by HSM of the sample (Figures 3.17a to e). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16 DSC scan at 10 ºC/min of sulphathiazole sample, obtained by cooling 
from ethanol 
 
In Figure 3.16, the sample crystallized from ethanol shows two transformation/melting peaks, 
one around 149°C and another around 171°C, prior to the final melting at 200.5°C. These 
transformations/melting events were also captured in HSM. As shown in Figures 3.17a and b, 
during the first transformation event most of crystals in the sample become opaque between 
142° to 155°C without changing morphology. However, during the second 
transformation/melting event a few small crystals showed melting between 171° to 176°C as 
shown in Figure 3.17c and d. Finally all other crystals melted completely above 201°C 
(Figure 3.17e and f). 
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(a)              (b)   
        
 
              (c)            (d)   
 
             (e)              (f) 
 
Figure 3.17 Sulphathiazole crystal sample, obtained by cooling from ethanol, 
analysedunder Hot Stage Microscopy to observe the thermal events (a) at 142 °C (b) at 
155 °C (c) at 171 °C (d) at 176 °C (e) at 200 °C (f) at 205 °C 
60 µm 60 µm 
60 µm 60 µm 
60 µm 60 µm 
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From previous studies (Kordikowski et al, 2001; Melesly et al, 1971), the first endotherm 
around 149 °C in Figure 3.16 could be assigned to the transformation of polymorph IV into 
Form I. The second small endotherm around 171 °C could be assigned to the transformation 
of the polymorph II or III into Form I. However, from HSM it was observed that most of 
crystals in a sample become opaque and showed transformation at around 149°C. This would 
suggest the predominant presence of Form IV in the sample. Finally all crystals show 
melting, as converted Form I, at 201°C. From the DSC and HSM analysis of the sample, 
obtained from ethanol, the sample could be Form IV with the presence of a small amount of 
Form II or III.  
 
 
The DSC of sulphathiazole sample, obtained by cooling crystallization from methanol, is 
presented in Figure 3.18. The DSC scan is also supported by the HSM of the sample in 
Figures 3.19a to e. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18 DSC scan at 10 ºC/min of sulphathiazole sample obtained by cooling from 
methanol  
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             (a)            (b) 
 
             (c)                       (d) 
       
                             (e)       (f) 
        
Figure 3.19 Sulphathiazole crystal sample obtained by cooling from methanol, 
analysed under Hot Stage Microscopy to observe the thermal events (a) at 147 °C (b) at 
155 °C (c) at 165 °C (d) at 175 °C (e) at 198 °C (f) at 204 °C 
 
60 µm 60 µm 
60 µm 60 µm 
60 µm 60 µm 
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In the DSC results (Figure 3.18), the sample crystallized from methanol showed two 
transformation/melting peaks, one around 152.5°C and another around 172°C, prior to final 
melting at 200.8°C. These transformations/melting events were also captured by HSM as 
shown in Figure 3.19a and b, during the first event a few crystals become opaque between 
147° to 155°C. Most of the other crystals became opaque during the second 
transformation/melting event between 165° to 173°C as shown in Figure 3.19c and d. All 
opaque crystals finally melted above 201°C (Figure 3.19e and f). 
 
From previous studies (Kordikowski et al, 2001; Melesly et al, 1971), the first endotherm 
around 152.5 °C in Figure 3.18 could be assigned to the transformation of polymorph IV into 
I. The second small endothermic peak around 172 °C could be assigned to the transformation 
of polymorph II or III into Form I. However, from HSM it was observed that most of crystals 
in the sample became opaque and showed transformation around 165-173 °C. This would 
suggest the predominant presence of either Form II or Form III in the sample. Finally, all 
crystals showed melting, as converted Form I, at 201 °C. From the DSC and HSM of the 
sample obtained from ethanol, it could be said that the sample was Form II or III with a small 
quantity of Form IV present.  
 
3.3  Characterization of sulphathiazole crystals obtained by evaporation  
 
Crystallization experiments of sulphathiazole by evaporation were also performed with the 
five different alcohol solvents as described in Section 2.2.2.2. The list of these experiments 
are given in Table 2.6 
 
Samples, obtained from evaporative crystallization, were analyzed by optical microscopy, 
PXRD, and single crystal x-ray diffraction to determine their polymorphic identity. 
115 
 
3.3.1 Morphological analysis of crystallized samples 
 
The evaporation experiments were regularly observed by optical microscopy to study the 
growth and changes in morphologies of the crystals. These time-resolved images of the 
morphologies of the crystals are shown in Figures 3.20 to 3.24. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20 (a)  Sample from methanol within Figure 3.20 (b)  Sample from methanol  
5 minutes of nucleation    after complete evaporation 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 3.21 (a)  Sample from ethanol within   Figure 3.21 (b)  Sample from ethanol  
5 minutes of nucleation      after complete evaporation 
 
 
 
 
 
 
 
60 µm 60 µm 
60 µm 60 µm 
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Figure 3.22 (a)  Sample from 2-propanol  Figure 3.22 (b) Sample from  
within 5 minutes of nucleation   2-propanol after complete evaporation 
 
Figure 3.23 (a)  Sample from 1-propanol             Figure 3.23 (b) Sample from 1-propanol  
within 5 minutes of nucleation  after complete evaporation  
 
 
Figure 3.24 (a) Sample from n-butanol                 Figure 3.24 (b) Sample from n-butanol  
within 5 minutes of nucleation   after complete evaporation 
 
60 µm 60 µm 
60 µm 60 µm 
60 µm 60 µm 
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As shown in Figures 3.20 to 3.24, microscopic observation of the samples obtained from 
crystallization by evaporation displayed similar morphological behaviour to that observed 
during cooling crystallization experiments. However, crystals obtained by evaporation, were 
larger compared to crystals obtained from similar solvents by cooling crystallization as the 
evaporative crystallizations were slower in nature and proceeded without any agitation. All 
samples initially crystallised as elongated, or needle particles, which is established as the 
morphology of metastable form I (Anwar et al, 1989, Blagden el al, 1998).   
 
When methanol or ethanol was used as the solvent, needles nucleated initially followed by 
small hexagonal plates within 2 minutes of nucleation (Figures 3.20a & 3.21a).  The needles 
dissolved within a few minutes of nucleation; whereas, the hexagonal crystals grew in size 
and thickness, resulting in hexagonal prisms in the case of methanol (Figure 3.20b), and 
elongated thin hexagons in the case of ethanol (Figure 3.21b) with complete evaporation of 
solvent. Single crystal XRD identified that crystals grown from methanol were Form II, and 
from ethanol were Form IV (see Table 3.6).  
 
In the case of 2-propanol as the solvent, sulphathiazole initially nucleated as needles and very 
small square plates (Figure 3.22a).  Initially needle-shaped crystals predominated. However, 
with time, square plates grew slowly in size and numbers, and the needles disappeared from 
the slurry/solution when left overnight for complete evaporation as shown in Figure 3.22b. 
Square plates also converted into hexagonal plates by developing faces on the angles of 
square plates. The rate of growth was slower than for those crystals grown from the straight 
chain alcohols, with growth continuing for more than 4 hours after nucleation.  Therefore, a 
few square plates were unable to develop faces on the angles before the complete evaporation 
of solvent (Figure 3.22b). Crystals were identified by single crystal X-ray diffraction as Form 
III.   
 
As shown in Figures 3.23 and 3.24, 1-propanol and 1-butanol allowed nucleation of needle-
shaped crystals. Once the evaporation of solvent started, nucleation of needles was prompt 
with maximum growth having occurred within 17-20 minutes of nucleation.  No further 
growth was observed and the particles remained without transformation until the complete 
evaporation of the solvents.  PXRD and single crystal XRD confirmed that each of these 
samples was Form I. 
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3.3.2 Powder x-ray diffraction analysis of Sulphathiazole samples  
 
Sulphathiazole samples, crystallized immediately after nucleation (early samples) by 
evaporation of each of the solvents (Section 2.3.2.2), were isolated by filtration from the 
crystallising solution in order to check the early polymorphic identity during the 
crystallization process. The isolated sulphathiazole samples were dried and analysed by 
PXRD as described in Section 2.4.3. The PXRD patterns of these samples were compared 
with the PXRD of those isolated after complete evaporation of solvent (mature samples) to 
observe if any polymorphic transformation occurred during the crystallization process. The 
results are presented in Figures 3.25, 3.26, 3.27, 3.28, and 3.29. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.25 PXRD patterns of sulphathiazole crystal samples, (a) isolated within 5 
minutes of nucleation and (b) isolated after complete evaporation of 2-propanol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.26 PXRD patterns of sulphathiazole samples, (a) isolated within 5 
minutes of nucleation and (b) isolated after complete evaporation of ethanol. 
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Figure 3.27 PXRD patterns of sulphathiazole samples, (a) isolated within 5 minutes of 
nucleation and (b) isolated after complete evaporation of methanol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.28 PXRD patterns of sulphathiazole samples, (a) isolated within 5 minutes of 
nucleation and (b) isolated after complete evaporation of 1-propanol 
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Figure 3.29 PXRD patterns of sulphathiazole samples, (a) isolated within 5 minutes of 
nucleation and (b) isolated after complete evaporation of n-butanol 
 
As shown in Figures 3.25(a), 3.26(a), and 3.27(a), when methanol, ethanol or 2-propanol was 
used respectively as a solvent, PXRD patterns of early samples (isolated within 2 minutes of 
nucleation) indicated the presence of Form I by displaying characteristic peaks for Form I at 
11° 2 (see Section 3.2.2 for reference PXRD peaks reported previously for sulphathiazole 
polymorphs) but did not show a complete match with the reference PXRD spectra of Form I 
obtained from the CCDC (Section 3.2.2 - Figure 3.8). In addition to the identification peak 
for Form I at 11° 2, these samples also showed similarities/peaks with the CCDC patterns of 
Form II, III and IV, which suggests that apart from metastable Form I these early samples 
also contained Form II, III, or IV. These PXRD results also showed consistency with the 
time-resolved morphological studies of methanol, ethanol, and 2-propanol samples (Sections 
3.3.1), where early samples showed the presence of needle-shaped Form I crystals in pictures 
with other small platey crystals. When mature samples were isolated, the peak at 11° 2 was 
not present in any of the samples (Figure 2.25(b), 2.26(b), and 2.27(b)) and displayed a good 
match with the CCDC patterns of Forms II to IV (Figure 3.8), which indicate that any crystals 
of Form I had transformed into a more stable polymorph II, III, or IV. However, as explained 
in Section 3.2.2, due to similarities in the PXRD patterns of Forms II, III, and IV, it was not 
possible to positively distinguish them from their PXRD patterns. These results were also 
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consistent with the time resolved morphological studies of mature samples (Section 3.3.1), 
which showed the dissolution of needle-shaped Form I and growth of other stable crystals 
with time.  
When 1-propanol or n-butanol was used as solvent, PXRD patterns of early samples and 
mature samples showed an exact match with each other (Figures 3.28 and 3.29). All samples 
displayed the identification peak for Form I at 11° 2 and showed good similarity with the 
reference pattern of Form I obtained from the CCDC (Figure 3.8), which suggests the 
predominant presence of Form I in both early and mature samples, without any polymorphic 
transformation or changes with time. This was also consistent with the time-resolved 
morphological studies of samples obtained from 1-propanol and n-butanol (Section 3.3.1), 
which shows no change in needle-shaped Form I crystals with time.   
 
3.3.3 Single crystal x-ray analysis of crystals obtained from evaporation 
 
Powder x-ray diffraction can be used for fingerprint identification of various solid materials. 
However in some cases, PXRD patterns for the different polymorphs of the same substance 
are very similar to each other due to their structural similarities. This makes it very hard to 
distinguish the precise polymorph from the PXRD patterns. Also in the current study, 
sulphathiazole samples crystallized from methanol, ethanol and 2-propanol showed similar 
PXRD patterns, although clear morphological changes were observed under microscopy 
(Sections 3.2.1 and 3.3.1) that suggest the possibilities of different polymorphs. It is known 
that all solid crystalline compounds have their own particular unit cell, which should be 
unique in its dimensions. Even different polymorphs of the same compound sulphathiazole 
would differ from each other in their unit cell dimensions a, b, c and see Section 1.1 
for more details about unit cell dimensions) Therefore single crystal x-ray study was used to 
identify the unit cell and hence the polymorphic form of sulphathiazole crystallized from 
each solvent. 
 
Sulphathiazole crystals were grown by evaporation from each solvent as described in Section 
2.3.2.2. A single crystal was mounted on a glass fiber in a random orientation. Using a Stoe 
IPDS (Imaging Plate Diffraction System) area detector, unit cell constants were calculated by 
least squares refinement using the setting angles of 25 reflections and compared with 
reference unit cell data as shown in Table 3.4. 
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Table 3.4 Comparison of unit cell data, obtained from single crystal x-ray diffraction, 
with the data obtained from literature for polymorphic identification  
 
                Current study               Literature values 
Unit 
cells 
1-
propanol 
and 1-
butanol 
methanol 2-propanol ethanol Form Ia Form 
IIb 
Form 
IIIa 
Form 
IVc 
a 10.45 Å 8.18 Å 17.40 Å 10.90 
Å 
10.55 Å 8.23 Å 17.57 Å 10.86 Å 
b 13.27 Å 8.56 Å 8.5 Å 8.56 
Å 
13.22 Å 8.55 Å 8.57 Å 8.54 Å 
c 17.20 Å 15.48 Å 15.9 Å 11.48 
Å 
17.05 Å 15.55 Å 15.58 Å 11.45 Å 
ȕ 107 ° 94.18 °  112 °  89.6 ° 108.06 ° 93.67 °  112.93 °  88.13 °  
 
Key for Literature values  a Kruger and Gafner (1971) 
   
b
 Kruger and Gafner (1972)  
   
c
 Bablidev et al (1987) 
 
From comparison with reference unit cell data, it was clear that sulphathiazole crystals 
crystallized from 1-propanol and n-butanol were Form I, whereas sulphathiazole crystallized 
from methanol, 2-propanol and ethanol showed good match with the reference unit cell data 
of Forms II, III and IV respectively, as shown in Table 3.4. Therefore samples crystallized 
from methanol, 2-propanol and ethanol were identified as polymorph II, III and IV 
respectively.  
 
 
3.4 Effect of grinding on polymorphic stability 
 
 
Grinding is one of the essential and routine operations for particle size reduction and tablet 
preparation. During the grinding process, the drug particle would be subject to high 
mechanical stress that could cause transformation of the solid drug compound. It is therefore 
desirable to check the stability of the metastable form of sulphathiazole against the 
mechanical stress of grinding. 
 
The effects of grinding on sulphathiazole Form I crystal samples, obtained from 
crystallization by cooling 1-propanol (Section 2.2.2.1), were observed by comparing the 
PXRD patterns of extensively ground samples with gently ground samples. Sulphathiazole 
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Form I sample was ground manually using a mortar and pestle for 10 minutes (extensively 
ground sample). The PXRD pattern of this sample was compared with the PXRD patterns of 
Form I which was ground gently for 2 minutes using a mortar and pestle. The results are 
shown in Figure 3.30. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.30 PXRD patterns of sulphathiazole samples, (a) reference pattern of Form I 
obtained from CCDC (b) Form I after grinding for 2 minutes (c) Form I after grinding 
for 10 minutes (d) reference pattern of Form II obtained from CCDC  
 
From Figure 3.30, it is clear that crystals of Form I showed a significant effect of grinding on 
polymorphic stability. As shown in Figure 3.30 (b), the sample, ground for 2 minutes, 
showed the identification peak for Form I at 11° 2 value and exactly matched with the 
reference PXRD pattern of Form I obtained from CCDC (Figure 3.30 a), which confirms that 
the sample was pure Form I. However, after grinding of the sample for 10 minutes, Form I 
lost its identity peak at 11° 2 value as shown in Figure 3.30 (c). In addition, Form I after 
extensive grinding for 10 minutes showed a PXRD pattern, which showed similarity with the 
reference PXRD pattern of Form II (Figure 3.30 d), obtained from CCDC. This result 
indicates that extensive grinding of sample of Form I for a long time would cause a 
polymorphic transformation in to the more stable polymorph II, III or IV.  
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3.5 Effect of Seeding 
 
According to Ostwald’s rule of stages, the sulphathiazole polymorphs would transform from 
the least stable metastable state (Form I) to the thermodynamically more stable states (Form 
II, III, or IV). Also seeding of the more stable polymorph into the sulphathiazole solution 
should draw the nucleation or transformation of crystals into the more stable seeded 
polymorph.  
 
In the current study, it is known from results (Sections 3.2 and 3.3) that Form I was stabilized 
when 1-propanol used as a solvent for the crystallization of sulphathiazole. The effects of 
seeding more stable Form II, III or IV on the crystallization of sulphathiazole was observed 
when 1-propanol used as a solvent. Form II, III and IV obtained from evaporative 
crystallization (Section 3.3.3) were used as seeds. The seeding experiments were performed 
as described in Section 2.2.2.1. Experiments are also listed in Table 2.3.   
 
After crystallization, crystals were separated for powder X-ray diffraction analysis in order to 
check the polymorphic identity of the samples. Results of PXRD analysis are shown in 
Figure 3.31. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.31  PXRD patterns of sample obtained from crystallization using 1-propanol 
with (a) seeding with Form IV, (b) seeding with Form III, (c) seeding with Form II, and 
(d) without any seeding  
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As shown in Figure 3.31, PXRD patterns of all samples showed the identification peak for 
form I at 11° βθ and showed an exact match with the reference PXRD pattern of Form I 
(Figure 3.8), which confirms the identity of all the samples as Form I. From above PXRD 
results it is clear that even seeding of more stable forms (II, III and IV) into 1-propanol-
sulphathiazole solution could not draw transformation of Form I into the more stable seeded 
forms. Even with seeding of a more stable form, 1-propanol stabilized metastable Form I 
only. PXRD patterns of the samples, crystallized from 1-propanol with or without seeding did 
not show any changes but showed identical behavior with each other. These results suggest 
that there was no effect of seeding with the more stable form on the stabilization of Form I 
from 1-propanol. This finding is consistent with the previous conclusion (section 3.2) that 1-
propanol and n-butanol stabilized the growth of Form I. 
 
 
3.6  Characterization of sulphathiazole solutions by solution NMR 
 
 
It is possible that with the use of different solvents, the pre-nucleation clusters of solute 
molecules can arrange differently as the solvents are able to engineer the intermolecular 
interaction. Davey et al (2001) demonstrated, using 2, 6 dihydroxybenzoic acid as a model 
system, that when solute molecules in the solution arranged differently prior to the 
nucleation, different polymorphs would be formed (Davey et al, 2001). In current study, 
sulphathiazole showed the crystallization of different polymorphs with the use of different 
alcohols as solvent. Use of different alcohol solvents might engineer different pre-nucleation 
clusters of sulphathiazole molecules, which could impact on the polymorphic outcome of 
sulphathiazole crystallization. The pre-nucleation clusters would differ from each other in 
their hydrogen bonding arrangements. These differences in their hydrogen bonding can be 
observed using 1H solution NMR by dissolving sulphathiazole in deuterated alcohol solvents. 
Here, sulphathiazole was dissolved in deutarated ethanol, methanol and n-butanol and 
samples were analysed in 1H solution NMR as explained in section 2.4.7. The results are 
presented in Figure 3.32. 
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Figure 3.32 1H NMR analysis of commercial sulphathiazole in (a) 1-butanol, in (b) 
ethanol and in (c) methanol  
 
Table 3.5 Chemical shifts of assigned hydrogen peaks in different solvents 
Solvent used H8 H4 & H7 H9 H5 & H6 
1-butanol 6.55 6.60 6.90 7.56 
Ethanol 6.61 6.62 7.00 7.56 
Methanol 6.62 6.63 7.04 7.56 
 
3.6.1 Phenyl ring hydrogens (H4, H7, H5, and H6) 
 
As shown in Figure 3.32, H4 and H7 are nearer to the amino (-NH2-) group, which is an 
electron donating group. Therefore, H4 and H7 experience more electron rich environments 
and require less energy to go to the higher energy state. In contrast, H5 and H6 are nearer to 
the sulphonamide (S=O) group, which is an electron withdrawing group. Therefore, H5 and 
H6 would experience an electron deficient environment compared to H4 and H7 and require 
more energy to reach the higher energy state. Hence H4 and H7 show a lower chemical shift 
(between 6.6 to 6.7) in all liquid NMR analysis; whereas H5 and H6 show higher chemical 
shifts (approximately at 7.6) in all the liquid NMR analyses. These hydrogens also show a 
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coupling effect (H4 with H5 and H7 with H6) and therefore they display doublets in their 
peaks. Also the consistent gap between the doublets in both peaks supports the peak 
assignments as hydrogens associated with an aromatic six carbon ring.  
 
3.6.2 Thiazole ring hydrogens (H8 and H9) 
 
In the thiazole ring, Sulphur (S2) is not connected to any other group (such as O or H), which 
makes it electron donating compared with the NH group (Nγ−Hγ). H8 is nearer to sulphur 
(S2) than H9 and therefore H8 would be more electron rich compared with H9 Hence, H8 
results in a lower chemical shift of 6.5 to 6.7; whereas, H9 results in a higher chemical shift 
of 6.9 to 7.1. Again, both hydrogens show coupling effects with each other and therefore 
peaks for both hydrogens display as doublets.  
 
As shown in Figure 3.32 and Table 3.5, 1H NMR analyses with different alcohol solvents 
show changes in the chemical shift for the peaks associated with H8 and H9.  
 
It is known from the experimental results (Section 3.3) that sulphathiazole crystallizes as 
Form I from 1-butanol; whereas, from methanol and ethanol it crystallized respectively as 
Form II and IV. Form I utilizes the thiazole ring H3 to make hydrogen bonds with N2 
(N2−H3) for the unique α-dimer ring formation (Figure 1.9). In contrast, the Forms II, III, 
and IV use the thiazole ring H3 with the more electron negative N1 (N1−H3) for its unique ȕ-
dimer ring formation (Figure 1.10). Due to the electron negativity of N1, the N1−H3 bond in 
ȕ-dimer would be stronger than N2−Hγ bond in α-dimer. Hence, H8 and H9 would have a 
greater electron rich environment in the α-dimer compare to the ȕ-dimer. Therefore, H8 and 
H9 in the α-dimer would require less energy to reach the higher energy state in the NMR 
magnetic field and show a lower chemical shift in the NMR spectra; whereas, H8 and H9 in 
the ȕ-dimer would require more energy and hence show a higher chemical shift in the NMR 
spectra. In this analysis, the lower chemical shift for H8 and H9, when 1-butanol was used as 
the NMR solvent compared to methanol and ethanol, suggest that the formation of pre-
nucleation cluster similar to the α-dimer (Form I) in 1-butanol and similar to the ȕ-dimer 
(Form II-IV) in methanol and ethanol.  
 
In this study all the liquid NMR samples were prepared with alcohol functionality solvents. 
Therefore, hydrogens associated with NH (H3) and NH2 (H1 and H2) groups are more likely 
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to make many hydrogen bonds with solvent or solute molecules and due to that they are more 
likely to show very weak unpredictable broad peaks, which could even be merged with the 
base-line in Liquid NMR. However, all the NMR spectra in Figure 3.32 represent a very 
weak signal of broad peak between 3.9 and 4.2. This peak could be assigned to the hydrogen 
in the NH group (H3) as the NH group less likely to take part in hydrogen bonding compared 
with NH2.Hence H3 would be more likely to appear on the NMR spectra compared with H1 
and H2
.
 As explained above, in the ȕ-dimer H3 is involved in stronger hydrogen bonding 
compared with the α-dimer. Hence, pre-nucleation cluster formations similar to the α-dimer 
in 1-butanol show a lower chemical shift for H3 (3.9) compared to the chemical shift of H3 in 
methanol and ethanol.  
 
These differences in hydrogen peaks also explain clustering formation and nucleation of 
different hydrogen arrangements related with particular polymorphs from a solvent and are 
consistent with other analytical and modelling results which explain the effect of solvents on 
the polymorph outcome. 
 
Further 1H NMR studies, as a titration of increasing sulphathiazole concentration in solvents, 
could provide more insight in to interactions between sulphathiazole and solvent molecules in 
saturated solutions. Since this work was conducted, the use of NMR to probe solution 
behaviour has been further developed.  For example, in a similar study, Lohani et al (2011) 
used 1H NMR to investigate the role of acetonitrile and ethanol in selection of Indomethacin 
polymorphs. From the results of 1H NMR studies at different concentrations of Indomethacin 
in deuterated acetonitrile and ethanol, they suggested that acetonitrile favours the nucleation 
of stable Ȗ-indomethacin as the critical supersaturation required to overcome the energy 
barrier for the nucleation is much lower in acetonitrile than in ethanol. Whereas, the 
nucleation of metastable α-indomethacin was favoured only at high supersaturation from 
ethanol solution as it required higher critical supersaturation to overcome the high energy 
barrier for nucleation. However, in this work, the current 1H NMR studies were simple, 
preliminary investigations which successfully indicated differences in solution behaviour 
between those solvents that stabilize Form I containing the α-dimer and those that stabilize 
other forms containing the ȕ-dimer (Figure 3.32).Further investigation of sulphathiazole 
interaction with solvent molecules and impact of that on polymorph selection is discussed in 
chapter 4 using molecular modelling. 
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3.7 Conclusion 
 
The solvent dependence of polymorph generation is well-established for sulphathiazole 
(Blagden et al 1998; Anwar et al, 1989). This study examined the effect of a range of 
alcohols on polymorph selection of sulphathiazole and investigated the role of alcohol 
functional group in the polymorph selection process. Samples from all experiments were 
characterized using optical microscopy, PXRD, DSC, IR, and single crystal X-ray diffraction 
for their polymorphic identity. Results showed that solvent had a significant impact on 
polymorph selection. In common with 1-propanol, 1-butanol was found to stabilize the most 
metastable Form I, containing the α-dimer, without showing any nucleation or transformation 
to more stable polymorphs II, III and IV. Even the seeding of more stable polymorphs (II, III, 
and IV) in 1-propanol could not prompt the transformation of Form I in to any of the more 
stable forms. Whereas, methanol, 2-propanol, and ethanol did not stabilize Form I but 
stabilized Forms II, III, and IV, respectively, containing the ȕ-dimer as their basic unit. It was 
observed by optical microscopy and PXRD that all samples initially crystallised as most 
metastable form I and then showed transformation to the more stable forms II, III, and IV 
when 2-propanol, methanol and ethanol were used as solvents.  
 
The formation of the ȕ-dimer is necessary for the transformation into the more stable forms 
II, III, and IV. Thus, for Form I to be kinetically stable, the formation of the α-dimer in 
solution must be favored and the formation of the β-dimer must be inhibited. In this study, 
where long chain alcohols (1-propanol and 1-butanol) stabilized α-dimer based Form I and 
shorter chain alcohols (methanol, ethanol and 2-propanol) stabilized  ȕ-dimer based Forms II, 
III, and IV suggest that it is not only the alcohol functionality but also the steric effects of the 
alkyl chain that contributed to the effect. The 1H NMR studies (Figure 7) also indicate 
differences in solution behavior between those solvents that favor the stabilization of the 
form containing the α-dimer and those that favor the formation of forms containing the ȕ-
dimer. These results clearly indicate that solvents play an important role in the selection of 
metastable and stable polymorphs of sulphathiazole. 
 
Also, the impact of grinding on the metastable Form I was investigated. It was observed that 
Form I was transformed into more stable Forms II to IV with grinding.  
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Chapter 4  Molecular modelling of sulphathiazole dimers 
 
4.1 Introduction 
The experimental results (chapter 3) indicated that 1-propanol and n-butanol stabilized Form 
I of sulphathiazole; whereas, methanol, ethanol, and 2-propanol resulted in the stabilisation of 
sulphathiazole Forms II, III and IV. It was also observed that initially Form I was nucleated 
and crystallised from all the solvents. However, Form I dissolved very quickly, within 
minutes of nucleation, with the crystallization of more stable Forms II to IV in the case of 
methanol, ethanol, and 2-propanol respectively. These polymorphic changes from the 
metastable to the stable form with time also indicated that sulphathiazole obeys Ostwald’s 
rule of stages. As reported previously (Section 1.11.2), the Form I structure contains the α-
dimer as its basic unit, whereas Forms II to IV contain the β-dimer as the basic unit. Hence, 
for the nucleation of Form I in solution, formation of the α- dimer would be required and for 
the nucleation of Forms II to IV in solution, formation of the β-dimer would be required. In 
the experimental results presented in Chapter 3, sulphathiazole crystallization from 1-
propanol and n-butanol did not show nucleation of Forms II to IV, which requires the 
formation of the β-dimer. The 1H NMR studies also indicated differences in solution 
behaviour between those solvents that inhibit the formation of β-dimer and those that favor 
its formation (Parmar et al, 2007). These results may suggest unfavourable conditions for the 
formation of β-dimer in 1-propanol and n-butanol. Therefore the role of solvent was 
investigated thermodynamically using molecular modelling tools for the formation of dimers. 
In the current study, initial molecular modelling was performed using the Cerius2 and Mopac 
software packages and more detailed modelling was performed via the grid-based systematic 
search approach (Hammond et al, 2006). 
 
 4.2 Molecular modelling of pre-nucleation clusters using Cerius2 and Mopac  
 
Solute molecules form clusters with solvent molecules prior to the nucleation, which are 
called pre-nucleation clusters (Blagden et al, 1998). For a particular polymorph to depend on 
solvent, these clusters may mimic the structural features of the polymorph. Hence pre-
nucleation clusters of sulphathiazole with 1-propanol and 1-butanol may resemble α dimers, 
which is basic structural unit of Form I. Whereas, pre-nucleation clusters of sulphathiazole 
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with methanol, ethanol, and 2-propanol may resemble β dimers, which is basic structural unit 
of Forms II to IV. The energy of proposed pre-nucleation clusters of sulphathiazole, based on 
α and β dimers in the presence of each of the solvents, was investigated using Cerius2 and 
Mopac software packages. The details of Cerius2 and Mopac applications and calculations 
are described in Section 2.4.8.  
 
The crystal structures of the polymorphs of sulphathiazole were adopted from the Cambridge 
Crystallographic Database (CCDC) and imported into the Cerius2 suite. The α- and β-dimers 
were selected from the crystal structure of sulphathiazole polymorphs I (CCDC reference –
SUTHAZ01) and III (CCDC references SUTHAZ02) and loaded into Cerius2 visualiser 
windows separately. Thereafter the Dreiding force field was applied to both dimers, 
following which both dimers were energetically minimized (Figure 4.1 and 4.2).  
 
 
  
 
 
 
 
 
 
  
As shown in Figures 4.1 and 4.2, the α- and β-dimers are formed by two hydrogen bonding 
interactions between molecules A and B. The energy released, when these bonds are created 
and form a dimer, is represented as the interaction energy, Eint. To calculate the interaction 
energies of α- or β-dimers, the energies of formation of the individual molecules (A and B) 
were subtracted from the energy of formation of the dimer (Equations 4.1). Here, the energies 
of formation for the individual molecules (A and B) were calculated at fixed position from 
dimers. The formation energies were calculated using the MOPAC module within Cerius2. 
MOPAC is a general purpose semiempirical molecular orbital package for the study of solid 
state and molecular structures and reactions (Dewar et al, 1985). MOPAC provides the 
selection to choose a task and a method. Task and methods are the most fundamental 
Figure 4.1 Energetically minimized 
α-dimer 
Figure 4.2 Energetically minimized 
β-dimer 
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parameters that define the characteristics for a MOPAC based calculation. In the current 
study, single point energy and PM3 (Parameterized Model number 3) were selected as task 
and method, respectively, for the calculation. The formation energy of α/β dimer, and 
individual energies of molecules A and B of the dimer are listed in Table 4.1. These values 
were used in equation 4.1 to calculate the interaction energies of α/β dimers.  
�௜�� = ( �݋ݐ�݈ ݁݊݁ݎ݃ݕ ݋݂ ݈ܿݑݏݐ݁ݎ ݋ݎ ݀�݉݁ݎ) − ቌ �݊݁ݎ݃ݕ ݋݂ ݂݋ݎ݉�ݐ�݋݊ ݋݂ ݉݋݈݁ܿݑ݈݁ ܣቍ − ( �݊݁ݎ݃ݕ ݋݂ ݂݋ݎ݉�ݐ�݋݊ ݋݂ ݉݋݈݁ܿݑ݈݁ ܤ )  (Equation 4.1) 
 
Table 4.1 Calculated energies of dimers and their individual molecules using MOPAC 
Dimer Total formation 
energy of dimer 
Energy of formation 
for molecule A 
Energy of formation 
for molecule B 
Interaction 
Energy (Eint) 
 α 204.09 kcal/mol 109.36 kcal/mol  109.36 kcal/mol  -14 kcal/mol 
 β 292.48 kcal/mol 157.24 kcal/mol  157.24 kcal/mol  -22 kcal/mol 
 
As shown in Table 4.1, the interaction energy for the α-dimer was calculated as -14 kcal/mol 
using Equation 4.1; whereas, the interaction energy for the β-dimer was observed to have a 
lower value (compared to the α-dimer) of -22 kcal/mol. This indicates that the β-dimer is 
thermodynamically more stable than the α-dimer.  This is expected as it is known from the 
previous studies (Anwar et al, 1989; Blagden et al, 1998a) that structures containing β-dimer 
(Form II to IV) are thermodynamically more stable than Form I, which contains only the α-
dimer. 
 
4.2.1 Pre-nucleation clusters of α and β dimers with solvent molecule 
To try to model the influence of the solvent on the tendency to form either α or β-dimers, and 
therefore to influence polymorph nucleation, clusters were generated based on either the α-
structure or the β-structure with a solvent molecule inserted between the dimer pairs as 
shown in Figures 4.5 and 4.10. The clustering together of solute moleclues in the solution 
phase by interacting with each other and solvent can make a stable size cluster in solution 
which can nucleate as a crystal.  This is called a pre-nucleation cluster (Section 1.4).  
 
The possible location of the solvent molecule in such a cluster was determined from 
preliminary calculations where the lowest energy position from ten proposed positions was 
chosen as the preferred location of the solvent molecule. These ten proposed positions of the 
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solvent molecule were selected arbitrarily in three dimensional space such that a hydrogen 
bonding interaction could form with both sulphathiazole molecules involved in the α or β-
dimer formation. (This group of molecules will be referred to as a “cluster”). These 
preliminary calculations at ten proposed positions were performed with methanol being 
selected as the solvent molecule.  
 
4.2.1.1 Pre-nucleation cluster of α-dimer 
 
In the case of the α-dimer, two molecules of sulphathiazole are connected to each other by N-
--H hydrogen bonds. Methanol, as a solvent molecule, was inserted into 10 different positions 
around N---H hydrogen bonds of the α-dimer so that methanol could hydrogen bond with 
both molecules of the α-dimer across N and H sites to make an α-solvated cluster (as 
illustrated in Figure 4.5 for position 5). The interaction energies of each of the α-solvated 
clusters, with a methanol molecule at 10 different positions, were calculated using Equation 
4.2. In this equation total energy of this α-solvated cluster and individual energies of 
molecules were calculated at fixed positions. 
�௜�� (ݏ݋݈ݒ�ݐ݁݀ ߙ ݈ܿݑݏݐ݁ݎ ) = (�݋ݐ�݈ ݁݊݁ݎ݃ݕ ݋݂ ݏ݋݈ݒ�ݐ݁݀ ߙ ݈ܿݑݏݐ݁ݎ ) − ( 
 �݊݁ݎ݃ݕ ݋݂ ݂݋ݎ݉�ݐ�݋݊ ݋݂ ߙ ݀�݉݁ݎ ݉݋݈݁ܿݑ݈݁ ܣ ) 
 − ( 
 �݊݁ݎ݃ݕ ݋݂ ݂݋ݎ݉�ݐ�݋݊ ݋݂ ߙ ݀�݉݁ݎ݉݋݈݁ܿݑ݈݁ ܤ) 
 −(  
 �݊݁ݎ݃ݕ ݋݂ ݂݋ݎ݉�ݐ�݋݊݋݂ ݏ݋݈ݒ݁݊ݐ ሺ݉݁ݐℎ�݊݋݈ሻ ݉݋݈݁ܿݑ݈݁ ܥ ) 
  
 
                 (Equation 4.2) 
 
The calculated energies of the ten positions of the methanol molecule, using Equation 4.2, are 
shown in Table 4.2 for the solvated α-cluster. Methanol was inserted in ten positions with 
fixed orientation (Table 4.2).  
 
As shown in Table 4.2, from the above ten positions, position 5 displays the lowest energy, 
which would be the thermodynamically most preferred, from the ten positions, for a methanol 
molecule to interact with the α-dimer (Figure 4.3).   
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Table 4.2 Calculated interaction energy, Eint, of solvated α-cluster with a methanol 
molecule at 10 proposed positions (all the energies are kcal/mol) 
Position Total energy 
of cluster 
Energy of 
formation for 
molecule A 
kcal /mol 
Energy of 
formation for 
molecule B 
 kcal /mol 
Energy of 
formation for 
molecule C 
kcal /mol 
Interaction 
Energy 
(Eint)  
kcal /mol 
1 
 677.57 109.36  109.36 14.2 444.65 
2 1756.98  109.36  109.36 14.2 1527.06 
3 755.52  109.36  109.36 14.2 522.6 
4 579.43  109.36  109.36 14.2 346.51 
5 
 463.38  109.36  109.36 14.2 230.46 
6 
 522.32  109.36  109.36 14.2 289.4 
7 
 611.82  109.36  109.36 14.2 378.9 
8 
 787.45  109.36  109.36 14.2 554.53 
9 
 979.19  109.36  109.36 14.2 746.27 
10 
 1211.87  109.36  109.36 14.2 978.95 
 
 
 
 
 
 
 
 
 
Figure 4.3 Solvated α-cluster with methanol being the solvent at lowest energy 
position 5 
 
Hence, this position was selected as a thermodynamically preferred position and used as the 
preferred location for other solvent molecules (2-propanol, n-butanol, ethanol, and 1-
propanol) to make solvated clusters with the α-dimer. The interaction energies of solvated α-
clusters with 2-propanol, n-butanol, ethanol, and 1-propanol at the preferred location 5 were 
calculated in a similar manner using Equation 4.2 by replacing the methanol molecule with 
the respective solvent molecules as shown in Figure 4.4 to 4.7 and Table 4.3. 
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Table 4.3 Calculated Eint (Kcal/mol) of solvated α-clusters with n-butanol, 1-propanol, 
ethanol, 2-propanol and methanol at thermodynamically preferred position 5  
Solvent 
molecule 
Total 
energy of 
cluster 
kcal /mol 
Energy of 
formation for 
molecule A 
kcal /mol 
Energy of 
formation for 
molecule B 
kcal /mol 
Energy of 
formation for 
molecule C 
kcal /mol 
Interaction 
Energy (Eint) 
1-propanol 486.05  109.36  109.36  15.6  236.13 
n-butanol 425.86  109.36  109.36  16.2  190.94 
ethanol 485.52  109.36  109.36  15.1  251.70 
2-propanol 593.91  109.36  109.36  18.1  357.09 
methanol  463.38  109.36  109.36  14.2  230.46 
 
 
Figure 4.4  Solvated α-cluster with 1-
propanol being the solvent at position 5 
Figure 4.5  Solvated α-cluster with n-
butanol being the solvent at position 5 
Figure 4.6  Solvated α-cluster with 
ethanol being the solvent at position 5 
Figure 4.7  Solvated α-cluster with 2-
propanol being the solvent at position 5 
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4.2.1.2 Pre-nucleation cluster of β-dimer 
 
In the case of the β-dimer, two molecules of sulphathiazole are connected to each other by 
N1---H3 and O2---H1 hydrogen bonds. Out of these two hydrogen bonds, O2---H1, is 
presented in the crystal structure of all sulphathiazole Forms (I to IV), (Section 1.11.2); hence 
this bonding would not be the subject of solvent dependency. Therefore, methanol, as a 
solvent molecule, was inserted into 10 different positions around N1---H3 hydrogen bonds of 
the β-dimer so that the methanol molecule could hydrogen bond with both β-dimer molecules 
across N1 and H3 sites to make the β-solvated cluster (as illustrated in Figure 4.10 for 
position 8). The interaction energies of β-clusters, with methanol molecule at 10 different 
positions, were calculated in a similar manner using Equation 4.3. In this equation total 
energy of this β-solvated cluster and individual energies of molecules were calculated at fixed 
positions. 
�௜�� (ݏ݋݈ݒ�ݐ݁݀ ߚ ݈ܿݑݏݐ݁ݎ ) = ቌ�݋ݐ�݈ ݁݊݁ݎ݃ݕ ݋݂ ݏ݋݈ݒ�ݐ݁݀ ߚ ݈ܿݑݏݐ݁ݎ ቍ − ( 
 �݊݁ݎ݃ݕ ݋݂ ݂݋ݎ݉�ݐ�݋݊ ݋݂ ߚ ݀�݉݁ݎ ݉݋݈݁ܿݑ݈݁ ܣ ) 
 − ( 
 �݊݁ݎ݃ݕ ݋݂ ݂݋ݎ݉�ݐ�݋݊ ݋݂ ߚ ݀�݉݁ݎ݉݋݈݁ܿݑ݈݁ ܤ) 
 −(  
 �݊݁ݎ݃ݕ ݋݂ ݂݋ݎ݉�ݐ�݋݊݋݂ ݏ݋݈ݒ݁݊ݐ ሺ݉݁ݐℎ�݊݋݈ሻ ݉݋݈݁ܿݑ݈݁ ܥ ) 
  
  
 (Equation 4.3) 
Calculated energies of interaction of solvated β-cluster with methanol at ten different 
positions using equation 4.3 are shown in Table 4.4. 
 
Table 4.4 Calculated interaction energy (kcal/mol) of solvated β-clusters with methanol 
molecule at 10 proposed positions 
Position Total energy 
of cluster 
Energy of 
formation for 
molecule A 
Energy of 
formation for 
molecule B 
Energy of 
formation for 
molecule C 
Interaction 
Energy 
(Eint) 
1 1439.98  157.24  157.24 19.4 1106.1 
2 1019.54  157.24  157.24 19.4 685.66 
3 1265.89  157.24  157.24 19.4 932.01 
4 1338.88  157.24  157.24 19.4 1005 
5 1085.18  157.24  157.24 19.4 751.3 
6 755.58  157.24  157.24 19.4 421.7 
7 640.91  157.24  157.24 19.4 307.03 
8 558.00  157.24  157.24 19.4 224.12 
9 666.04  157.24  157.24 19.4 332.16 
10 985.71  157.24 157.24  19.4 651.83 
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As shown in Table 4.4, from the above ten positions position 8 displays the lowest energy, 
and would be the thermodynamically most preferred position, amongst all the ten positions, 
for a methanol molecule to interact with the β-dimer (Figure 4.8). 
 
 
 
 
 
 
 
 
Figure 4.8 Solvated β-cluster with methanol being the solvent at lowest energy 
position 8 
 
Hence, this position was selected as a thermodynamically preferred position and used as the 
preferred location for other solvent molecules (2-propanol, n-butanol, ethanol, and 1-
propanol) to make solvated clusters with the β-dimer. The interaction energies of solvated β-
clusters with 2-propanol, n-butanol, ethanol, and 1-propanol at the preferred location 8 were 
calculated using Equation 4.3 by replacing methanol molecule with the respective solvent 
molecule as shown in Figures 4.9 to 4.12 and Table 4.5. 
 
  
 
 
 
 
 
 
 
 
Figure 4.9  Solvated β-cluster with 1-
propanol being the solvent at position 8 
Figure 4.10  Solvated β-cluster with n-
butanol being the solvent at position 8 
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Table 4.5 Calculated Eint (Kcal/mol) of solvated β-clusters with n-butanol, 1-propanol, 
ethanol, 2-propanol, and 2- propanol at thermodynamically preferred position 8  
 
Solvent 
molecule 
Total 
energy of 
cluster 
kcal /mol 
Energy of 
formation for 
molecule A 
kcal /mol 
Energy of 
formation for 
molecule B 
kcal /mol 
Energy of 
formation for 
molecule C 
kcal /mol 
Interaction 
Energy (Eint) 
kcal /mol 
1-propanol 
 759.29  157.24 157.24   24.90  419.91 
n-butanol 
 704.99  157.24  157.24  28.70  361.81 
ethanol 
 574.84  157.24  157.24  22.50  237.86 
2-propanol 
 675.29  157.24  157.24  29.10  331.71 
methanol  558.00  157.24 157.24  19.20 224.12     
 
As shown in Tables 4.3 and 4.5, when the solvating molecule was chosen to be methanol, 
ethanol or 2-propanol, the -cluster was calculated to have a lower energy of interaction 
compared to the α-cluster, indicating the β-cluster to be more thermodynamically stable than 
the -cluster. This predicts that clustering similar to the -dimer would be present in solution, 
and provide a route to the nucleation of polymorphs based on the -dimer, namely Forms II, 
III, and IV. This is in agreement with the experimental observation that in these solvents, 
whilst Form I nucleates initially, one or more of the other forms nucleates, grows and is 
maintained in solution, as Form I dissolves.  
 
The position is reversed for 1-propanol and 1-butanol. The interaction energy of the -cluster 
has a much higher value than the -cluster, suggesting that -clusters would not form in 
Figure 4.11  Solvated β-cluster with 
ethanol being the solvent at position 8 
Figure 4.12  Solvated β-cluster with 2-
propanol being the solvent at position 8 
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solution, and polymorphs containing the -dimer would not be nucleated. Again this is in 
agreement with the experimental observation that Form I nucleates and remains stable in 1-
propanol and 1-butanol solution, with no transformation or nucleation of any other 
polymorphs. The H1 NMR studies (Section 3.6) also indicate differences in solution 
behaviour between those solvents that inhibit the formation of the  dimer, and those that 
favour its formation.  
 
These preliminary calculations indicate that the ability of the solvent to inhibit transformation 
may be linked to the energies of substrate-solvent interactions, and show that clustering in 
solution may be thermodynamically controlled (Parmar et al, 2007). However these 
preliminary calculations for α/β dimers interactions with a solvent molecule were performed 
at 10 fixed positions. Therefore a more detailed systematic search approach was undertaken 
(section 4.3) that uses a grid based search system (Hammond et al, 2006; Hammond et al, 
2003) of translations and rotations. This approach allowed us to access all the possible 
intermolecular packing arrangements between the sulphathiazole dimer and solvent molecule 
in direct space on the basis of atom-atom separation distance and intermolecular potential 
pair energy. 
  
4.3 The systematic search approach for molecular modelling of the solvated 
structure 
 
Following the results of preliminary calculations the molecular modeling study was expanded 
via the grid-based systematic search approach for the calculation of interaction energies of 
solvated clusters. The systematic search approach has been successfully applied to predict 
crystal structure of various materials from knowledge of unit cell parameters and space group 
alone, and to solve the crystal structure of various materials from the powder diffraction data 
(Kutzke et al, 2000; Smith et al 2001; Hammonds et al, 2003). The systematic search 
approach uses a grid based search system of translations and rotations to assess all the 
possible intermolecular packing arrangements or interactions in direct space. Hammond et al 
(2006) used the systematic search method to predict the host/counter ion binding for an 
organic salt of 3,4,6,7,8,9-Hexahydro-2H-pyrimido pyrimidinium (host molecule) with 
acetate (counter ion). In this study, dimer pairs between host and counter ion were identified 
by rotating and translating one molecule with the other at a fixed position. This grid-based 
140 
 
dimer search results in the generation of very large numbers of molecular pairs between host 
and counter ion. These pairs were further optimized and clustered to subsequently obtain the 
molecular pair with the lowest energy of formation, which was further analyzed and 
examined in the grid-based systematic search procedure (Hammond et al, 2003) to obtain the 
best match with the known salt structure from the CCDC database.  
 
This study uses the principle of the systematic search method to identify all solvated pairs 
between a sulphathiazole dimer and a solvent molecule.    
 
4.3.1 Method of GRID based systematic search  
 
In this method, the sulphathiazole dimer ( or ) was fixed at one co-ordinate location (used 
as a fixed molecule), while the solvent molecule was chosen as the mobile molecule. 
Potential molecular clustering (molecular pairs) between the sulphathiazole dimer and the 
solvent molecule was studied by rotating and translating a mobile solvent molecule in space 
at each grid cell around a fixed sulphathiazole dimer.  The solvent molecule was subjected to 
a grid based search, defined by three translational (x, y, and z) and three rotational degrees of 
freedom (x, y, and z) as shown in Figure 4.13. 
 
 
 
 
 
 
 
 
 
 
Figure 4.13 Sulphathiazole α-dimer (fixed molecule) and a methanol molecule (mobile 
molecule) in three dimensional space  
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Cartesian spherical polar coordinates were used with translation steps defined by a translation 
magnitude, , and a unit vector defined by two spherical polar angles (, ) with  and  
being the angular intervals defining distribution of similar sized grid cells on the spherical 
surface. The new atomic co-ordinates of the mobile molecule after translation and rotation 
were calculated using Equation 4.4. 
ቌݔ௜′ݕ௜′ݖ௜′ቍ = �(ݔ௜ݕ௜ݖ௜) +  ��        (Equation 4.4) 
where, xi, yi, and zi are the atomic co-ordinates of the mobile solvent molecule at its starting 
location, xi’, yi’, and zi’ are the coordinates upon transformation; M is a rotation matrix (a 
function of x, y, and z); R is the position vector of the centre of coordinates of the mobile 
molecule, and  is a translation magnitude that is minimized with respect to the 
intermolecular-pair potential energy. For each translation direction, defined by the mobile 
molecule, the minimum separation distance between the centres of the fixed and mobile 
molecules was determined by van der Waals radii. The separation distance was then used as 
the starting point for a one dimensional minimization of the pair potential energy to 
determine the final location of the mobile molecule for a given orientation and direction of 
translation. 
 
The Dreiding force field (Mayo et al, 1990) and its parameters were used for the potential 
energy calculation. Atomic charges were calculated using the PM3 method within MOPAC 
(Dewar et al, 1985) function of Cerius2 for the single point energy task. The intermolecular 
potential energy was calculated from the Equation 4.5. 
 � = ∑ ∑ [(− ஺೔ೕ�೔ೕ6 + ஻೔ೕ�೔ೕభమ) + (− ஼೔ೕ�೔ೕభబ + ஽೔ೕ�೔ೕభమ) + �೔�೔஽.�೔ೕ]�ೕ௝=1�೔௜=1          (Equation 4.5) 
 
Where Aij, Bij, Cij, and Dij are Dreiding force field parameters for atoms i and j in the first and 
second molecules; gi and gj are atomic point charges; D is the dielectric parameters, and rij is 
the central distance between atoms i and j.  
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In this study, the step size of the polar angle, , was selected as 300, and the step size of the 
corresponding polar angle, , was calculated from the relationship  = /(sin), with 0 ° < 
 < 180 °0, which divided the whole spherical surface into grid cells of the same size. The 
step size for the three rotational angles was set at 30C with range of variation from 0° to 360°. 
The energy cut off value was chosen as –3 kcal/mol so any pairs (cluster between 
sulphathiazole dimer and solvent molecule) resulting in an intermolecular energy greater than 
this value were removed from the calculation.  
 
4.3.2 Evaluation of experimental method 
 
The systematic search approach samples the potential energy surfaces at a set of equivalent 
points and with equivalent levels of intensity for a given solvent molecule. Hence, for a given 
solvent molecule it is reasonable to compare directly the distributions of pair energies for 
interactions with the different sulphathiazole dimers.  An underlying assumption of the 
approach is that the configurations represented by grid-points in the search are, a priori, 
equally likely to be sampled by a given solvent molecule in a given solution environment. 
This seems a reasonable assumption given that we are modelling small, highly-mobile 
molecules. So if the grid points permit a representative sampling of possible interaction 
energies, then the systematic searches can indicate which dimer of sulphathiazole is solvated 
more effectively by a given solvent molecule. 
 
A further factor which should be noted is that given the grid points are evaluated sequentially, 
two configurations that are favourable in energy may be mutually exclusive due to 
overlapping positions of the solvent molecule but, nevertheless, are both counted in 
compiling the histogram of pair energies.  There are two approaches to this problem: firstly, 
the simple approach is to assume that the number of mutually exclusive pairs is on average 
the same. Secondly, systematic searches, taking as a starting point the most favourable pair 
configurations and then searching on a second solvent molecule, could be used to evaluate 
the validity of the simple hypothesis but at substantially increased computational expense.  
Another consideration is whether to include multiple conformations for the conformationally 
flexible solvent molecules.  To do so adds a further degree of freedom in the systematic 
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search for every torsion angle considered.  However, this is tractable given the use of 
multiple processors and modularisation of the searches. 
 
4.3.3 Results 
 
A total of 2300 molecular pair structures were identified for each calculation between the 
sulphathiazole dimer (α or β) and a solvent molecule. The energy distributions for each of 
these calculations are plotted in Figure 4.14. 
The numbers of pairs between a fixed dimer (α or β) and a mobile solvent molecule decrease 
with decreasing pair potential energy. This overall energy distribution is also presented in 
Table 4.8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14 Pair energy distributions for sulphathiazole dimers with alcohol 
molecules  
Key: energy distribution of α dimer with methanol, α dimer with ethanol, α dimer with 2-
propanol, α dimer with 1-propanol, α dimer with 1-butanol, β dimer with methanol, β dimer 
with ethanol, β dimer with 2-propanol, β dimer with 1-propanol, β dimer with 1-butanol 
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The 23000 pairs, obtained from each calculation, were ranked in terms of their minimized 
lattice energy requirement for the formation of the solvated pair. The top 50 energetically 
favourable pairs (lowest energy pairs) or in other words the energetically most favourable 50 
locations of a 1-butanol molecule to interact with the α dimer are shown in Figure 4.15. 
 
Table 4.6 Energy distribution of all the α and β dimer pairs with solvent molecule 
obtained by Grid based systematic search method. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15 Thermodynamically favourable Top 50 pairs of interaction between α 
dimer and 1 butanol  
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Thermodynamically, the lower energy configurations of α and β-clusters are more favourable. 
Therefore all the pairs of sulphathiazole dimer with a given solvent molecule within the 
energy range of -9 to -6 Kcal/mol were considered as lower energy pairs (Table 4.6).  
 
Within this lower energy range (-9 to -6 kcal/mol), a 1-butanol molecule made 1268 pairs of 
α-clusters with an α-dimer molecule; whereas, 1-butanol manifests only 72 pairs of the β-
clusters with a β-dimer molecule. Similarly, 1-propanol made 618 pairs of α-clusters with the 
α-dimer molecule compared to 105 pairs of β-clusters with β-dimer within this lower energy 
range. This result indicates that 1-butanol and 1-propanol can more effectively solvate the α-
cluster, which provides the route to the formation of α-dimer. This is consistent with the 
experimental observation that only metastable Form I, which is based on the packing of α-
dimers, nucleates, grows and remains stable in 1-propanol and 1-butanol solution, with no 
transformation to or nucleation of any other polymorphs observed. 
 
In the case of methanol, 39 pairs of β-clusters were observed between a β-dimer and a 
methanol molecule; whereas, only 4 pairs of α-clusters were observed between an α-dimer 
and a methanol molecule within the lower energy range of -9 to -6 kcal/mol. Similarly, for 
ethanol, 80 pairs of β clusters were observed compared to only 20 pairs of α-clusters between 
a dimer and ethanol molecule. This result indicates that methanol and ethanol can more 
effectively solvate the β-cluster, which provides the route to the formation of β-dimer. Again 
this is in agreement with the experimental observation that in these solvents, although the 
metastable Form I nucleates initially, one or more of the other Forms II to IV, which contain 
the β dimer as a basic unit, nucleates, grows, and is maintained in the solution, as Form I 
dissolves. 
 
Interestingly, when 2-propanol was used as a mobile solvent molecule in a GRID search, it 
showed a great tendency to form α clusters with α-dimer (560 pairs) over the formation of β-
clusters with β-dimer (94 pairs) within the overall lower energy range of -9 to -6 kcal/mol. 
However, as shown in table 4.8, between -9 to -8 kcal/mol, 2-propanol shows 1 pair of β-
cluster compare to 0 pair of α-cluster, which also indicate the tendency of 2-propanol to 
solvate β-clusters. These results indicate that 2-propanol can effectively solvate the α-cluster 
and β-cluster, which provides the route to the formation of α-dimer and β-dimer. 
Experimentally, it was observed that the metastable Form I nucleates initially and stayed in 
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solution for more than 24 hours whilst Form III, which contains the β-dimer as a basic unit, 
nucleates, grows, and is maintained in the solution, as Form I dissolves. Metastable Form I 
shows slow rate of transformation to Form III when 2-propanol was used as a solvent.  This is 
likely to be as a result of some other factor which inhibits nucleation of the β-dimer in 
comparison to ethanol and methanol. 
 
Overall, in most of the cases, it could be said that the systematic search study was able to 
predict successfully and explain the solvent’s ability to influence particular cluster formation 
(α or β) and hence the nucleation of a particular polymorph based on the chosen cluster 
within those solvents.  
 
4.4 Conclusion 
The thermodynamics of possible clustering of the solvent with the sulphathiazole molecules 
(dimers) prior to nucleation has been examined here in a molecular modelling study, which 
constituted a preliminary test using the Cerius2 suite and more detailed grid-based systematic 
search studies to determine whether there are thermodynamic differences in the interactions 
between the growth synthons that make up different structural patterns in the polymorphs. 
Both molecular modelling studies have successfully indicated that clustering between 1-
propanol (or 1-butanol) and α-type dimers of sulphathiazole, which lead to the nucleation of 
Form I, are energetically favoured compared to clusters between 1-propanol (or 1-butanol) 
and β-type dimers, which promote the nucleation of other polymorphs. 
Similarly, when short chain alcohols such as methanol, 2-propanol, and ethanol are modelled, 
the metastable α-dimer is not favoured thermodynamically, and thus consistent with the 
experimental observation that more stable polymorphs (Forms II, III, and IV) containing the 
β-dimer result from the crystallization. It was observed from experimental studies that 
methanol, ethanol, and 2-propanol also showed selection for a specific polymorph based on 
the β-dimer, i.e., Form II was crystallized from methanol, Form III was crystallized from 2-
propanol, and Form IV was crystallized from ethanol solution. Each of these forms has the β-
dimer as a basic unit; however, as explained in chapter 1, structural differences between them 
are subtle, relating to ring to ring contacts and contacts between the chains/sheets of β-
dimers. It is possible that specific solvent interactions stabilise chain to chain contacts of 
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hydrogen bonding specific to each polymorph, and may have a similar energetic basis to 
those presented here. 
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Chapter 5 Controlling the morphology of sulphathiazole Form I 
 
5.1 Introduction 
 
Crystal morphology is defined as the external shape a crystal adopts, and is an important 
characteristic as many physical properties of crystals are implicitly dependent on their 
shape. Particularly, particle morphology can have a great affect on filterability, 
flowability, porosity, compactibility, and cohesiveness of powder. Adverse effects on any 
of these properties due to changes in particle morphology, can have a major impact on the 
manufacturing ability to formulate particles into finished products. For example, needle-
shaped crystals display poor compaction behaviour and poor flowability compared to 
plate-shaped crystals. In addition, crystal morphology can also affect the performance 
characteristics of the drug product such as drug dissolution within the human body.  
  
The different growth rates of crystal faces are responsible for the final morphology of a 
crystal (see Section 1.8). From previous literature (Section 1.8), it is known that a 
solvent, additive or impurity molecule has the ability to interact and bind preferentially to 
certain crystal faces. The use of solvent or additive can provide the route to control or 
engineer nucleation and crystal growth processes from the molecular level to design the 
crystal with desirable morphology (Weissbuch, and Lahav, 2001). 
 
5.2 Control over the Morphology – Case of Sulphathiazole   
 
Sulphathiazole Form I has been observed as a sharp, pointed needle-like morphology in 
the current studies as well as previous work. Examination of the fastest growing face 
(010) of form I (Blagden, 2001) indicates that this surface exposes the acceptor imine 
nitrogen (N2), sulfoxide oxygen (O2) groups and the donor amino hydrogen (H2). 
Molecules in a sulphathiazole Form I crystal are linked via α dimers and then extended 
into sheets and layers via amino hydrogen and sulfato oxygen bonding. Presumably this 
extended structure, linked through the α dimer in the (010) face, is responsible for the 
sharp, pointed morphology. It is known from experimental results described in Chapter 3 
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(page 73 to 79) that crystallization using 1-propanol and 1-butanol resulted in needle-like 
Form I crystals; whereas, using shorter chain alcohols (methanol and ethanol) resulted in 
plates of more stable Forms II to IV. Hence in this study, the effect of different ratios of 
1-propanol with methanol (mixed solvent system) on crystal morphology and polymorph 
were investigated.   
 
5.3   Characterization of sulphathiazole crystals obtained from cooling 
crystallization 
 
Crystallization experiments of sulphathiazole by cooling were performed with different 
ratios of methanol and 1-propanol (mixed solvent system) as described in Section 2.2.2.1. 
Details of these experiments are listed in Table 2.4. 
 
Samples, obtained from cooling crystallization, were analyzed by optical microscopy, 
Powder X-ray diffraction, and Differential Scanning Calorimetry for morphological and 
polymorphic analysis. 
 
5.3.1   Morphological Analysis 
 
Morphologies were observed periodically under a microscope throughout the experiment 
in order to observe the nucleation, growth and polymorphic transformation of the 
crystals. These time resolved morphologies of crystals are shown in Figures 5.1 to 5.8. 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5.1 crystals obtained from  Figure 5.2 crystals obtained from 
crystallization in 100 % methanol  crystallization in 100 % 1-propanol 
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(a)                                           (b) 
Figure 5.3 Crystals obtained from 80:20 ratios of methanol and 1-propanol solution; 
(a) within 10 minutes of nucleation, and, (b) 1 hour after nucleation   
   
 
 
 
 
 
 
 
 
 
 
(a)                              (b) 
Figure 5.4 Crystals obtained from 60:40 ratios of methanol and 1-propanol solution; 
(a) within 10 minutes of nucleation, and, (b) 2 h after nucleation 
 
 
(a)                                              (b)                                                  (c)                                                               
Figure 5.5 Crystals obtained from 50:50 ratios of methanol and 1-propanol solution; 
(a) within 10 min of nucleation, (b) 1h after nulceation, and (c) 2 h after nucleation. 
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  (a)     (b)   
Figure 5.6 Crystals obtained from 40:60 ratios of methanol and 1-propanol solution; 
(a) within 10 min of nucleation, and (b) 1h after nucleation 
 
 
          (a)                                 (b) 
Figure 5.7 Crystals obtained from 20:80 ratios of methanol and 1-propanol solution; 
(a) within 10 min of nucleation, and (b) 1h after nucleation 
 
 
 
 
 
 
 
 
 
 
 
 
(a)                          (b) 
Figure 5.8  Crystals obtained from 10:90 ratios of methanol and 1-propanol 
solution; (a) within 10 min of nucleation, and (b) 1h after nucleation 
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It has already been established (See Chapter 3) that 1-propanol produces Form I crystals, 
which are the needle-like crystals as shown in Figure 1b and methanol produces 
hexagonal thick plates as shown in Figure 1a, which are identified as the more stable 
Form II (Section 3.3). 
 
When 80:20, 60:40, 50:50, or 40:60 ratio of methanol: 1-propanol was used as the 
crystallization solvent, small hexagonal plates and needles were observed within 10 
minutes of nucleation (Figure 5.3a, 5.4a, 5.5a, and 5.6a). The distribution of hexagonal 
plates and needles in these samples could be related to the percentage of methanol and 1-
propanol used in the crystallization solvent. From previous experiments it is known that 
methanol favors the crystallization of thick hexagonal Form II crystals; whereas 1-
propanol favors the crystallization of Form I needles. In case of 80:20 ratio (Figure 5.3a), 
the higher percentage of methanol (80 %) could be responsible for the dominant presence 
of hexagonal plates compared to a few needles due to the smaller percentage of 1-
propanol. The numbers of needles, at 10 minutes after nucleation, were increased with the 
increased ratio of 1-propanol in the crystallisation solvent (Figure 5.4a, 5.5a, and 5.6a). 
All samples observed 1-2 h after nucleation showed the disappearance of needles and 
presence only of hexagonal plates. This suggests that even 60 % 1-propanol was not able 
to stabilize kinetically the most metastable Form I for a long period and Form I needles 
were seen to transform into the thermodynamically more stable hexagonal plates (in 
accordance with Ostwald’s rule) due to the influence of methanol in the solution.  
 
When 20:80 methanol: 1-propanol was used as a solvent, mainly small, sharp needles 
were observed as shown in Figure 5.7a. Eventually, after 1h, elongated hexagonal plates 
were also observed with needles as shown in Figure 5.7b. The dominant presence of 1-
propanol in the solvent was able to stabilize many needles in the sample even after 1 h. 
However, 20 % methanol was also able to transform many of those needles, into 
elongated plates,. Hence the sample, even after one hour, showed the presence of both 
types of crystal and the conversion of needles into plates was slower compared to other 
samples. 
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When 1-propanol was doped with 10 % methanol, only small needles were observed and 
showed significant growth with time (Figure 5.8a and 5.8b). Form I needles were 
kinetically stable and the other forms (plates) were not observed over time (1 week). 
Additionally, the crystal habit of Form I needles was observed to be modified, being less 
elongated with well defined sides and end faces instead of the usual sharp needle-like 
morphology. 
 
5.3.2 PXRD Analysis 
 
Samples from cooling crystallisation (Table 2.4) were analysed by powder X-ray 
diffraction for polymorphic identification as described in Section 2.4.3. The PXRD 
patterns are shown in figures 5.9 to 5.16. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9 Powder –X-Ray pattern of sulphathiazole sample obtained from 100% 
methanol 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10 Powder –X-Ray pattern of sulphathiazole samples obtained from 
100% 1-propanol 
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Figure 5.11 Powder –X-Ray pattern of sulphathiazole samples obtained from 
80:20 ratios of methanol and 1-propanol 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12 Powder –X-Ray pattern of sulphathiazole samples obtained from 
60:40 ratios of methanol and 1-propanol  
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 5.13 Powder –X-Ray pattern of sulphathiazole samples obtained from 
50:50 ratios of methanol and 1-propanol    
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Figure 5.14 Powder –X-Ray pattern of sulphathiazole samples obtained from 
40:60 ratios of methanol and 1-propanol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15 Powder –X-Ray pattern of sulphathiazole samples obtained from 
20:80 ratios of methanol and 1-propanol     
  
  
  
             
 
 
 
 
 
 
  
 
 
 
Figure 5.16 Powder –X-Ray pattern of sulphathiazole samples obtained from 
10:90 ratios of methanol and 1-propanol      
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The sample obtained from 100 % 1-propanol solvent was identified as Form I by a peak 
at a 2 value of 11, which is a characteristic peak for Form I (Blagden et al, 1998a & 
Appearly et al, 1999). In addition, an intense peak at 21.9 in this sample also stands as 
one of the identification peaks for Form I (Appearly et al, 1999). Furthermore, PXRD 
patterns of this sample also showed an exact match with the PXRD pattern of Form I 
obtained from CCDC (Chapter 3, Section 3.2.2).  
 
Samples isolated from 100:00, 80:20, 60:40, 50:50 and 40:60 Methanol: 1-propanol did 
not show a peak at 2 value of 11 (Figure 5.11 to 5.14), so the possibility of the presence 
of polymorph I in these samples could be eliminated. By comparing the PXRD patterns 
of these samples with the reference patterns in Section 3.2.2, it was clear that these 
patterns contained most of the peaks which are found in reference PXRD patterns of 
Form II, III and IV. Therefore it is likely that sulphathiazole samples crystallized by 
cooling from the above solvent ratios may contain Form II, III or IV, or a mixture of 
these polymorphs. However from single crystal X-ray Diffraction studies, described in 
Section 3.4, it is known that 100% methanol produces Form II crystals of sulphathiazole. 
It is likely, therefore that the samples contain Form II. 
 
The sample isolated from a 20:80 ratio of methanol: 1-propanol solution showed a small 
peak at 2 value of 11 (Figure 5.15), which confirms the presence of Form I in the 
sample. The PXRD pattern of this sample also contains many of the peaks which are 
found in Form II, III and IV PXRD patterns. This confirms that the sample contains only 
a small quantity of Form I as well as other forms.   
 
The sample isolated from 10:90 ratio of methanol: 1-propanol solution showed an exact 
match with the PXRD pattern of Form I (Figure 5.16). The sample did not show any 
similarity with the PXRD patterns of Form II to IV, which suggests the absence of Forms 
II to IV in the sample. Hence, the sample was identified as pure Form I. 
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5.3.3 DSC Analysis 
 
In DSC analysis, the endothermic melting behaviour and transformation of polymorphic 
forms were observed. All the samples, obtained from experiments listed in Table 2.4, 
were scanned in a closed pan at 10 oCmin-1 as described in Section 2.4.3 (Chapter 2). 
 
Figure 5.17 DSC thermograph of sulphathiazole samples obtained from 100 % 1-
propanol (trace collected on a DSC7, Perkin Elmer, USA). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.18 DSC thermograph of sulphathiazole samples obtained from 100 % 
methanol (trace collected on a DSC7, Perkin Elmer, USA). 
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Figure 5.19 (a) 10:90 methanol: 1-propanol, (b) 20:80 methanol:1-propanol, (c) 
40:60 methanol:1-propanol, (d) 50:50 methanol:1-propanol, (e) 60:40 methanol: 1-
propanol, (f) 80:20 methanol: 1-propanol (Trace collected on a DSC1, Metler 
Toledo, Switzerland). 
 
Figure 5.17 and 5.18 represent the DSC scan of samples obtained from 100% 1-propanol 
and 100% methanol, respectively. The sample obtained from 100 % 1-propanol solution 
did not show any transformation prior to melting at 201 °C. This result perfectly matches 
with the reference scan of Form I described in Section 3.2.4 and hence this sample was 
identified as Form I.The sample from 100% methanol showed broad peaks between 140 
to 170 °C followed by final melting at 201 °C.  The boiling point of methanol is 68 °C 
(Green and Perry, 2007) and hence this broad peak between 140 to 170 °C is unlikely to 
be a solvent loss peak.  As reported in literature (Section 3.2.4), Forms II to IV show the 
transformation between 120 to 170 °C followed by final melting as Form I at 201 °C. 
However from single crystal X-ray Diffraction studies, described in Section 3.4, it is 
known that 100% methanol produces Form II crystals of sulphathiazole. It is likely, 
therefore that the samples contain Form II. 
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The sample crystallized from 90:10 1-propanol:methanol solution did not show any 
transformation or melting peak prior to the final melting of Form I at 201 °C (Figure 
5.19a). This confirms that this sample is Form I only and does not contain any other 
forms.  In comparison, the sample obtained from 20:80 methanol:1-propanol showed a 
small endothermic peak around 160 °C, likely to be due to transformation,  prior to final 
melting at 201 oC (Figure 5.19b). This suggests that this sample contains a mixture of 
Forms II, III or IV with Form I.  
 
As the percentage of methanol increased, the size of the transformation peak, prior to the 
final melting peak, increased (Figure 5.19 c to 5.19 f). These results coupled with PXRD 
results (Figures 5.11 to 5.14) suggest the predominance of Form II, III or IV, or a mixture 
of these forms in the samples.  
 
5.4 Discussion   
 
According to Cardew and Davey (1985) solvent mediated phase transformation goes 
through the dissolution of the metastable phase to form a solution supersaturated with 
more stable phase, followed by nucleation and subsequent growth of the more stable 
phase. Results from this study shows good agreement with Cardew and Davey’s 
description (1985) for solvent mediated phase transformation. When more than 10% 
methanol is present in 1-propanol, Form I dissolves in the solution at a faster rate due to 
increased solubility of Form I in mixed solvents. As the Form I dissolves (section 5.3.1), 
the solution becomes supersaturated with the more stable Forms II to IV and eventually 
shows the nucleation and growth of β-type clusters and thus more stable Forms (II to IV) 
which then dominate the samples. Whereas, less than 10% methanol in 1-propanol may 
not influence the solubility of Form I significantly and hence the Form I in 10% 
methanol: 90% 1-propanol solution stays stable for a long time without showing 
dissolution. As described in the results (Section 5.3.1), it is found that 10 % methanol in 
1-propanol worked as a habit modifying additive and tailored the sharp pointed needle 
face into a defined face (Figure 5.8), which is a more desirable shape. PXRD results also 
confirm that polymorph I has been maintained in both cases.  
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The observed end face in the modified crystals may arise from inhibition of growth at the 
fastest growing face [010] of Form I.  Examination, using ‘Mercury’, CCDC molecular 
modelling software (Macrae et al, 2006), showed in Figure 5.20 that this surface exposes 
the acceptor imine nitrogen (N2), sulfoxide oxygen (O2) groups, and the donor amino 
hydrogen (H2).  Sulphathiazole molecules are linked via α-dimers and then extended into 
sheets and layers via amino hydrogen and sulfato oxygen bonding.   
 
The presence of methanol molecules in solution at low concentration, may lead to direct 
absorption of methanol at this surface, blocking H-bonding sites with subsequent 
inhibition of growth.  Alternatively, -dimer clusters with methanol (Figure 4.10) may be 
present in low concentration, which act as direct growth synthons, joining to available 
crystal surfaces, and inhibiting growth. We know that when the concentration of 
methanol is increased, Form II is nucleatedimplying the presence of -dimers.  This 
modified habit clearly illustrates that the methanol interacts differently with the growing 
crystal than the main solvent, 1-propanol.  Figures 5.20 and 5.21 show the growth in the 
[010] direction (needle axis) with available sites for H-bonding visible.  The methanol 
molecule may dock into one of these sites, or facilitate -type interaction with another 
sulphathiazole molecule. 
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Figure 5.20 Visualisation showing molecular interactions along [010] direction of 
sulphathiazole Form I.   
Keys: - O, amino hydrogen; O, thiazole hydrogen; O, imine nitrogen; O, sulfoxide 
oxygen. 
              
Figure 5.21 Schematic showing  habit modification (by growth inhibition) of [010] 
face of Form I. 
 
5.5 Conclusion 
The different solvent interactions of solvents such as methanol, with the sulphathiazole 
molecule have been highlighted by the habit modifying effects of the additions of low 
concentrations of methanol to a 1-propanol crystallising solution.  It is likely that the 
methanol molecules will form β- type clusters with the sulphathiazole.  Since these are in 
very low concentration, Form I still nucleates and is kinetically stable.  However, in the 
same way that structural additives (Weissbuch et al, 1994) modify habit by interacting at 
the substrate-solvent interface in a different way to the main solvent, the presence of 
methanol has shown a habit modifying effect, which improves the morphology.  If the 
concentration of methanol becomes too high, then the -clusters dominate and Form II 
results. 
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Chapter 6  Crystallisation of Indomethacin polymorphs in presence of additives 
 
Crystallisation of materials with control over the size and morphology is an important aspect 
in the development of new materials in many fields including the pharmaceutical industry as 
they can affect both the production of effective and safe dosage form, and the biological 
behaviour of the finished form. 
 
The crystallization of indomethacin polymorphs has been previously investigated (Section 
1.12.1 and 1.12.5) and reported to exhibit an undesirable needle-like morphology. The work 
contained in this chapter focuses on morphological control of the α– Form of indomethacin 
using various organic solvents and additives. The effects of additives with a carboxylic acid 
group: adipic acid; myristic acid and oleic acid on the morphology of indomethacin have 
been investigated. The effect of a structurally related additive, 3-indoleacetic acid, on the 
morphology of indomethacin has also been investigated. Various organic solvents were 
selected for the crystallization of indomethacin. Crystal samples were characterised using 
optical microscopy and PXRD for morphological and polymorphic analysis. Details of 
experimental methods are described in Section 2.2 (Chapter 2). 
 
6.1 Solubility of indomethacin 
 
The solubility of indomethacin was determined at 60 °C in a range of organic solvents listed 
in Table 6.1. Amounts of indomethacin were added gradually into the solvent to determine its 
solubility, as described in Chapter 2. The solubility in various organic solvents are shown in 
Table 6.1. 
 
Table 6.1 Solubility data of indomethacin in various organic solvents 
 
 Solvents 
Solubility of 
Indomethacin at 60º C 
Solubility of 
Indomethacin at 25º C 
Ethanol 1.35 g/100 ml 0.67 g/100 ml 
Acetonitrile 1.42 g/100 ml 0.79 g/100 ml 
Ethyl acetate 1.44 g/100 ml 0.8 g/100 ml 
Aqueous Acetic acid  1.05 g/100 ml 0.58 g/100 ml 
Butanol 0.98g/100 ml 0.54 g/100 ml 
Acetone 1.20g/ 100 ml 0.58 g/100 ml 
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Solubility obtained at 60 °C was used to determine the amount of indomethacin to be added 
to obtain a saturated solution at 60 °C in the crystallization experiments. 
 
6.2 Crystallization of Indomethacin without additives 
 
Indomethacin was crystallized without additives from each of the solvents listed in Table 2.5 
by cooling crystallization as described in Section 2.2.2.1 (Chapter 2). In addition 
indomethacin was also crystallized without additives by liquid precipitation using ethanol as 
solvent and water as anti-solvent as described in Section 2.2.2.3. Samples, obtained from 
crystallization experiments, were analyzed using optical microscopy and powder X-ray 
diffraction to determine polymorphic identity.  
 
6.2.1 Morphological analysis of crystallized samples 
 
Samples were taken from each experiment and analysed under the optical microscope to 
observe the morphologies of crystals as shown in Figures 6.1 to 6.7.  
 
 
 
 
 
Figure 6.1 Sample obtained by cooling Figure 6.2 Sample obtained by cooling 
crystallization from ethanol   crystallization from acetonitrile 
 
 
As shown in above figures 6.1, 6.4, and 6.5, sample crystallized by cooling using ethanol, 
aqueous acetic acid, and n-butanol resulted in a similar fibrous, thin, needle-like morphology. 
In all cases, these needles were aggregated. Sample crystallized from ethanol by liquid 
(water) precipitation also showed fibrous, thin, needle-like morphology with increased 
aggregation as shown in figure 6.7. Aggregated fibrous needles were precipitated as soon as 
water was added drop wise to the ethanol solution due to solubility difference of 
60 µm 60 µm 
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indomethacin between water and ethanol. This kind of fibrous needle-like morphology is 
established in the literature as the morphology of α-Indomethacin (Section 1.12.5).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 Sample obtained by cooling   Figure 6.4 Sample obtained by cooling 
crystallization from Ethyl acetate   crystallization from aqueous acetic acid 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 Sample obtained by cooling   Figure 6.6 Sample obtained by cooling 
crystallization from butanol     crystallization from acetone 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7 Sample obtained from crystallization by liquid precipitation from ethanol 
 
 
 
60 µm 60 µm 
60 µm 60 µm 
60 µm 
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As shown in Figure 6.2, the sample crystallized from acetonitrile exhibited a more defined 
rectangular morphology. Kistenmacher et al (1972), Borka et al (1974), and Slavin et al 
(2002) reported similar morphology when indomethacin was crystallized from acetonitrile. 
Cooling crystallization from ethyl acetate (Figure 6.3) and aqueous acetic acid (Figure 6.6) 
showed irregular plate like morphologies, which are in agreement with Pakula et al (1977) 
and Slavin et al (2002). These rectangular and irregular plate-like morphologies are 
established in the literature (Section 1.12.5) as the morphology of γ-Indomethacin.  
 
6.2.3 PXRD analysis of crystallized samples 
 
Powder X-ray diffraction studies were carried out for polymorphic identification of samples. 
The results of the PXRD patterns were compared with previous PXRD studies for the 
identification of Indomethacin polymorphs. Imaizumi et al (1980), Kaneniwa et al (1985), 
Otsuka et al (1986a & 2000), Lin et al (1992 &1999), Andronis et al (1997), Okumura et al 
(2006), Wu and Yu (2006) and Masuda et al (2006) reported PXRD patterns of Indomethacin 
polymorphs. They reported unique identification peaks for α-Indomethacin at 2 value of 8.5 
and for γ-Indomethacin at 2 value of 11.6.  In addition, PXRD patterns of Indomethacin 
polymorphs (CCDC reference codes: INDMTH, INDMTH1) were obtained from the 
Cambridge Crystallographic Database and used as reference for polymorphic identification of 
samples (Kistenmacher and Marsh, 197; Chen et al, 2002). 
 
The powder diffraction data of each sample were collected using a Miniflex (Rigaku 
Corporation) laboratory powder x-ray diffractometer. The data were collected using a rotating 
flat plate sample holder over the 2 range 5 – 34 °2  in 5 ° steps at ambient conditions as 
described in Section 2.4.3. The PXRD patterns are shown in Figures 6.8 and 6.9.
166 
 
 
Figure 6.8 PXRD patterns obtained from recrystallized Indomethacin samples compared against reference pattern obtained from CCDC 
(Chen et al, 2002). 
Key: samples obtained from cooling crystallisation using ethanol, aqueous acetic acid, n-butanol, and by water precipitation using ethanol as a 
solvent. PXRD pattern of α-Indomethacin obtained from CCDC (reference code INDMTH1). 
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Figure 6.9 PXRD patterns obtained from recrystallized samples of Indomethacin compared against reference pattern obtained from CCDC 
(Kistenmacher and Marsh, 1972) 
Key: samples obtained from cooling crystallisation using acetonitrile, ethyl acetate, and acetone. PXRD pattern of γ-Indomethacin obtained from 
CCDC (reference code INDMTH). 
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A detailed comparison between experimental pattern, literature data and reference pattern 
obtained from CCDC was carried out to investigate the polymorphic identity of the 
indomethacin samples obtained from crystallization experiments. From comparison, it was 
clear to identify samples crystallized from ethanol, aqueous acetic acid, and n-butanol as 
predominantly α-Indomethacin (Figure 6.8). These samples were identified by a unique peak 
with a 2 value of 8.5, which is a characteristic peak for α-indomethacin (Lin et al, 1999; 
Kaneniwa et al, 1985; Andronis et al, 1997). Furthermore, PXRD patterns of these samples 
also showed an exact match with the PXRD pattern of α-indomethacin obtained from CCDC 
(Figure 6.8). Slavin et al (2002) and Chen et al (2002) identified sample as α-Indomethacin 
when crystallized by cooling or water precipitation using ethanol as a solvent. However, the 
sample crystallised from ethanol showed an additional small peak around 2 value of 13 
(Figure 6.8). This peak is present in the PXRD pattern of γ-indomethacin obtained from 
CCDC (Figure 6.9) and hence it suggests the small presence of γ-indomethacin in the sample. 
This evaluation of PXRD patterns leads to the conclusion that the sample crystallized from 
ethanol, aqueous acetic acid, and n-butanol were each predominantly α-indomethacin. 
 
PXRD patterns of samples crystallized from acetonitrile, ethyl acetate, and acetone (Figure 
6.9) displayed a peak at a 2θ value of 11.6, which is reported as a characteristic peak of γ (Lin 
et al, 1999; Kaneniwa et al, 1985; Andronis et al, 1997). In addition the PXRD pattern of 
these samples also showed an exact match with the PXRD pattern of γ-Indomethacin 
obtained from CCDC (CCDC reference code: INDMTH; Kistenmacher and Marsh, 1972) 
(Figure 6.9). Hence the samples crystallized from acetonitrile, ethyl acetate and acetone were 
identified as γ-idomethacin. Crystallization of γ-indomethacin from acetonitrile, ethyl acetate, 
and acetone is in agreement with Slavin et al (2002) and Pakula et al (1977).  
 
6.3 Selection of additives for indomethacin crystallization 
 
In the current project the focus is on controlling the fibrous needle-like morphology of α 
Indomethacin using additives. To understand the morphology it is necessary to study the 
crystal structure of α Indomethacin (Section 1.12.2). It is known from previous literature 
(Kistnemacher et al, 1972 and Chen et al, 2002) that the carboxylic acid functionality of the 
indomethacin molecule plays a significant role in the crystal structure of the α polymorph by 
forming a trimer in the asymmetric unit (Section 1.12.2). 
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The crystal structure of α-Indomethacin is reported in the CCDC (Cambridge 
Crystallographic Database) by Chen et al (2002). This crystal structure was viewed in 
Mercury (Macrae et al, 2006) and used to calculate morphology by BFDH (Bravais-Friedel 
Donnay-Harker) methodology (Bravais, 1866; Friedel, 1907; Donnay and Harker, 1937). 
This calculation predicted a needle-like morphology (Figure 6.10), which is a good match 
with morphology of α-indomethacin reported by Chen et al (2002) and the experimental 
morphology observed. Therefore this model was used to examine the crystal faces 
responsible for the long needle-like morphology. 
 
 Figure 6.10 Predicted morphology of α-indomethacin from the reported crystal structure 
(Chen et al, 2002) in CCDC using BFDH method of Mercury 2.1 
 
In α Indomethacin as shown in Figure 6.10 the carboxylic groups are important for the 
stacking of indomethacin molecules in the (-1 0 0) and (1 0 0) directions by forming 
hydrogen bonds. Therefore it was considered that additives with a carboxylic acid group 
would be able to form bonds with the carboxylic acid group of indomethacin to prevent 
further addition of indomethacin molecule on these faces and thus inhibit the growth along 
the needle axis. Therefore, myristic acid, adipic acid, and oleic acid (Figure 6.11) were 
selected as additives. In addition, the Sigma Aldrich catalogue was searched for a structurally 
similar related additive. From this search, 3-Indoleacetic acid (Figure 6.11) looked 
structurally very similar to Indomethacin molecule and therefore it was also selected as an 
additive for this project.   
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Figure 6.11 Molecular structure of additive molecules selected for Indomethacin 
crystallisation. 
 
The selected additive was used at 2 and 10%w/w concentration. Experimental methods for 
crystallisation of indomethacin with additive were performed according to method described 
in Section 2.2.2.1.  
 
6.3.1 Microscopic analysis of indomethacin samples crystallized using additives. 
 
Samples were taken from each experiment of indomethacin crystallisation with additives and 
analysed under the optical microscope to observe the morphologies of crystals as shown in 
Figures 6.12a to 6.15b.  
 
 
 
Indomethacin 
3-Indoleacetic acid 
Adipic acid 
Myristic acid 
Oleic acid 
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Figure 6.12a Sample from crystallisation using       Figure 6.12b Sample from crystallisation 
2% myristic acid as additive                       using 10 % myristic acid as additive 
 
Figure 6.13a Sample from crystallisation using       Figure 6.13b Sample from crystallisation 
2% adipic acid as additive                        using 10 % adipic acid as additive 
 
Figure 6.14a Sample from crystallisation using       Figure 6.14b Sample from crystallisation 
2% oleic acid as additive                        using 10 % oleic acid as additive 
60 µm 60 µm 
60 µm 60 µm 
60 µm 60 µm 
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Figure 6.15a Sample from crystallisation using       Figure 6.15b Sample from crystallisation 
2% 3-Indoleacetic acid as additive                      using 10 % 3-Indoleacetic acid as additive 
 
As shown in figures 6.12 to 6.15b samples crystallized by cooling using ethanol as a solvent 
in presence of selected additives resulted in needle-like morphology. However, differences 
were observed in the size and shape of needles with the use of additives. When 2% myristic 
acid, 10 % myristic acid, 2% adipic acid or 2% 3-indoleacetic acid used as additive, small 
and thin aggregated needles were produced (Figures 6.12a, 6.12b, 6.13a, and 6.15a). 
Whereas; in presence of 10% adipic acid, 2% oleic acid or 10% oleic acid as additives, 
bigger, thicker and less fibrous needles were observed (Figure 6.13b, 6.14a, and 6.14b). 
These needles were well defined but aggregations were still observed in all samples. When 
10% 3-indoleacetetic acid used as additive; thin, less aggregated and well defined needles 
were produced (Figure 6.15b). No literatures have reported the use of additives in 
crystallization process of α-indomethacin.  
 
From above results it is clear that presence of additive did not change the needle like 
morphology of α-indomethacin but less fibrous, well defined, and less aggregated needles 
were observed in presence of additives. These improvements in needle properties may 
improve the performance of downstream processes, such as, filtration, drying, and milling.   
 
 
 
 
 
 
60 µm 60 µm 
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6.3.2 PXRD Characterization of indomethacin samples crystallized using additives   
 
Powder X-ray diffraction studies were carried out for polymorphic identification of samples 
obtained from cooling crystallization with additives. The results of the PXRD patterns were 
compared with previous PXRD studies as before  
 
 
 
 
 
Figure 6.16 PXRD result of a sample crystallized with (a) 2% myristic acid as additive and 
(b) 10% myristic acid as additive (c) reference pattern of α-indomethacin obtained from 
CCDC 
 
Figure 6.17 PXRD result of a sample crystallized with (a) 2% adipic acid as additive and 
(b) 10% adipic acid as additive (c) reference pattern of α-indomethacin obtained from CCDC  
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Figure 6.18 PXRD result of a sample crystallized with (a) 2% oleic acid as additive and (b) 
10% oleic acid as additive (c) reference pattern of α-indomethacin obtained from CCDC  
 
 
Figure 6.19 PXRD result of a sample crystallized with (a) 2% 3-Indoleacetic acid as 
additive and (b) 10% 3-Indole-3-acetic acid as additive (c) reference pattern of α-
indomethacin obtained from CCDC 
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As shown in figure 6.16 to 6.19, PXRD patterns of all samples displayed a unique peak at a 
2 value of 8.5, which is a characteristic peak for α-indomethacin (Lin et al, 1999; Kaneniwa 
et al, 1985; Andronis et al, 1997). PXRD patterns of these samples also displayed good match 
with the reference PXRD pattern of the α-indomethacin obtained from CCDC. However, 
sample crystallised from ethanol using 10% myristic acid (Figure 6.16b), 2% adipic acid 
(Figure 6.17a), or 10% oleic acid (Figure 6.18a) as additive showed an additional peak 
around 2 value of 13, which can be attributed to the presence of y-indomethacin (see Figure 
6.9 for the reference PXRD pattern of γ-indomethacin). PXRD patterns of samples with 2% 
adipic acid, or 10% oleic acid also displayed increased intensity in peaks compare to peaks in 
pure α-indomethacin pattern between 2 values of 16 to 17. This could be due to either 
preferred orientations of samples in x-ray diffraction or small presence of γ-indomethacin in 
samples as the γ-indomethacin display intense peaks between 2 values of 16 to 17. 
   
From above investigation, it was clear to identify all samples, crystallized from ethanol using 
myristic acid, adipic acid, oleic acid, or 3-Indole-3-acetic acid as additive, as predominantly 
α-indomethacin with small presence of y-indomethacin in some cases. It was also observed 
that low (2%) or high (10%) doping of additives did not change the outcome of Indomethacin 
polymorph crystallized using ethanol as a solvent.  
 
6.4 Conclusion 
 
As shown in microscopic analysis, each sample crystallized as α-indomethacin with needle-
like morphology. The presence of any of the selected additives did not change the needle-like 
morphology of α-indomethacin when crystallized by cooling using ethanol as a solvent. 
However less fibrous, well defined, and/or less aggregated needles were observed in the 
presence of adipic acid, oleic acid, or 3-Indole-3-acetic acid. Whilst changing or improving 
the needle-like morphology of α-indomethacin using additives, the objective was also to 
maintain the polymorphic outcome of the crystallization process as α-indomethacin. PXRD 
results confirm that all samples, crystallized by cooing from ethanol with additives, were 
predominantly α-indomethacin.  
 
After studying crystal structure and crystal faces of α-indomethacin, It was proposed that 
additives with carboxylic acid functionality would have more propensity to form hydrogen 
bond with growing crystal of α-indomethacin at (1 0 0) or (-1 0 0) faces and prevent further 
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addition of indomethacin molecule on these faces to inhibit long thin needle-like 
morphology. However, experimental results suggest that additive did not change the needle-
like morphology of α-indomethacin and hence may have not displayed any association with 
the growing α-indomethacin crystal on (1 0 0) or (-1 0 0) faces.  
 
A number of reasons can be discussed to explain why additives did not modify the needle like 
morphology of α-Indomethacin. Driving force for the growth of α-indomethacin needles 
could be very strong and it would have been difficult for additives to overcome this force. It 
is possible that the additives may have associated with the fastest growing face of needles but 
the effect was not sufficient to produce and equidimensional morphology. Results showed 
less fibrous crystals when adipic acid, oleic acid, or 3-Indole-3-acetic acid used as additives, 
which indicated some inhibition of growth in (1 0 0) or (-1 0 0) faces. 
 
Also the interaction between one molecule of Indomethacin with another molecule of 
Indomethacin or interaction between one molecule of additive with another molecule of 
additive could be thermodynamically more favorable than the interaction between one 
molecule of Indomethacin with another molecule of a selected additive. If that is the case 
then interaction between Indomethacin and a selected additive is not preferred 
thermodynamically and hence both may crystallize independently as pure components.  
 
The solubility of the additive in ethanol can be also important during crystallization. During 
the experiment, when additive is added to the solution, it was observed that additives were 
readily soluble in ethanol. In the current study crystallization of Indomethacin was performed 
by cooling ethanol solution up to 20 °C. If ethanol solution is undersaturated for additive 
during crystallization of indomethacin then additive may stay in solution phase and hence 
will not associate with crystals of α-indomethacin during crystal growth process. 
 
For any future study detailed molecular modeling can be performed to investigate 
thermodynamically favorable interaction between Indomethacin and additive molecules. Also 
the solubility of additives should be checked at various temperatures to make sure that 
crystallization solvent does not stay undersaturated with additives. 
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Chapter 7 Discussion and future work 
 
As described in section 1.13, the current study focuses on understanding the role of solvents and 
additives on the polymorph selection and morphology of crystals. Sulphathiazole and 
Indomethacin were used as model active ingredients.  
 
7.1 Discussion: Sulphathiazole 
 
For Sulphathiazole, the aim of the project was to examine the effect of a range of alcohols on the 
crystallisation of sulphathiazole and attempt to understand the mechanism of alcohols in the 
polymorph selection process. Experimental results (Chapter 3) clearly showed that long chain 
alcohols (1-propanol and 1-butanol) stabilized the α-dimer based, metastable Form I and did not 
show transformation to the ȕ-dimer based, more stable Forms (II, III, and IV). Shorter chain 
alcohols methanol, ethanol and 2-propanol showed transformation of Form I into the more 
stable, ȕ-dimer based Forms II, III, and IV, respectively. It was also observed that doping of 1-
propanol with 10% methanol caused a habit modification of Form I (from needle to rod-shaped 
crystals) while maintaining the stabilization of Form I (Chapter 5). When 1-propanol was doped 
with more than 10% of methanol, Form I was transformed in to more stable, ȕ-dimer based 
Forms II to IV. This habit modification of Form I may arise from the inhibition of growth at 
fastest growing surfaces, [010] (Blagden N, 2001). It is likely that methanol molecules will form 
ȕ-type clusters with sulphathiazole at very low concentration and hence Form I will still nucleate 
and bekinetically stable. However, these ȕ-cluster with methanol molecules may interact [010] 
face differently and block the H-binding sites with subsequent inhibition of growth, which 
resulted in improved morphology. This modified habit of Form I illustrates that methanol 
interacts differently with the growing crystal of sulphathiazole than the longer chain alcohol 1-
propanol. 
 
These results also indicate that it is not only the alcohol functionality but also the steric effects of 
the alkyl chain which impacts upon the selection of polymorph. To understand the role of solvent 
on the polymorph selection process, the energy of the proposed clusters (α- and ȕ-dimer based 
pre-nucleation clusters in the presence of each of the solvents) was calculated using Cerius2 and 
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Mopac software packages, and more detailed calculations were performed via the grid-based 
systematic search approach (Chapter 4). 
 
From the molecular modelling of proposed clusters, it was clear that clustering between a longer 
chain alcohol molecule (1-propanol or 1-butanol) and α-type dimers of sulphathiazole, which 
lead to the nucleation of Form I, are energetically favored compared to the clusters of long chain 
alcohol (1-propanol or 1-butanol) molecule with ȕ-type dimer, which lead to the nucleation of 
stable Forms II to IV. Similarly, when short chain alcohols such as methanol, 2-propanol and 
ethanol were modeled, clustering with more stable ȕ-dimer was favored thermodynamically. 
Thus the molecular modelling results were in agreement with the experimental observation that 
long chain alcohols stabilised Form I; whereas, crystallization using short chain alcohol solvents 
resulted in the more stable Forms II to IV. The 1H NMR studies also indicated differences in the 
solution behavior between long chain alcohol solvent (1-butanol) that inhibit the formation of ȕ-
dimer based Forms (and favor the stabilization of α-dimer Form) and short chain alcohol 
solvents (methanol, ethanol) that favored ȕ-dimer based Forms (Section 3.6).  
 
These experimental and molecular modelling results clearly indicate that solvent plays an 
important role in the selection of polymorphs. Results also illustrate that the ability of the solvent 
to inhibit polymorphic transformation is linked to the energies of substrate-solvent interactions 
and shows that the clustering in the solution is thermodynamically controlled.  
 
7.1.1 Future Work: Sulphathiazole 
 
In this project, molecular modelling was limited to investigating thermodynamic differences 
between proposed α-dimer based clusters, which favored Form I, and proposed ȕ-dimer based 
clusters, which favored Form II to IV. 
 
It was observed from the experimental results that methanol, ethanol and 2-propanol select a 
specific polymorph, i.e., Form II from methanol, Form III from 2-propnaol, and Form IV from 
ethanol. Each of these forms has the ȕ-dimer as a basic unit and structural differences between 
them are related to ring to ring contacts and contacts between the sheets of ȕ-dimer rings 
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(Blagden et al, 1998). It is possible that specific solvent interactions may thermodynamically 
favor the ring structure specific to each polymorph and may have a similar energetic basis to 
those presented in this study. It will be interesting to perform further molecular modelling studies 
to calculate energies of pre-nucleation clusters, which are based on ring structures specific to 
Form II, III, and IV, in the presence of short chain alcohol solvent molecules. This work could 
help to understand the mechanism of polymorph selection for sulphathiazole when shorter chain 
alcohols are used as solvents.  
 
As discussed above, doping of 10% methanol in 1-propanol modified the morphology of Form I 
crystals from needle-like to rod-like shape. It is believed that methanol or ȕ-dimer clusters, 
favored by methanol, may have interacted on the fast growing faces [010] of Form I and resulted 
in improved rod-like morphology of Form I. These results also suggest that doping of a small 
concentration of a solvent can have a significant impact on the morphology of final crystals and 
may work like habit modifying additives. Further molecular modelling studies on sulphathiazole 
could be performed to understand this impact of solvent on the growing crystal. Future molecular 
modelling studies would include docking of each of the possible solvent molecules, 
sulphathiazole molecule, α-dimer and ȕ-dimer on the fastest growing surfaces of sulphathiazole 
polymorphs. Interaction energies of each of these molecules or dimers with the fastest growing 
faces of sulphathiazole polymorph can be calculated and rationalized using molecular modelling 
via the grid based systemic search approach (Hammond et al, 2006). The results would help to 
evaluate the impact of thermodynamically favorable interactions on final morphology and 
polymorphism. It would be also valuable to plan an experimental study to validate the results 
from such modelling. This methodology could then be applied to other industrially relevant 
active ingredients to choose better solvent systems to achieve improved morphology with desired 
polymorph.  
 
7.2 Discussion: Indomethacin 
 
As mentioned in Chapter 1 (section 1.12.1), Indomethacin is known to exhibit at least five 
polymorphs but only the stable Ȗ Form and metastable α Form are reported to be reliably 
produced by standard methods. The metastable α Form has an undesirable fibrous needle-like 
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morphology. The current study focused on producing crystals of α Indomethacin with a well-
defined morphology using additives.  
 
After studying the crystal structure and crystal faces of α-indomethacin in Mercury (section 6.3), 
it was believed that fastest growing faces [1 0 0] and [-1 0 0] are responsible for the thin, needle-
like morphology and additives with carboxylic acid functionality were identified as suitable 
candidates to interact at these faces. Adipic acid, myristic acid, oleic acid and 3-indoleacetic acid 
were selected as additives and their impact on the morphology and polymorphism of 
indomethacin were investigated in this study. 
 
However, experimental results from microscopy and PXRD suggest that additives did not 
significantly change the needle-like morphology of α-indomethacin but less fibrous and less 
aggregated needles were observed in presence of adipic acid, oleic acid and 3-indole-3-acetic 
acid.  
 
7.2.2 Future Work: Indomethacin 
 
As described above, additives selected in this study showed only limited success in modifying 
the morphology of α-indomethacin. Hence, in future a molecular modelling study it would be 
very helpful to investigate in more detail the action of the selected additives. For these additives 
to interact with indomethacin, interaction between additive molecules and indomethacin should 
be thermodynamically more favorable than the additive to additive and indomethacin to 
indomethacin interactions. Molecular modelling can be performed to calculate these interaction 
energies to provide explanation for the failure of additives used in current project. 
   
Detailed molecular modelling studies using grid based systematic search or Absorption Locator 
module of Material Studio should be performed to identify more suitable additives with 
thermodynamically favorable interaction with the growing faces of α indomethacin. Interaction 
energies of these additives can be ranked to shortlist best additives for experimental studies. 
Thereafter experimental studies should be planned to validate results from molecular modelling. 
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Alternatively, co-crystals of indomethacin can be also investigated in future to obtain crystal 
with desired physical properties. Molecular modelling (Musumeci et al, 2011) based on 
electrostatic potential of molecule surfaces can be applied to select suitable co-formers for co-
crystallisation. Experimental co-crystal screening work should be also performed to validate 
results from molecular modelling and investigate the physical properties of resulting co-crystals. 
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ABSTRACT: Sulfathiazole is a highly polymorphic model system exhibiting at least five polymorphic forms: I, II, III, IV, and V.
Polymorph stability is known to be susceptible to solvent environment, and it is established that 1-propanol stabilizes the most
metastable form I. This study examines the effect of a range of alcohols on polymorph selection and attempts to elucidate the
mechanism. The role of the alcohol functional group in the polymorph selection process is thus investigated and evaluated. Crystals
were characterized using optical microscopy, SEM, PXRD, DSC, IR, and single-crystal X-ray diffraction for their polymorphic
identity. The role of solvent in the stabilization of polymorphs was investigated by visualizing and calculating energy requirements
for the interaction of each solvent molecule with R- and â-dimers of sulfathiazole, using Cerius2 modeling software. This study
showed that solvent had a significant impact on polymorph selection. In common with 1-propanol, 1-butanol was found to stabilize
form I by inhibiting the formation of the â-dimer, which is necessary for nucleation of and transformation to forms II-IV. Shorter
chain alcohols and branched chain alcohols such as methanol, 2-propanol, and ethanol did not stabilize form I but stabilized forms
II, III, and IV, respectively, showing that it is not only the alcohol functionality but also the steric effects of the alkyl chain that
contributed to the effect. Sulfathiazole form I normally has a needlelike morphology. Form I with a modified rodlike morphology
was produced by crystallization from 1-propanol with the addition of methanol in low concentration, showing that it is possible to
control the morphology and selectively isolate polymorphs.
Introduction
Understanding the factors that control the nucleation of
polymorphic materials, which have the ability to exist in two
or more distinct crystalline phases,1 has made advances in the
past decade. The polymorph screening process now encompasses
high throughput methods2,3 and in silico prediction.4 Under-
standing of the supramolecular processes that take place when
polymorphic materials nucleate is expanding and can be applied
to a variety of systems to control the polymorphic outcome of
nucleation.5 This is of scientific and commercial importance,
as the well-known cases of Ritanovir6,7and Zantac8 illustrate.
Despite this, fundamental understanding remains incomplete
and, in many cases, system specific. Polymorphs can exhibit
different mechanical, thermal, and physical properties, such as
compressibility, melting point, solubility, and crystal habit,
which can have great influence on the bioavailability, filtration,
and tableting properties of pharmaceuticals.9
Sulfathiazole is a highly polymorphic system, which is used
to demonstrate the ability to isolate polymorphs with solvent.
Already the subject of extensive study, the sensitivity of this
material to solvent environment is well-established.10,11 Sul-
fathiazole, see Figure 1 for molecular structure, is known to
exhibit five polymorphic forms: I, II, III, IV, and V.11-16
Relative thermodynamic stabilities are generally accepted to
follow the order of the densities of the structure, i.e., III ≈ IV
> II > I, with form I being the most metastable at room
temperature.10,15 At higher temperatures, when analyzed by
DSC, form I does not show any transformation prior to melting
at 201 °C. On the other hand, forms II-IV show transformation
into form I at temperatures between 140 and 170 °C, prior to
melting as transformed form I at 201 °C17. The nature of the
structures has been described using a combination of graph set
analysis and hydrogen-bonding motifs because the differences
are subtle and require supramolecular treatment.10 There has
been some inconsistency in the literature regarding the naming
of the various forms; the numbering system used here follows
that described by the work of Blagden et al.10 (see Table 1). It
has been established that the polymorphic outcome of crystal-
lization of this material is influenced by the solvent10 and that
the most metastable polymorph, form I, can be selectively
stabilized by 1-propanol.10-12,18 In common with many meta-
stable forms, the morphology is elongated, a shape generally
considered to be undesirable. In this contribution, the mechanism
of selection of the metastable form by solvent is probed by
investigating the influence of a range of alcohols on the
polymorphic outcome of crystallization. The importance of
molecule-molecule interactions is evaluated by investigating
a series of solvents with the same functionality. In addition,
the nature of this mechanism is exploited to improve the particle
morphology of the isolated, metastable crystal form.
Background: Polymorphism and Crystal Chemistry
The structure of sulfathiazole and its polymorphs has been
the subject of investigation for almost 60 years.19 The differences
in the crystal chemistry, molecular arrangement, and structural
* Corresponding author. E-mail: m.parmar@2003.ljmu.ac.uk (M.M.P.);
L.Seton@ljmu.ac.uk (L.S.).
Figure 1. Molecular structure of sulfathiazole.
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motifs are responsible for the distinctiveness of the most meta-
stable form I and the similarities found within forms II-IV10,20
Form I contains a unique dimer, defined by graph set analysis
and referred to as R,10 consisting of two molecules that are
hydrogen-bonded via two imine nitrogen and amino hydrogen
contacts N2-H3 (see Figure 2a for atom labeling). These dimers
are linked in eight-member chains through the H1-O2 hydrogen
bonding. However, forms II, III, and IV are all based on a
common second level dimer, reported as â,10 which in all three
cases is constructed from a sulfato oxygen to aniline hydrogen
(O2-H1) contact and aniline nitrogen to amino hydrogen (N1s
H3) contact (see Figure 2b). According to Ostwald’s Rule of
Stages,21 form I is likely to form initially in all cases. Each of
the forms II, III, and IV contains the â-dimer and its presence
is necessary for the transformation into the more stable forms
II-IV. Thus, for form I to be kinetically stable, the formation
of the R-dimer in solution must be favored and the formation
of the â-dimer must be inhibited.
Experimental Section
Sulfathiazole was supplied by Sigma-Aldrich, UK. Five HPLC-grade
alcohols, namely, methanol, ethanol, 1-propanol, 2-propanol, and
1-butanol, were selected as solvents. Batch crystallization experiments
were conducted in thermostated, jacketed beakers. Samples were
obtained by dissolving sulfathiazole between 1 and 1.5 g in 100 mL of
solvent at 65 °C with stirring followed by cooling to 26 °C. Larger
single crystals were obtained from each solvent by slow evaporation.
In addition, sulfathiazole was crystallized from 1-propanol solutions
doped with methanol. Batch crystallizations were performed by slow
cooling from 1-propanol doped with 10, 20, and 40 v/v % methanol.
The morphology of the resulting samples was analyzed by optical
microscopy; polymorph identification was conducted by powder X-ray
diffraction (PXRD), infrared spectroscopy (IR), differential scanning
calorimetry (DSC), and single-crystal X-ray diffraction. The powder
diffraction data of each sample were collected using the Miniflex
(Rigaku Corporation) laboratory powder X-ray diffractometer. The data
were collected using a rotating flat-plate sample holder over the 2θ
range 5-45° in 5° steps at ambient conditions. Previous studies11,20
have reported that the spectra of forms II, III, and IV are similar and
suggest that is due to the structural and molecular similarities within
polymorphs II-IV. It is therefore not possible to differentiate between
these forms by PXRD (Figure 3). However, the pattern of form I (Figure
3) is distinguished by a peak at a 2θ value of 11°, which is characteristic
of form I,11,22-23 so it was possible to identify those samples that
contained form I. Similarly, it was possible to confirm the presence of
form I by DSC and IR, but not to positively identify the other three
polymorphs. To differentiate between the other forms, the unit cells of
three individual single crystals grown from each of the solvents were
collected by single-crystal X-ray diffraction. Using a Stoe IPDS area
detector, we calculated unit-cell constants by least-square refinement
using the setting angles of 25 reflections and compared them with
reference unit cell-data.10-16
Additionally, to attempt to understand the solution behavior, 1H
nuclear magnetic resonance (NMR) was performed on a Bruker Avance
300 MHz spectrometer operating via XWIN-NMR, version 3.5, and
locked using the deuterium signal from the deuterated methanol, ethanol,
and 1-butanol.
Results
All samples initially crystallized as elongated or needle
particles. This is established in the literature as the morphology
of form I and is predicted by Ostwald’s Rule to crystallize first.
Figure 2. (a) R-Dimer, basic unit of form I; (b) â-dimer, basic unit of forms II-IV.
Table 1. Comparison of Unit-Cell Dimensions Obtained from Single-Crystal X-ray Diffraction with Literature Values
current study literature values
unit cells
form I
(1-propanol & 1-butanol)
form II
(methanol)
form III
(2-propanol)
form IV
(water) form I10 form II11 form III10 form IV12
a (Å) 10.45 8.18 17.40 10.90 10.55 8.23 17.57 10.86
b (Å) 13.27 8.56 8.5 8.56 13.22 8.55 8.57 8.54
c (Å) 17.20 15.48 15.9 11.48 17.05 15.55 15.58 11.45
â (deg) 107 94.18 112 89.6 108.06 93.67 112.93 88.13
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When methanol or ethanol was the solvent, needles nucleated
initially followed by small hexagonal plates, which appeared
within 2 min of nucleation. The needle-shaped particles dis-
solved very quickly, within a few seconds of nucleation, and
the hexagons grew in size and thickness, resulting in a hexagonal
prism in the case of methanol (Figure 4a), and thin plates in
the case of ethanol (Figure 4b). This change in aspect ratio as
growth progressed could be a maturation effect or may indicate
polymorphic change as growth progressed. Once mature crystals
were obtained, there was no further change in the morphology.
Single-crystal XRD identified that crystals grown from methanol
were form II and those from ethanol were form IV (see Table
Figure 3. Powder X-ray patterns of sulfathiazole samples obtained from alcohols. Peak at 11° 2θ indicates the presence of form I.
Figure 4. Microscopic results of sulfathiazole sample crystallized from each solvent. Scale bar is 60 µm.
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1). PXRD of samples isolated immediately after nucleation
indicated that form I was present in the sample by the presence
of a peak at 11° 2θ. When mature samples were isolated, after
the dissolution of the needle shapes, this peak was not present
in the trace, indicating that any crystals of form I had
transformed into a more stable polymorph.
When 2-propanol was the solvent, sulfathiazole initially
nucleated as needles and very small square plates. The square
plates grew in size and the needles disappeared as shown in
Figure 4c. The rate of growth was slower than for those crystals
grown from the straight chain alcohols, with growth continuing
for 100 min after nucleation. There was no change to the
morphology during growth. Crystals were identified by XRD
as form III. As with samples grown from methanol and ethanol,
PXRD of early samples indicated the presence of form I,
whereas no form I peak was detected in mature samples.
For 1-propanol and 1-butanol, nucleation of needle-shaped
crystals was very prompt, within a minute of reaching temper-
ature, with maximum growth having occurred within 17-20
min of nucleation. No further growth was observed, and the
particles remained without transformation for the length of the
experiment (1 h) as shown in images d and e in Figure 4. No
platey or prismatic crystals were observed. PXRD, DSC, IR,
and single-crystal XRD confirmed that each of these samples
was form I. When 1-propanol was doped with methanol, it was
found that if there was 20% or more methanol in the solvent
mix, form I was not kinetically stable, but transformed to form
II. However, if the methanol was kept to 10%, then form I was
kinetically stable and other forms were not observed. Addition-
ally, the crystal habit was observed to be modified, being less
elongated with well-defined side and end faces (Figure 5).
PXRD confirmed that these modified crystals were the meta-
stable form I (Figure 6).
All experiments were repeated at three different concentra-
tions and temperatures to confirm that the selection of poly-
morphs is dependent on solvent composition rather than other
experimental variables. Changes in temperature and concentra-
tion did not affect the polymorphic outcome. Polymorph V was
not observed during this study.
The 1H NMR spectra obtained of sulfathaizole dissolved in
ethanol and methanol were similar (Figure 7). The peak
attributed to the thiazole hydrogen, H3 (see Figure 1), can be
seen at a chemical shift of 7.0, whereas in 1-butanol, this peak
is shifted slightly to 6.9, indicating a slightly more shielded
environment. This atom hydrogen bonds to N1 to form the
â-dimer and N2 to form the R-dimer. This suggests that there
are hydrogen-bonding differences in the solutions made from
different solvents
Molecular Modeling of Prenucleation Clusters. It is clear
from the results that 1-propanol and 1-butanol stabilized the
metastable form I and inhibited the transformation of form I
into more stable forms II-IV. To understand the polymorph
selection process, it is necessary to study the different structural
motifs present in the sulfathiazole forms. This has been done
using a combination of graph set analysis and hydrogen-bonding
motif.10
The form I structure contains the R-dimer only, and the other
polymorphs contain a mixture of R and â. The energy of
proposed clusters of sulfathiazole-based on R- and â-type
dimers, in the presence of each of the solvents was investigated
using Cerius224 and Mopac25 software packages. The sulfathia-
zole structures of each of the polymorphs were taken from the
Cambridge Crystallographic Database (CCD).26 The R- and
â-dimer pairs were taken from the structures of form I and form
II, respectively, and minimized energetically with Dreiding force
field,27 such that the integrity of the bonding was maintained
(structures a and b in Figure 8). Charges were generated using
PM3 method within Mopac for a single point energy task. The
R-dimer is formed by two hydrogen-bonding interactions
between molecules A and B, shown in Figure 8. The interaction
energy, E int (R-dimer), represents the energy released when
these bonds are formed. This energy was calculated using
MOPAC as shown by eq 1 and found to be -14 kcal/mol.
Similarly, the â-dimer is formed by two different hydrogen-
bonding interactions; the H3-N1 interaction in particular is
unique to the â-dimer pairing. Eint (â-dimer) was also calculated
and found to have a lower value of -22 kcal/mol.
Similarly
The value of Eint is lower for the â-dimer than for the R-dimer.
This indicates that the â-dimer is thermodynamically more stable
than the R-dimer, which is expected because we know that the
structures containing the â-dimer are thermodynamically more
stable than form I, which contains the R-dimer.
To try to model the influence of the solvent on the tendency
to form either R- or â-dimers and therefore influence polymorph
nucleation, we generated clusters based on either the R-structure
or the â-structure, with a solvent molecule inserted between
the dimer pairs (Figures 9 and 10). The location of the solvent
Figure 5. (a) Crystals growing in 100% 1-propanol; (b) modified
crystals in 90:10 1-propanol:methanol.
Eint (R-dimer) ) total energy of cluster -
energies of formation of molecules A & B (1)
Eint (R-dimer) ) 204.09 - 109.36 - 109.36 )
-14.87 kcal/mol
Eint (â-dimer) ) -22 kcal/mol
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molecule was determined from preliminary calculations where
the lowest energy position from ten proposed positions was
chosen as the preferred location of the solvent molecule. The
calculated energies of the ten positions are shown in Table 2,
with position 5 having the lowest energy value for the R-type
cluster, and position 8 for the â-type cluster. These were chosen
for the energy calculations as illustrated in Figures 9 and 10
with methanol being the solvent.
The energy of interaction of the solvated R-type cluster was
calculated in a similar manner using Mopac, according to eq 2.
For example, in the case of solvated R-cluster with methanol
in the lowest energy position 5 (Table 2), eq 2 gives
In the same way, the energy of interaction was calculated for a
â-cluster solvated with methanol and both calculations were
repeated for each solvent, the results of which are shown in
Table 3.
Discussion
When the solvating molecule was chosen to be methanol,
ethanol, or 2-propanol, the â-cluster was calculated to have a
Figure 6. (a) PXRD (100% 1-propanol); (b) PXRD (90:10 1-propanol:methanol).
Figure 7. H1 NMR of sulfathiazole (a) in 1-butanol, (b) in ethanol,
and (c) in methanol.
Figure 8. (a) Energetically minimized R-dimer, Eint ) -14 Kcal/mol;
(b) energetically minimized â-dimer, Eint ) -22 Kcal/mol.
Eint (methanol R-cluster) )
total energy of solvated cluster -
energies of formation of molecules A, B, & C (2)
Eint (methanol R-cluster) )
463.38 - 109.36 - 109.36 - 14.2 ) 230.46 kcal mol-1
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lower energy of interaction, indicating it to be more thermo-
dynamically stable than the R-cluster. This predicts that cluster-
ing similar to the â-dimer would be present in solution, and
provide a route to the nucleation of polymorphs based on the
â-dimer, namely II-IV. This is in agreement with the experi-
mental observation that in these solvents, although form I
nucleates initially, one or more of the other forms nucleates,
grows, and is maintained in solution, as form I dissolves. The
position is reversed for 1-propanol and 1-butanol. The interaction
energy of the â-cluster has a much higher value than the
R-cluster, suggesting that â-clusters would not form in solution,
and polymorphs containing the â-dimer would not be nucleated.
Again, this is in agreement with the experimental observation
that form I nucleates and remains stable in 1-propanol and
1-butanol solution, with no transformation or nucleation of any
other polymorphs. The H1 NMR studies (Figure 7) also indicate
differences in solution behavior between those solvents that
inhibit the formation of â-dimer and those that favor its
formation. Further NMR studies may reveal more information.
These preliminary calculations indicate that the ability of the
solvent to inhibit transformation may be linked to the energies
of substrate-solvent interactions and show that that clustering
in solution may be thermodynamically controlled. However, a
more detailed systematic search approach is currently being
undertaken that uses a grid-based search system28,29 of transla-
tions and rotations. This will be able to assess all of the possible
intermolecular packing arrangements between the sulfathiazole
dimer (fixed position) and solvent molecule (mobile position)
Figure 9. Solvated R-cluster, based on R-dimer and incorporating a
methanol molecule in the lowest energy position of those examined.
Figure 10. Solvated â-cluster, based on â-dimer and incorporating a
methanol molecule in the lowest energy position of those examined.
Figure 11. Visualization showing molecular interactions along the [010] direction of sulfathiazole form I. Keys: red O, amino hydrogen; blue O,
thiazole hydrogen; green O, imine nitrogen; pink O, sulfoxide oxygen.
Table 2. Calculated Eint at 10 Proposed Positions for Solvated r-
and â-Clusters with Methanol as Solvent
position
Eint of solvated R-cluster
(kcal mol-1)
Eint of solvated â-cluster
(kcal mol-1)
1 436.15 1096.3
2 1506.7 681.36
3 512.4 923.01
4 340.61 996.2
5 230.46 743.8
6 286.8 417.6
7 367.4 305.23
8 548.93 224.12
9 732.87 331.76
10 963.65 648.53
Table 3. Lowest Calculated Eint of Solvated Clusters for r- and
â-Dimers, Incorporating Each of the Solvents Examined
solvent
Eint of solvated R-cluster
(kcal mol-1)
Eint of solvated â-cluster
(kcal mol-1)
methanol 230.46 224.12
ethanol 251.70 237.86
2-propanol 357.09 331.71
1-propanol 236.13 419.91
1-butanol 190.94 361.81
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in direct space on the basis of atom-atom separation distance
and intermolecular potential pair energy.
It is observed that methanol, ethanol, and 2-propanol select
a specific polymorph, i.e., form II was grown from methanol,
form III from 2-propanol, and form IV from ethanol, and the
solvent dependence of polymorph generation is well-established
for sulfathiazole. Each of these forms has the â-dimer as a basic
unit; structural differences between them are subtle, relating to
ring-to-ring contacts and contacts between the sheets of â dimer
rings. It is possible that specific solvent interactions stabilize
other ring structures specific to each polymorph, as proposed
by Blagden et al.,10 and may have a similar energetic basis to
those presented here.
Doping of 1-propanol with 10% methanol caused a habit
modification while maintaining the stabilization of form I. The
observed end face in the modified crystals may arise from
inhibition of growth at the fastest growing face [010] of form
I.10,22 Examination showed that this surface exposes the acceptor
imine nitrogen (N2), sulfoxide oxygen (O2) groups, and the
donor amino hydrogen (H2). Sulfathiazole molecules are linked
via R-dimers and then extended into sheets and layers via amino
hydrogen and sulfato oxygen bonding.
The presence of methanol molecules in solution at low
concentration may lead to direct absorption of methanol at this
surface, blocking H-bonding sites with subsequent inhibition
of growth. Alternatively, methanol â-clusters may be present
in low concentration, which act as direct growth synthons,
joining to available crystal surfaces and inhibiting growth. We
know that when the concentration of methanol is increased, form
II is nucleated, implying the presence of â-dimers. This modified
habit clearly illustrates that the methanol interacts differently
with the growing crystal than the main solvent, 1-propanol.
Figure 11 shows the growth in the [010] direction (needle axis)
with available sites for H-bonding visible. The methanol
molecule may dock into one of these sites or facilitate â-type
interaction with another sulfathiazole molecule.
Conclusion
The study has confirmed that the most metastable form, form
I, is stabilized when crystals are grown from propanol and
1-butanol, whereas methanol, ethanol, and 2-propanol stabilized
the more stable forms II, III, and IV, respectively. In common
with many metastable forms, sulfathiazole form I displays an
elongated, needlelike morphology. The thermodynamics of
possible clustering of the solvent with the sulfathiazole molecule
prior to nucleation has been examined in a modeling study,
which constitutes a preliminary test to determine whether there
are thermodynamic differences in the interactions between the
growth synthons that make up the different structural patterns
in the polymorphs. This study has indicated that clustering
between 1-propanol (or 1-butanol) and R-type dimers of
sulfathiazole, which lead to form 1, are energetically favored
compared to clusters between propanol and â-type dimers, which
promote the nucleation of the other polymorphs.
Similarly, when short chain alcohols such as methanol,
2-propanol, and ethanol are modeled, the metastable R-dimer
is not favored thermodynamically, and thus more stable poly-
morphs containing the â-dimer result from the crystallization.
The different solvent interactions of solvents such as metha-
nol, with the sulfathiazole molecule have been highlighted by
the habit modifying effects of the additions of low concentrations
of methanol to a 1-propanol crystallizing solution. It is likely
that the methanol molecules will form â-type clusters with the
sulfathiazole. Because these are in very low concentration, form
I still nucleates and is kinetically stable. However, in the same
way that structural additives30 modify habit by interacting at
the substrate-solvent interface in a different way from the main
solvent, the presence of methanol has shown a habit modifying
effect, which improves the morphology. If the concentration of
methanol becomes too high, then the â-clusters dominate and
form II results.
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